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Abstract 
 
 
 
Anthocyanins are polyphenolic plant pigments that are responsible for much of the 
attractive colour displays found in many flowers, fruit and vegetables. Anthocyanins are 
divided into different classes based on the number of hydroxyl groups on their phenyl 
B-ring and subsequent side chain modifications. 
 
It has been shown in our laboratory that the introduction of the regulatory genes Delila 
and Rosea1 activates the biosynthetic pathway leading to accumulation of 
trihydroxylated anthocyanins in tomatoes. Tomato DFR substrate specificity for 
trihydroxylated precursors prevents the formation of other anthocyanin classes. By 
inhibiting the activity of F3’5’H, blocking biosynthesis of trihydroxylated anthocyanins, 
and introducing a non-specific DFR from A. majus, I developed two transgenic tomato 
lines that produced mono- and dihydroxylated anthocyanins. My work demonstrated 
that tomatoes could be enriched with different classes of anthocyanins using a metabolic 
engineering approach.  
 
Dietary consumption of plant secondary metabolites such as anthocyanins and other 
polyphenols are linked to a reduced risk of developing chronic, non-communicable 
diseases such as cancer, type 2 diabetes and cardiovascular diseases. High-anthocyanin 
tomato extracts induced cell death, cell cycle alteration and apoptosis in the human 
breast cancer cell lines, MCF-7 and MDA-MB-231, whilst WT tomato extracts exerted 
no biological effects. Purified anthocyanins and polyphenolic compounds had no or 
little effect on the metabolic status of breast cancer cells, suggesting that anthocyanins 
exert their biological effects in synergy with other components in the food matrix. 
 
Polyphenolic compounds may act as chemosensitizers for the treatment of tumours with 
chemotherapeutic agents. Co-treatment of breast cancer cells with the chemotherapeutic 
agents, doxorubicin or roscovitine, and high-anthocyanin or -resveratrol tomato extracts 
showed that dietary polyphenols might potentiate the effects of pharmacological agents 
in vitro.  
 
This work demonstrated that the health benefits of dietary plants can be significantly 
improved through nutritional enrichment with plant bioactives using metabolic 
engineerin
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1 General Introduction 
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1.1 Plant secondary metabolism 
Plants synthesise a vast range of organic molecules that have been traditionally 
classified as primary or “essential” and secondary metabolites. Primary metabolites are 
associated with the survival and reproduction of the plant and have essential roles in 
photosynthesis, respiration, growth and development. The other group of metabolites, 
many of which accumulate in high amounts in some species, have been referred to 
historically as non-essential or secondary metabolites. Initially associated with 
inessentiality, Williams (1989) summarized some of the historic views regarding the 
purpose of secondary metabolites as “waste or detoxification products”, “a reservoir of 
non-functional variety out of which new functional processes can emerge” or “designed 
to permit a network of enzymes that is operative in primary metabolism”. However, it is 
now recognized that many of these compounds are involved in crucial plant metabolic 
pathways such as lignin biosynthesis, while others play important roles in plant 
chemical defence mechanisms or act as signalling molecules to attract pollinators and 
seed-dispersing animals. Secondary metabolites are important for the plant’s survival 
and fitness and represent adaptive traits that were subjected to natural selection and 
evolution. 
 
Interest and understanding of secondary metabolism in plants has grown steadily, and 
tens of thousands of structurally different compounds have been identified so far. 
Despite their structural diversity, secondary plant metabolites can be divided into three, 
large families: phenolics, terpenes, and alkaloids, of which the phenolics are the most 
widespread family o metabolites. 
 
Phenolic compounds are ubiquitous in plants and are characterized by their 
hydroxylated aromatic ring(s). Several thousand phenolic structures have been 
identified so far, ranging from low molecular weight, single aromatic-ringed 
compounds, to highly complex tannins and polyphenols. Phenolics are classified 
according to the number and arrangement of their carbon atoms that are usually 
decorated with sugars and organic acids, and are divided into two groups: the flavonoids 
and the non-flavonoids. 
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Table 1i: Phenolic compound classification. 
 
Compound family Basic carbon skeleton 
simple phenols, benzoquinones C6 
phenolic acids and aldehydes C6–C1 
acetophenones, phenylacetic acids C6–C2 
hydroxycinnamic acids, coumarins, phenylpropanes, 
chromones 
C6–C3 
Naphthoquinones C6–C4 
Xanthones C6–C1–C6 
stilbenes, anthraquinones C6–C2–C6 
flavonoids, isoflavonoids, neoflavonoids C6–C3–C6 
bi-, triflavonoids, proanthocyanidin dimers, trimmers (C6–C3–C6)2,3 
lignans, neolignans (C6–C3)2 
Lignins (C6–C3)n 
catechol melanins, phlorotannins (C6)n 
condensed tannins (C6–C3–C6)n 
 
 
1.2 Flavonoid Pathway 
The flavonoids are a diverse group of aromatic molecules that are derived from p-
coumaroyl coenzyme A (CoA) and malonyl-CoA. Flavonoids comprise fifteen carbons, 
with two aromatic rings connected by a three-carbon bridge (C6-C3-C6). This large 
group includes seven major subclasses, of which six (chalcones, flavones, flavonols, 
flavandiols, anthocyanins, and condensed tannins) are commonly found in higher plants. 
The aurones form the seventh group and are widespread but not ubiquitous in higher 
plants. Flavonoids serve as UV protectants, signal molecules in plant-microbe 
interactions and antibiotics in plant defences responses as well as attractants for 
pollinators and seed dispersers. Many of the striking colours observed in fruits, flowers 
and other plant organs can be attributed to the presence of various flavonoids.  
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Flavonoids are synthesised through the concerted, sequential action of several structural 
genes encoding enzymes catalysing the biosynthetic steps in the flavonoid pathway 
(Martin and Gerats, 1993). The pathway is well understood and conserved among seed 
plants. All flavonoids are produced from malonyl-CoA and 4-coumaroyl CoA, which is 
derived from the amino acid, phenylalanine. The molecule 4-coumaroyl CoA, is formed 
through three enzymatic conversions collectively known as general phenylpropanoid 
metabolism catalysed by phenylalanine ammonia-lyase (PAL), cinnamate 4-
hydroxylase (C4H), and 4-coumarate:CoA ligase (4CL; Davies and Schwinn, 2006). 
The first committed step in flavonoid biosynthesis is the formation of naringenin 
chalcone catalyzed by chalcone synthase (CHS) which condenses one molecule of 4-
coumaroyl CoA and three molecules of malonyl CoA (Figure 1.1). Naringenin chalcone 
is required for the synthesis of flavones, flavonols and anthocyanins but not stilbenes. 
Stilbenes such as resveratrol are formed from 4-coumaroyl CoA and malonyl CoA via 
the action of stilbene synthase, an enzyme which is structurally related to CHS. 
Naringenin chalcone is rapidly isomerized into the colourless flavanone, naringenin, by 
the enzyme chalcone isomerase (CHI), although this isomerisation can also occur 
spontaneously. Naringenin is a major branch point in flavonoid biosynthesis: Isoflavone 
synthase (IFS) directs biosynthesis towards isoflavonoid production, and flavanone 3-
hydroxylase (F3H), a 2-oxoglutarate-dependent dioxygenase (OGD), hydroxylates 
naringenin at the 3-position yielding dihydrokaempferol (DHK), a dihydroflavonol. 
Using DHK as a substrate two cytochrome P450 enzymes, flavonoid-3’-hydroxylase 
(F3’H) and flavonoid-3’5’-hydroxylase (F3’5’H), catalyse the hydroxylation of DHK to 
form dihydroquercetin (DHQ) and dihydromyricetin (DHM), respectively. F3’H and 
F3’5’H are key enzymes in determining the structure of anthocyanins and thus their 
colour. They modify the hydroxylation pattern of the B-ring and play key roles in the 
formation of cyanidin and delphinidin, respectively.  
 
The dihydroflavonols DHK, DHQ and DHM serve as precursors for the formation of 
the three flavonols, kaempferol, quercetin and myricetin, respectively, through the 
action of flavonol synthase (FLS). FLS is not required for production of anthocyanin 
pigments but competes with F3’5’H, F3’H and DFR for common dihydroflavonol 
substrates and may influence anthocyanin synthesis (de Jong et al., 2004, Luo et al., 
2008). Further downstream, dihydroflavonol 4-reductase (DFR) reduces kaempferol, 
quercetin and myricetin to their corresponding leucoanthocyanidins. 
4 
 
Leucoanthocyanidins are substrates for anthocyanidin synthase (ANS), another member 
of the OGD family that catalyses the synthesis of the corresponding coloured 
anthocyanidins, pelargonidin (Pg), cyanidin (Cy) and delphinidin (Dp; Tanaka et al., 
2008).  
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Figure 1.1: Schematic representation of the phenylpropanoid pathway leading to anthocyanin 
biosynthesis. PAL, phenylalanine ammonia lyase; 4CL, 4-coumarate:coenzyme A ligase; C4H, 
cinnamate 4-hydroxylase; C3H, 4-coumarate 3-hydroxylase; IFS, isoflavone synthase; IFH, 
isoflavone hydroxylase; IFR, isoflavone reductase; STS, stilbene synthase; CHS, chalcone 
synthase; CHI, chalcone isomerase; F3H, flavanone-3-hydroxylase; F3'H, flavonoid-3'-
hydroxylase; F3'5'H, flavonoid-3'5'-hydroxylase; FLS, flavonol synthase; DFR, dihydroflavonol 
reductase; LCR, leucoanthocyanidin reductase; ANS, anthocyanidin synthase; 3-GT, flavonoid 
3-O-glucosyltransferase; RT, flavonoid 3-O-glucoside-rhamnosyltransferase AAC, anthocyanin 
acyltransferase; 5-GT, flavonoid-5-glucosyltransferase; GST, glutathione S-transferase. 
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Within the family Solanaceae, which included the crop species, tomato and potato, one 
biosynthetic enzyme in the main flavonoid pathway, DFR, shows substrate specificity 
for DHM and, less effectively, for DHQ but cannot accept DHK as a substrate. Petunia 
hybrida is one of the classical model plant species in which the flavonoid pathway and 
anthocyanin biosynthesis in particular, has been thoroughly analysed. In Petunia, both 
delphinidin- and cyanidin-derivatives are formed, but no pelargonidin pigments are 
produced. This is a consequence of the substrate specificity of the Petunia DFR, which 
cannot reduce the pelargonidin precursor molecule DHK (Meyer et al., 1987). Meyer 
and colleagues showed that by transforming Petunia with a DFR gene from maize (Zea 
Mays), which does not have the same strict substrate specificity as the Petunia DFR, 
pelargonidin-type pigments could be produced in Petunia. DFR catalyses the 
conversion of dihydroquercetin into leucocyanidin that can then be further processed 
into pelargonidin-3-glucosides. Johnson and collaborators (2001a) further investigated 
the substrate specificity of DFR and identified a 26 amino acid region in the Gerbera 
dfr gene. This was highly variable between different species and likely to determine 
substrate specificity. Petunia and Gerbera DFR cannot convert DHK but a site-directed 
mutation of asparagine 134 to leucine enabled Gerbera DFR to accept DHK as 
substrate, suggesting a crucial role of this amino acid in DFR substrate specificity. The 
DFR from Antirrhinum majus (A. majus) can convert DHK to leucopelargonidin as 
evidenced by the production of pink pelargonidin in the eos mutant of A. majus (eos 
encodes F3’H). 
 
In tomato, naringenin chalcone, rutin and kaempferol-3-O-rutinoside are the main 
flavonoids and predominantly accumulate in the peel of the fruit. Transcripts of chs, f3h 
and fls, encoding flavonol biosynthetic enzymes, have been detected in tomato peel. In 
contrast, chi transcript levels are below the levels of detection resulting in the 
accumulation of the CHI substrate, naringenin chalcone. Flavonoids are virtually absent 
from the flesh tissue, suggesting that the flavonoid biosynthetic pathway is active only 
in tomato peel tissue Muir et al. (2001). 
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1.3 Anthocyanins 
Anthocyanins are members of the large group of secondary plant metabolites known as 
flavonoids. Their name is derived from the Greek; anthos (flower) and kyanos (blue)  
based on the blue colour of the corn flower from which they were first isolated 
(Willstätter and Everest, 1913). They are widespread plant pigments found in most fruit, 
vegetables and flowers as well as other plant organs. Anthocyanins are responsible for 
most of the orange-to-blue coloration in pigmented plant tissues. They are thought to act 
primarily as attractants to pollinators and seed dispersing animals. In addition, 
anthocyanins are often produced in stem and leaf tissues of young seedlings and some 
mature plants, indicating a possible role as protectants from UV light, oxidative stress 
and other environmental stresses (Kubasek et al., 1992). More than 600 naturally 
occurring anthocyanins have been reported so far, with more structural variants likely to 
be discovered (Andersen and Jordheim, 2006). Despite their extraordinary variety, just 
six types of anthocyanins, delphinidin (Dp), cyanidin (Cy), pelargonidin (Pl), peonidin 
(Pe), petunidin (Pt) and malvidin (Mv), account for most of the total anthocyanin 
production in plants (Figure 1.2). Glycosides of the non-methylated anthocyanidins Dp, 
Cy and Pg are the most ubiquitously synthesised variants and are found in 80% of 
pigmented leaves, 69% of fruits and 50% of flowers (Kong et al., 2003). Modification 
of the anthocyanins occurs by glycosylation or acylation with the latter resulting in a 
blue shift and stabilisation of the compounds in solution. Glycosylation leads to a 
reddening effect (Tanaka et al., 2008).  
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Figure 1.2: Chemical structure of anthocyanin aglycones. Anthocyanins differ structurally in 
their substitutions on the phenyl B-ring and can be further modified by the attachment of sugar 
residues that may involve acylation with aromatic acids including p-coumaric, caffeic, ferulic, 
sinapic, gallic or p-hydroxybenzoic acids, and/or aliphatic acids such as malonic, acetic, malic, 
succinic or oxalic acids. These acyl substitutions are commonly, but not exclusively, bound to 
the C3 sugar. 
 
 
Anthocyanins are polar, water soluble glycosides and acyloglycosides that are mainly 
stored in the vacuoles in the epidermal tissues of flowers and fruits as well as in stems 
and leaves. Due to their long 2-phenylbenzopyrylium (flavylium) chromophore of eight 
conjugated double bonds carrying a positive charge, they are strongly coloured under 
acidic conditions, where they behave like pH indicators, being red at low pH, blue at 
intermediate pH and colourless at high pH (Mazza and Miniati, 1993). In acidic, 
aqueous solutions, four anthocyanin species exist in equilibrium: the red coloured 
flavylium cation AH
+
, the blue quinoidal base, as well as the colourless carbinol 
pseudobase and the chalcone (Mazza and Brouillard, 1987, Brouillard and Delaporte, 
1977). 
 
 
1.3.1 Biosynthesis and chemistry  
 
1.3.1.1 Anthocyanin aglycones 
All anthocyanin aglycones, also known as anthocyanidins, share a common structure 
consisting of a C-6 (A ring)-C-3 (C ring)-C-6 (B ring) carbon skeleton (Figure 1.2). 
Anthocyanidin
s 
 
Pelargonidin R1 = R2 = H 
Cyanidin R1 = OH, R2 = H 
Delphinidin R1 = R2 = OH 
Peonidin R1 OCH3, R2 = H 
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Depending on the hydroxylation and/or methylation pattern on different positions on the 
A-ring, and the B-ring in particular, 23 naturally occurring anthocyanidins have been 
identified so far in higher plants (Tanaka et al., 2008, Andersen and Jordheim, 2006). 
The variation in colouring between the aglycones is due to differences in the 
hydroxylation pattern on the B ring: An increase in the number of hydroxyl groups 
causes a shift in the visible absorption maximum to longer wavelengths, leading to a 
colour change from orange to blue (Mazza and Miniati, 1993). Pg is hydroxylated only 
in the 4'-position of the B-ring and responsible for orange, salmon, pink and red colours. 
Cy has hydroxyl groups in the 3'- and 4'-positions providing most magenta and crimson 
flower colours. Hydroxylation of the Dp molecule occurs at positions 3', 4', and 5' 
positions giving rise to most purple and blue colours (Forkmann, 1991).  
 
1.3.1.2 Glycosylation and acylation 
The extraordinary variation within the anthocyanins results from the substitution of 
hydroxyl groups by sugar moieties. The nature, number and position of decorating sugar 
moieties, as well as the acylation patterns, define each of the individual compounds. 
Glucose, galactose, rhamnose and rabinose and their di- and trisaccharides are the 
sugars most commonly bound to anthocyanidins. Glycosylation of the C3 hydroxyl 
group is essential for the stability of anthocyanins in solution (Mazza and Brouillard, 
1987). Acyl substituents, such as aromatic acids, including p-coumaric, caffeic, ferulic, 
sinapic, gallic or p-hydroxybenzoic acids, and/or aliphatic acids such as malonic, acetic, 
malic, succinic or oxalic acids are often bound to the C3 sugar. Such modifications 
affect the physical and chemical properties of the molecule by altering its size and 
polarity.  
 
Anthocyanin aglycones are very unstable compared to their glycosides. Glycosylation 
improves the stability of anthocyanins through a network of intramolecular H-bonds 
within the anthocyanin molecule (Borkowski et al., 2005). Hydroxylation at the C5 
position and substitution at the C3 position stabilize the coloured form by protecting the 
anthocyanin molecule from hydration and subsequent structural transformation into the 
colourless forms (Mazza and Miniati, 1993). Anthocyanins differ from each other in the 
number and position of their hydroxyl and/or methoxy groups. Any modifications to the 
latter can have a marked effect on the colour intensity of the anthocyanins. 
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The nature and intensity of colouring depends on pigment concentration and also 
physicochemical conditions, such as pH, temperature and co-pigmentation. The stability 
of anthocyanins in solution at a given pH may vary significantly between different 
anthocyanins but the majority of compounds are most intensely coloured under acidic 
conditions. At very low pH, the red flavylium cation is generally the dominant structure. 
With increasing pH, its concentration decreases in favour of the blue quinoidal base. As 
the pH exceeds 5, hydration of the coloured structures leads to the rapid formation of 
the colourless pseudobase and chalcone species (Castañeda-Ovando et al., 2009, Mazza 
and Brouillard, 1987).  
 
1.3.1.3 Co-pigmentation 
Together with pH, co-pigmentation is the most important factor in determining 
anthocyanin colouration. Since its discovery in 1931 by Robinson and Robinson (1931), 
this phenomenon has been extensively studied and has helped to elucidate the structural 
transformations that anthocyanins undergo in solution. Complexation of the co-
pigmentation molecule and the flavylium cation prevents hydration of the anthocyanin 
molecule and offers protection to the flavylium ring against water attack. Complex 
formation competes directly with the formation of pseudobases. Most natural 
anthocyanins form co-pigmentation complexes under suitable conditions and many 
different kinds of co-pigmentation molecules, including flavonoids, metals, amino 
acids, polysaccharides or even other anthocyanins, have now been identified 
(Brouillard, 1988). Co-pigmentation co-factors are generally colourless but upon 
interaction with the anthocyanin, they produce higher absorbance values (a 
hyperchromic shift) resulting in an intensification of colouring. Certain pigments may 
also give a bathochromic shift in the absorption maximum and a blueing of the colour 
(Boulton, 2001).  
 
1.3.2 Regulation of anthocyanin biosynthesis 
Anthocyanin biosynthesis is induced by transcription factors that regulate the 
expression of the structural genes involved in flavonol biosynthesis. Transcriptional 
regulation involves three families of proteins that are characterized by their MYB 
domains, basic helix-loop-helix (bHLH) domains and WD40 repeats (WDR). 
Regulation of biosynthetic genes late in the biosynthetic pathway leading to the 
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formation of anthocyanins and condensed tannins is orchestrated by a tertiary MYB-
bHLH-WD40 (MBW) complex involving members of all three regulator families. Plant 
MYB proteins were first identified in 1987 and are the largest family of transcriptional 
regulators that are characterized by having either one (R1), two (R2 and R3) or three 
(R1, R2, R3) imperfect repeats of the MYB DNA-binding domain (Martin and Paz-
Ares, 1997) that bind to specific cis-elements in the DNA, called MYB-binding sites. 
R2R3-MYB proteins are the most common MYB protein members in plants and are 
involved in the regulation of flavonoid biosynthesis. Different R2R3-MYB regulators 
control separate branches in the pathway leading to the formation of different 
flavonoids. MYB proteins often interact with a 200 amino acid sequence on the N-
terminal side of bHLH proteins to alter gene expression. The bHLH proteins are 
characterized by two α-helices that are involved in DNA-binding which are separated 
by a loop. The loop is responsible for the three-dimensional conformation and stability 
of the protein and increases DNA recognition specificity (Nair and Burley, 2000, 
Toledo-Ortiz et al., 2003). Members of bHLH protein family can bind DNA either alone 
or in conjugation with MYB proteins. Several functional partnerships between MYB 
and bHLH transcription factors to coordinate anthocyanin biosynthesis have been 
identified, including maize ZmC1 MYB and ZmB bHLH, the Petunia AN2 MYB and 
AN1 bHLH, and the A. majus Ros1 MYB and Del bHLH (Goff et al., 1992, Goodrich et 
al., 1992, Schwinn et al., 2006, Quattrocchio et al., 1998). 
 
The third group of transcriptional regulators involved in flavonoid biosynthesis are 
WD40 proteins which belong to a group of proteins characterized by a peptide motif of 
44-60 amino acids on the N-terminal side and the WD dipeptide on the C-terminus 
(Smith et al., 1999). WD40 proteins are thought not have DNA-binding activity but 
rather enhance gene activation and facilitate protein-protein interactions in the MBW 
complex because they are able to interact with several proteins simultaneously. Several 
of the tertiary MBW complexes that regulate anthocyanin biosynthesis have been 
identified in different plants. In maize for example, ZmC1 and ZmPL1 (MYBs) interact 
with ZmR1, B1, SN1 and HOPl1 (bHLHs) and ZmPAC1 (WD40) to induce anthocyanin 
biosynthesis and a similarly complex network of transcriptional regulators has been 
identified in Arabidopsis (reviewed by Petroni and Tonelli, 2011). 
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MBW protein complexes are also known to regulate other branches of the flavonoid 
biosynthetic pathway such as proanthocyanidins that compete with anthocyanins for the 
products of the enzymatic reactions catalysed by DFR and ANS. In Arabidopsis, AtTT2 
MYB, AtTT8 bHLH and AtTTG1 WD40 are necessary for the correct expression of 
BANYULS (BAN) which encodes the core enzyme of proanthocyanidin biosynthesis in 
seed coat of A. thaliana (Baudry et al., 2004). Similarly, a MBW complex regulating 
proanthocyanidin biosynthesis during strawberry fruit development involving the 
functional interaction of FaMYB9, FabHLH3 and a WD40 FaTTG1 was recently 
identified (Schaart et al., 2013). This suggests that MBW complexes probably regulate 
all steps in flavonol biosynthesis. To date, only one MYB-like transcriptional regulator 
of anthocyanin biosynthesis in tomato has been identified (Mathews et al., 2003). ANT1 
regulates the expression of biosynthetic genes such as CHS and DFR and is involved in 
the regulation of genes responsible for anthocyanin glycosylation and transportation 
into the vacuole. 
 
Most transcriptional regulators of anthocyanin biosynthesis are involved in the 
activation of the enzymatic pathway and so far, only a small number of negative 
regulators have been identified. Anthocyanin-deficient mutants have helped to shed 
light on the regulatory processes that control activation and repression of anthocyanin 
biosynthesis. One of the first repressors of flavonol and anthocyanins biosynthesis 
identified was the strawberry FaMYB1 MYB protein which interacts with bHLH 
regulators of anthocyanin biosynthesis to repress formation of anthocyanin and 
flavonols (Aharoni et al., 2001). In Arabidopsis a number of negative regulators of 
anthocyanin biosynthesis have been identified to date. AtMYBL2, a MYB protein 
interacts with the TT8 bHLH and negatively controls anthocyanin biosynthesis (Matsui 
et al., 2008). Similarly, CPC, a single-repeat R3-MYB negative regulator, tightly 
controls anthocyanin accumulation by competing with the R2R3-MYB transcription 
factor PAP1/2 to form the tertiary transcriptional complex required for anthocyanin 
biosynthesis genes (Zhu et al., 2009).  
 
By understanding the intricate regulation of flavonoid biosynthesis, the pathway can be 
manipulated to engineer fruits and vegetables with novel enhanced flavonol contents 
and consequently nutritional content.  
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1.3.3 Biological roles of anthocyanins in plant 
The most important function of anthocyanins is to impact the colour of the flowers and 
fruit in which they occur. The intense colouration of many plant reproductive and 
fruiting bodies provides a visual attractant for pollinators and seed-dispersing animals 
alike. Unsurprisingly, anthocyanins have played an important role in the coevolution of 
plant-animal interactions and are of substantial relevance to the plant’s survival and 
reproduction. 
 
Most plants also accumulate anthocyanins in their vegetative tissues where they are 
thought to be involved in protecting plants from herbivore attack, microbial disease and 
photo-induced damage. Several studies have linked increased accumulation of 
anthocyanins in the foliage to decreased foraging by herbivores. California maple 
aphids, for example, have been found to preferentially feed on yellow-orange leaves of 
the Japanese maple but largely ignore the leaves of red-coloured trees (Furuta, 1986). 
Similarly, light brown apple moths showed a significant preference for green- over red-
foliaged apple trees suggesting a role for anthocyanins as herbivore deterrents 
(Markwick et al., 2013). 
 
Furthermore, anthocyanins may be produced in the foliage to protect photo-sensitive 
defence compounds from light-induced degradation. Page and colleagues (2002) found 
that Asteraceae protect photolabile thiarubrines, a group of chemicals with strong 
antibacterial and antifungal activity, by surrounding them with anthocyanin-containing 
cells.  
 
Under high-light conditions anthocyanins can serve as optical filters protecting the 
photosynthetic apparatus from reactive oxygen species (ROS)-induced damage (Gould 
et al., 2010, Havaux and Kloppstech, 2001, Nielsen and Simonsen, 2011, Zeng et al., 
2010). Chloroplasts generate ROS when they receive more light than they can use in the 
dark reactions of photosynthesis. Anthocyanins in the vacuole may be able to absorb 
excess high-energy quanta and divert them away from the saturated photosynthetic 
electron transport chain. The accumulation of foliar anthocyanins has also been 
implicated in scavenging of free radicals (Gould et al., 2002, Wang et al., 1997)  and the 
acquisition of tolerance to a variety of environmental stresses including chilling and 
freezing, desiccation and wounding. 
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Anthocyanins are some of the most versatile and ubiquitous secondary metabolites that 
are implicated in the survival and adaptivity of higher plants by conferring protection 
from biotic and abiotic stresses together with enhancing reproductive success by 
attracting pollinators and seed-dispersing animals. 
 
 
1.4 Polyphenols: abundance in food  
The abundance and diversity of polyphenols in different taxonomic groups is very much 
a reflection of evolutionary divergence in higher plants. Anthocyanins are absent from 
non-vascular plants such as mosses and liverworts but are found in some lower vascular 
plants like ferns (Chai et al., 2012, Harborne, 1965). Whilst some branches of the 
polyphenol metabolism such as anthocyanins are nearly ubiquitous in gymnosperms and 
angiosperms, their production may be limited to certain plant organs. Other phenolic 
compounds such as isoflavonoids in legumes, however, may be unique to a single clade. 
Thus, it is not surprising that dietary intake of total and different classes of polyphenolic 
compounds depends dramatically on individual dietary habits as well as cultural food 
traditions involving geographically unique plant products. For example, the influence of 
regional dietary habits on total polyphenol intake is evident in the relatively low mean 
total intake of polyphenols of only 863 ± 415 mg/day in Finnish adults reflecting their 
low fruit and vegetable consumption (Ovaskainen et al., 2008) compared to 2,500 to 
3,000 mg/day in Spanish adults (Saura-Calixto et al., 2007).  
 
 
1.5 Metabolic fate and bioavailability of anthocyanins 
Polyphenols, and particularly anthocyanins, can be present in very large amounts in 
some dietary components. Average servings of aubergines, black grapes or berries can 
deliver between several hundred to thousand mg of anthocyanins. In 2005, Manach and 
colleagues published a comprehensive review of almost 100 studies regarding the 
bioavailability and bioefficacy of polyphenols in humans. Bioavailability is defined as 
the fraction of an administered substance that becomes available to the circulatory 
system or target tissue. Relative urinary excretion of the parental forms of anthocyanins 
ranged from 0.004% to 0.1% and plasma concentrations were usually in the order of 10 
to 50 nmol/L. Similar absorption figures have also been reported in more recent studies 
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investigating the bioavailability of cranberry and elderberry anthocyanins (American 
Institute for Cancer Research, 1997, Fernandes et al., 2012). These findings suggest that 
bioavailability of anthocyanins is very low and often less than 0.1% of the ingested 
dose. Absorption and elimination of anthocyanins occurred rapidly but absorption took 
place with poor efficiency, possibly by absorption through the gastric wall.  
 
However, these bioavailability values are largely based on the presence of the parent 
anthocyanin molecules in plasma and urine and may be significant absorption 
underestimates when taking anthocyanin metabolites and catabolites into consideration. 
Only recently, have studies, to determine tissue concentrations of anthocyanins, been 
conducted. Anthocyanins were recovered from several tissues, including the bladder, 
prostate, heart, liver, brain and adipose tissue of rats fed a high-anthocyanin diet 
(Fernandes et al., Serra et al., 2011). By evaluating both circulatory and tissue 
concentrations of anthocyanins, existing bioavailability estimates may require further 
review.  
 
For decades, detection methods have focused largely on parental or intact anthocyanins. 
Indeed, small proportions of intact anthocyanins have been recovered from urine and 
serum (Serra et al., 2011), but the majority of anthocyanins are likely to undergo 
extensive modification and metabolism by the colonic microflora upon ingestion. 
Furthermore, anthocyanins undergo rearrangement in response to pH. The red flavylium 
cation predominates at pH 1 to 3 but with increasing pH the colourless carbinol 
pseudobase becomes the major component. Detection methods relying on the sole use 
of absorbance spectra between 500 and 550 nm (at which coloured anthocyanins show 
maximum absorbance) will fail to detect anthocyanins in higher pH environments, in 
which the colourless carbinol pseudobase dominates. Upon passage through the 
gastrointestinal tract the environment becomes less acidic and this is likely to lead to 
pH-dependent rearrangements of the anthocyanins. Whether or not this will affect 
absorption or bioefficacy is not known. Furthermore, anthocyanins will undergo 
significant post-ingestion modification, including methylation, glucuronidation and 
sulfation. In fact, several studies have shown that anthocyanin conjugates accounted for 
the majority of the recovered anthocyanins and are likely to be the predominant forms in 
which anthocyanins are transported in human serum and urine (American Institute for 
Cancer Research, 1997, Felgines et al., 2009, Felgines et al., 2007). As the compounds 
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pass from the small to the large intestine, they will be exposed to the colonic microflora, 
which are likely to contribute to the degradation and elimination of significant 
proportions of the ingested anthocyanins. Finally, decoration patterns of individual 
anthocyanin types may further impact the bioavailability of the compound. Yi and 
colleagues (2006) demonstrated that glucosylated anthocyanins had significantly higher 
transport efficiency than galactosylated anthocyanins and that increased numbers of free 
hydroxyl groups and fewer methoxy groups could significantly reduce bioavailability. 
 
Additional evidence has started to emerge that suggests a beneficial association between 
polyphenol ingestion and gut bacterial growth. Several in vitro and in vivo studies have 
demonstrated that increased polyphenol ingestion may have positive effects on human 
health through modulation of the composition of the colonic microflora.  Most studies 
have reported an increase in the number of Bifidobacteria and Lactobacilli which are 
considered beneficial for intestinal function and a suppression of Bacteroides, such as 
Staphylococcus aureus, Salmonella typhimurium, Campylobacter jejuni, Listeria and 
other pathogenic bacteria such as Clostridium and Propionibacterium (Dolara et al., 
2005, Hidalgo et al., 2012, Park et al., 2013, Parkar et al., 2008). Bacteria such as 
Clostridium have detrimental actions on colonic mucosa and lead to diarrhoea, and 
subsequently, reduced nutrient uptake. Animal studies have also provided evidence that 
the microbial community composition differs significantly between obese and lean 
individuals (Backhed et al., 2004). In obese animals, a shift in the Bacteroidetes-
Firmicutes ratio was observed that increased the efficiency to harvest energy from a 
given diet and deposit fat (Tremaroli and Backhed, 2012). Lipogenesis, and 
subsequently weight gain, in mice fed a high-fat diet was significantly inhibited by the 
administration of anthocyanin-rich orange juice but not water (Titta et al., 2010, 
Salamone et al., 2012). These findings suggest that polyphenolic compounds including 
anthocyanins can regulate pathways involved in lipid homeostasis as well as playing an 
important role in maintaining a healthy gut microflora. This provides some evidence for 
an evolutionary relationship between an ancestral diet high in polyphenol-containing 
fruit and vegetables and the evolution of the human superorganism. 
 
Current understanding of the bioavailability of anthocyanins remains somewhat 
inconclusive. While overall bioavailability of anthocyanins is relatively low compared 
to other flavonoids, most absorption is likely to occur in the stomach, with some 
17 
 
anthocyanins or their metabolites transported to the lower gastrointestinal tract. The 
mechanisms by which anthocyanins are transported across cellular membranes have not 
been identified yet but may involve hydrolysis of the glycosides by various hydrolases 
and absorption of the phenolic aglycones, if similar to absorption of flavonols. 
Furthermore, bioavailability values reported in the literature should be reviewed in the 
light of newly identified circulating and excreted metabolites such as methylated and 
glucuronidated conjugates. Recently it has been demonstrated that the vast majority of 
ingested anthocyanins are not transported around the human body in their intact form 
but that it is their metabolites, formed in the small intestine and hepatic cells, or low 
molecular weight catabolites produced by the gut microflora that reach the circulatory 
system and body tissues to elicit bioactive effects. A large proportion of the ingested 
anthocyanins is metabolized to protocatechuic acid by the gut microbiome (Vitaglione 
et al., 2007, Tsuda et al., 1999, Aura et al., 2005). Protocatechuic acid, a simple 
phenolic acid, has strong antioxidative activity and potent anti-cancer properties and 
significantly reduced the progression of skin and liver cell tumours in rats (Tseng et al., 
1998, Tanaka et al., 1993). 
 
More research is needed to establish the role of these metabolites and catabolites in 
exerting health benefits and in the light of this newly emerging data, existing 
bioavailability values may need to be revised upwards. 
 
 
1.6 Health benefits of anthocyanins  
The abundance of anthocyanins in many plants consumed as foods make them possibly 
the most important of all dietary flavonoids. They are commonly found in dark-coloured 
fruits such as berries, plums, grapes, currants and cherries as well as in a number of 
vegetables including eggplant, red onion, red cabbage, black bean and red-leafed lettuce 
(Wu et al., 2006). Reports, concerning the average daily intake of anthocyanins in the 
US, vary significantly, with estimates ranging from as little as 12.5 mg/day reported 
recently by the United States Department of Agriculture (Wu et al., 2006) to as much as 
200 mg/day (Kuehnau, 1976). Compared to the dietary uptake of most other health-
promoting phytochemicals, these are relatively large quantities. Total anthocyanin 
intake depends on individual dietary choices and habits, and there have been no reports 
of ill effects from excessive anthocyanin consumption. 
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Numerous studies have shown a strong correlation between an anthocyanin-rich diet 
and reduced incidence of various chronic diseases, including cancer, cardiovascular 
diseases (CVDs) and inflammatory diseases, as well as obesity and associated age-
related degenerative diseases. Following recognition of their potential health-promoting 
effects and their applications as natural food colorants in the food industry, research 
interest in dietary anthocyanins has increased significantly in recent years.  
 
Traditionally, health-promoting effects of anthocyanins have been assigned to their 
powerful antioxidant capacities observed in vitro (Kähkönen and Heinonen, 2003, 
Wang et al., 1997, Wang et al., 1999). However, more recently, evidence has started to 
emerge that cellular effects may be mediated not only by radical scavenging but also by 
direct interactions between the anthocyanins and specific DNA sequences. Many of the 
proteins these genes encode are involved in intracellular signalling pathways, including 
protein kinase and lipid kinase signalling cascades (Choe et al., 2012, Hwang et al., 
2011a). Inhibitory or stimulatory actions of anthocyanins are likely to be a result of 
anthocyanin-mediated modulation in the phosphorylation or methylation state of target 
molecules (Lee et al., 2010, Wang et al., 2013) and/or by alteration in gene expression 
(Hwang et al., 2011b, Williams et al., 2004, Titta et al., 2010). New molecular targets 
for anthocyanin-mediated modulation are being identified at an unprecedented speed, 
many of them with potentially significant implications for the prevention and 
management of diseases such as cancer or CVDs. The picture that is starting to emerge 
from both in vitro and in vivo studies is highly complex: anthocyanins, and other 
phytochemicals, seem to be able to exert significant regulatory effects on genes 
involved in cellular signalling pathways. They may be able to maintain and protect 
cellular homeostasis through regulation of deregulated pathways that are associated with 
many chronic diseases or inflammatory processes. How anthocyanins exert these 
remarkable biological effects, whether by direct interaction with the DNA or its 
translational products, remains still largely unknown. Improvement of our 
understanding of the molecular mechanisms that cause the observed pharmacological 
effects, may lead to the formulation of future dietary recommendations or even the use 
of anthocyanins as adjuvants in pharmacological treatment regimes. 
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1.6.1 Anthocyanins as anti- or prooxidants  
Anthocyanins act as powerful antioxidants in vitro. They reduce reactive oxygen species 
(ROS) such as hydrogen peroxide or peroxyl radicals, scavenge superoxide anions as 
well as nitric radicals and prevent lipid oxidation (Pietta, 2000). The stability of an 
anthocyanin in an aqueous solution depends greatly on the pH. Wang and colleagues 
(1997) investigated the antioxidant properties of fourteen anthocyanins including the 
five aglycones, delphinidin, cyanidin, pelargonidin, malvidin and peonidin at neutral 
pH, using an oxygen radical absorbance capacity (ORAC) assay. Cyanidin-3-glucoside 
showed the highest antioxidant capacity, being 3.5 times more potent than the water-
soluble vitamin E analogue, Trolox, a powerful antioxidant. Even pelargonidin, which 
had the lowest ORAC value, was still as powerful as Trolox. Interestingly, Noda et al. 
(2001) suggested that anthocyanin antioxidant capacity is not due to direct radical 
scavenging activity but possibly due to chelation of ferrous ions in the hydroxyl radical 
generation system. There is a substantial body of evidence from in vitro assays that 
anthocyanins and other polyphenolic compounds may also act as prooxidants through 
oxidative polymerization and reduction of Cu
2+
 to Cu
+
 with subsequent generation of 
various ROS (Hadi et al., 2007, Halliwell, 2008, Lambert et al., 2007). 
 
However, there is very limited or highly variable evidence for their antioxidant effects 
in vivo (Halliwell et al., 2005). Even though anthocyanin absorption does occur in the 
gastrointestinal tract, concentrations in the plasma are usually too low to support 
significant roles as antioxidation agents in the circulatory system. However, they may 
work as direct antioxidants in the gastrointestinal tract and thus contribute to the 
maintenance of gastrointestinal health and modulation of the gut microbial composition 
(Hidalgo et al., 2012). Furthermore, methylation and glucuronidation in the human body 
leads to decreased antioxidant (or prooxidant) abilities because of the blocking of the 
phenolic hydroxyl groups involved in such activities (Williamson et al., 2005). 
 
While their antioxidant properties may be of use and relevance for their application as 
colorants in the food industry, there is substantial doubt whether they can act as 
effective antioxidants once absorbed. But through modulation of signalling pathways 
anthocyanins could induce free radical scavenging pathways in animals (Martin et al., 
2011, Martin et al., 2013). 
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1.6.2 Anticarcinogenic properties 
Anthocyanins have potential uses as therapeutics. They occur naturally in significant 
quantities and display strong pharmacological effects in vitro. Numerous studies have 
demonstrated anthocyanin-induced antiproliferative effects and apoptotic properties in 
various human cancer cell lines. Anthocyanin extracts from different natural sources, 
have been shown to effectively inhibit several types of cancers such as colon 
adenocarcinoma, prostate cancer, breast cancer, cervical, and lung cancer cell lines. The 
link between cancer-inhibiting effects and anthocyanins in food has led to increased 
research into dietary chemoprevention as a potential protective and/or inhibiting 
strategy for some cancers, complementary to conventional pharmacological 
interventions.  
 
Most pharmacological studies have used purified compounds or anthocyanin extracts 
from berries or grapes, tart cherries, plums and other fruits (Bagchi et al., 2004, Chen et 
al., 2006, Kang et al., 2003, Katsube et al., 2002, Seeram et al., 2004) and have reported 
a positive correlation between the dose-dependent application of anthocyanins and the 
inhibition of malignant cells or tumours. Anthocyanin-mediated cancer cell death may 
be the result of activation of apoptotic mechanisms including activation of the caspase 
cascade (a central element of mammalian apoptosis), cleaving poly (ADP-ribose) 
polymerase (PARP), inducing p38/p53 and p38/c-jun signalling pathways, depolarizing 
mitochondrial membrane potential, and releasing cytochrome c (Huang et al., 2011, Hui 
et al., 2010, Lee et al., 2009, Shin et al., 2009). Cancer cells evade programmed cell 
death through the upregulation of antiapoptotic proteins and inhibition of proapoptotic 
signals. There is increasing evidence that anthocyanins reduce the expression of 
oncogenic signalling pathways like Wnt and Notch and their downstream targets like β-
catenin, MYC, cyclin D1, cyclin B1, extracellular-signal-regulated kinases (ERKs), and 
vascular endothelial growth factor (VEGF) proteins (Kausar et al., 2012, Shin et al., 
2011, Wang et al., 2013). 
 
Several studies reported anthocyanin-mediated reduction in the invasion and metastasis 
potential through suppression of matrix metalloproteinase (MMP)-2 and MMP-9 in 
various cell lines including non-small-cell lung cancer (NSCLC) and cervical cancer 
HeLa cells (Ho et al., 2010, Lu et al., 2013, Yun et al., 2010). Increasing evidence from 
animal cancer models suggests that anthocyanins and anthocyanin-rich extracts can 
21 
 
significantly reduce the tumour burden or delay the onset of tumour development in 
vivo. Dietary supplementation with anthocyanins led to a reduction in number and size 
of intestinal adenoma formation in Apc
Min
 mice, which is used as a genetic model of 
human familial adenomatous polyposis (Cai et al., 2010, Cooke et al., 2006, Kang et al., 
2003). Feed supplemented with anthocyanin-rich tomato extract increased the lifespan 
of Trp53
-/-
 knockout mice, an aggressive cancer model characterized by the spontaneous 
formation of a wide range of tumour types, by 30% (Butelli et al., 2008). Topical 
application of anthocyanin-rich pomegranate fruit extract significantly inhibited and 
delayed skin tumour incidence in a multistage mouse skin (CD-1) carcinogenesis model 
(Afaq et al., 2005). These findings show that anthocyanins or their metabolites can exert 
preventative and inhibitory effects in vivo against various types of cancer affecting 
different tissues. Furthermore, these studies confirm that upon ingestion 
chemopreventive activity is retained, but may be exerted by metabolites or catabolites 
of dietary anthocyanins. 
 
There is some evidence that the inhibitory effects depend not only on the type of cancer 
but also on the class of anthocyanin and their chemical modifications. Lazze and 
colleagues (2004) investigated the effects of the anthocyanin aglycones Dp and Cy on 
cell cycle progression and induction of apoptosis in human cancer cell lines. The two 
anthocyanins differ only in the number and position of hydroxyl groups on the phenyl 
B-ring with three hydroxyl groups on positions 3, 4, and 5 in Dp and two hydroxyl 
groups on positions, 3 and 4 in Cy. Both anthocyanins exerted antiproliferative effects 
on normal fibroblast cells, but only Dp showed pro-apoptotic properties in the tumour 
cell lines. Hou (2004) studied the effects of the six different anthocyanins on the 
oncogene activator protein 1 (AP-1). Dp, Pt and Cy, but not Pl, Pe and Mv inhibited cell 
proliferation, transformation, and apoptosis. Data from both in vivo and in vitro studies 
revealed significant pharmacological differences between the anthocyanin glycosides 
and their aglycones (Kang et al., 2003, Seeram et al., 2001, Wang et al., 1999). These 
findings suggest that hydroxylation, glycosylation and methylation patterns may change 
the chemical and physical properties of the compound and may affect the therapeutic 
potential of a particular anthocyanin subclass. However, the results remain somewhat 
inconclusive as the pharmacological effects reported for an individual anthocyanin type 
are inconsistent and vary between studies and cell types. In vitro studies suggest that 
aglycones seem to be more bioactive than their corresponding anthocyanins. 
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Anthocyanins are, however, synthesised by plants in the form of glycosides as they 
increase compound stability. Aglycones do not really exist in nature as they are very 
unstable. Anthocyanin glycosides can be absorbed in the stomach or be transformed into 
aglycones or other metabolites through hydrolysis by intestinal enzymes or by the 
colonic microflora. Aglycones are more hydrophobic and smaller than their glycosides, 
factors that may improve their bioavailability by facilitating passive penetration of the 
epithelial layer in the gut (He and Giusti, 2010). Nonetheless, the microflora does not 
only transform compounds but also reduces the efficiency of absorption by degradation 
of the aglycones and production of various simple aromatic acids (Manach et al., 2004, 
Fleschhut et al., 2006). 
 
More research into in vivo bioavailability and absorption is required to determine 
whether the health-promoting effects can be attributed to the action of anthocyanins or 
other health-promoting compounds in the food matrix. Some of the effects may be the 
result of synergistic effects between the anthocyanins, polyphenols and/or other plant 
compounds.  
 
1.6.3 Disease prevention and diet 
In 2004, the World Health Organisation (WHO) adopted the "Global Strategy on Diet, 
Physical Activity and Health" to reduce the risk factors for chronic diseases associated 
with unhealthy diets and physical inactivity together with increasing awareness and 
understanding of the influences of diet and physical activity on health. Disease 
prevention by improving diet and promoting physical activity was given a central role 
for formulating and implementing effective strategies for substantially reducing deaths 
and disease burden worldwide.  
 
Health benefits associated with healthy dietary patterns, like the Mediterranean diet, that 
are characterized by a high intake of fruit and vegetables, fish, plant protein and fibre 
together with a low intake of red and processed meats, dairy products and saturated fats, 
are not at all surprising when viewed in the context of an ancestral hunter-gatherer diet, 
which significantly shaped our genetic make-up through millions of years of evolution 
(O'Keefe Jr and Cordain, 2004). Humans emerged as a distinct taxonomic clade 2.6 
million years ago heralding the beginning of the Palaeolithic era which came to an end 
around 10,000 before present time (BP). During the Palaeolithic era, humans grouped 
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together in small societies leading a nomadic lifestyle characterized by spending long 
hours gathering plants, hunting or fishing. Diet was highly dependent on regional and 
seasonal availability but included, as principal components, fibre-rich sweet and ripe 
fruits and berries, shoots, buds and young leaves, carbohydrate and oil-rich roots, bulbs, 
nuts, and non-grass seeds and lean muscle meat, organ meats, ﬁsh, shellﬁsh, insects, 
larvae and eggs as important sources of protein and fat. Human dietary patterns evolved 
rapidly and drastically with the development of agriculture and farming, changing the 
characteristics of formerly wild food through breeding for increased starch and fat 
content together with the later development of food-processing (Cordain et al., 2005).  
 
With the onset of the industrial revolution dietary patterns experienced a dramatic shift 
towards increased consumption of dairy products, cereals, refined sugars, refined 
vegetable oils, and alcohol which together make up 72% of the total daily energy 
consumed by people in the United States (Cordain et al., 2000). Such dramatic changes 
in the dietary patterns of modern humans have had significant effects on the health 
status of Westernized societies that are now inundated by lifestyle-related chronic 
disease like CVDs, type 2 diabetes, metabolic syndrome and cancer, which are the 
leading killers in Westernized society. These diseases are increasing dramatically in 
developing nations as they adopt Westernized lifestyles. More worryingly, a global 
obesity pandemic is rapidly spreading in industrialized and emerging economies and led 
to an estimated 400,000 deaths in 2000 alone (Adams et al., 2006, Masters et al., 2013, 
Roberts and Barnard, 2005). Mortality from chronic diseases is likely to rise and we are 
only just beginning to understand the causal relationships between diet, obesity and 
occurrence of cancer (Calle et al., 2003). Return to a Palaeolithic-style diet, described as 
the diet to which humans are genetically adapted to, is seen by some as the only solution 
to prevent and stop the spread of Western chronic diseases (reviewed by Carrera-Bastos 
et al. 2011, Lindeberg 2012). This idea has been supported by reports of superior health 
markers in traditional hunter-gatherer societies and reports from a number of clinical 
trials showing improved glucose tolerance and cardiovascular disease markers in 
Palaeolithic diet intervention groups (Jönsson et al., 2009, Lindeberg et al., 2007). 
However, the high costs associated with fresh fruit and vegetables and high-quality 
animal protein of a biomass-rich Palaeolithic diet together with the global issues of 
expanding world population and decreasing areas of arable land make the Palaeolithic 
diet an unrealistic long-term solution for a global population. 
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Estimates suggest that between 30% and 40% of all cancers could be prevented by 
appropriate diets, physical activity, and maintenance of appropriate body weight 
(American Institute for Cancer Research, 1997). This relationship is likely to be even 
higher for certain cancers like those that affect the gastrointestinal tract. Tsugane and 
Sasazuki (2007) reviewed several epidemiological studies investigating the link 
between diet and incidence of gastric cancer and concluded that vegetable and fruit 
intake, even in relatively low amounts, was associated with a lower risk of gastric 
cancer and was likely to confer protective effects. 
 
Publications regarding the relationship between diet and overall cancer incidence have 
been highly heterogeneous and variable in quality and design, leaving many gaps in our 
current understanding of the different factors that may be involved. Whilst there is 
overwhelming evidence from in vitro test systems that many dietary components, in 
particular anthocyanins and other polyphenols, can inhibit the growth and proliferation 
of cancer cell cultures, such clear causal relationships have not been produced by all 
epidemiological studies.  
 
Some of the most compelling evidence linking a healthy diet rich in different fruit and 
vegetables and low in fats and red meat, to a lower risk of developing certain chronic 
diseases came from the European Prospective Investigation into Cancer and Nutrition 
(EPIC) study, a cohort study involving several hundred thousand participants, studying 
dietary patterns and chronic disease incidence across European countries. One of the 
most striking outcomes of the EPIC study was the significantly reduced incidence of 
certain cancer and CVDs in populations following a Mediterranean dietary pattern. In 
addition, several other cohort studies have reported a possible inverse relationship 
between the adherence to a Mediterranean-style diet and prolonged survival of cancer 
patients indicating potentially protective effects against development of cancer (Benetou 
et al., 2008, de Lorgeril et al., 1998, Gallus et al., 2004, La Vecchia, 2004, 
Trichopoulou et al., 2003, Trichopoulou et al., 2000, Stoner, 2009). After analysing the 
outcomes of several cohort and case-control studies regarding the relationship between 
the adherence to a Mediterranean diet, mortality and incidences of cancer and other 
chronic diseases, two meta-analyses also suggested a protective role of the 
Mediterranean-style dietary pattern towards cancer in general (Sofi et al., 2008, Boffetta 
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et al., 2010). Most studies observed a trend between healthy dietary patterns and lower 
incidence of overall cancer but failed to establish a statistically significant correlation. 
Despite inconsistent outcomes from epidemiological studies investigating the effects of 
the Mediterranean-style diet on total cancer incidence, strong inverse relationships have 
been reported from several large cohort studies for certain types of cancer, particularly 
those of the gastrointestinal tract such as colorectal and gastric (Messina and Hilakivi-
Clarke, 2009, Salas-Salvadó et al., 2011, Pritchard, 2010, Tsugane and Sasazuki, 2007).  
 
The study of regional diets across cultures has provided strong evidence that certain 
dietary patterns can promote health and are associated with a lower risk of developing 
certain cancers and CVDs. Despite the cultural differences in the cuisines worldwide, 
there are some shared characteristics of healthy dietary patterns. They are all 
characterized by high intakes of fruit, vegetables, legumes, whole grains, dietary fibre, 
fish and are relatively high in ω-3 fatty acids, with low intakes of dairy products, red 
meats, saturated fats, trans-fats, and dietary cholesterol. Increasing our understanding of 
dietary patterns and prevalence of non-communicable, chronic diseases may offer 
crucial clues about how to stop the global pandemic of obesity and lifestyle-related 
chronic diseases as the global population is shifting towards a Western-style diet. 
 
Nutritional epidemiology has been highly successful in identifying inverse relationships 
between dietary agents and wide array of epithelial cancer but these observations have 
often failed to be repeated in randomized clinical trials. A number of cohort studies 
using controlled intervention trials have investigated the relationship between dietary 
patterns characterised by either low-fat (Prentice et al., 2006) or high-fruit and 
vegetables (Pierce et al., 2007) and incidence of invasive breast cancer but did not 
report any differences between the intervention groups and the control. An analysis of 
the EPIC cohort assessing relationships between total fruit and vegetables and cancer 
risk during 1992 and 2000 revealed only a very small inverse association (Verberne et 
al., 2010). 
 
There are several possible explanations for the apparent lack of association between 
certain dietary components and cancer progression. A balanced diet rich in fruit and 
vegetables may deliver the entire biological action package and, subsequently, 
supplementation with a single dietary compound or food group may be not as effective 
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as the epidemiological study may have suggested as most of the health benefits are 
delivered by the combinatorial activity of different components in the diet. 
 
Another possible reason for the inconsistency in the results from dietary intervention 
and epidemiological studies could be the difficult nature of conducting and reporting 
medium- to long-term studies. Both study types rely on self-measurement of dietary 
patterns that are often assessed with considerable measurement errors. Furthermore, 
clinical intervention trials focus on the diet during adult life and may not acknowledge 
crucial time windows early in life. Most cancers will result from genetic alterations 
accumulated over an individual’s lifetime and dietary agents may be particularly 
effective during childhood and puberty when the body is undergoing crucial growth and 
developmental changes. Many cancers have been associated with epigenetic changes. 
The accumulation of such disadvantageous alterations may well be influenced by 
dietary habits throughout childhood and into early adulthood. Also, the follow-up time 
of most intervention studies is between five and ten years which may simply be too 
short to capture the role of diet as a preventative or protective factor for cancer. Finally, 
the role of genetic and epigenetic variations as well as individual differences in the gut 
microbiota of an individual are still not sufficiently researched but may strongly affect 
the responsiveness to dietary interventions and subsequently the outcomes of clinical 
trials. 
 
1.6.4 Dietary changes and the treatment of chronic, non-communicable 
diseases 
Along with the prevention or delayed onset of many chronic diseases, lifestyle 
intervention studies have demonstrated large reductions in the progression of these 
diseases and even rendered pharmacotherapy redundant in some cases. Dietary changes 
have been particularly successful in the treatment of CVDs and type 2 diabetes. Clinical 
studies have provided evidence that adequate dietary changes can significantly reduce 
the requirement for antihyperglycemic drug control of type 2 diabetes. The 
Mediterranean-style diet, for example, with high proportions of fruit and vegetables, 
and monounsaturated fat, provided significant cardiovascular beneﬁts together with 
increased insulin sensitivity. A four-year Mediterranean-style intervention diet showed 
that 56% of patients with newly diagnosed type 2 diabetes did not require 
antihyperglycemic drug control, lost more weight and experienced greater 
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improvements in some glycemic and coronary risk measures than the patient control 
group assigned to a low-fat diet (Lindeberg, 2012). Similarly, adherence to a 
Mediterranean-style diet decreased the risk of developing type 2 diabetes in individuals 
at high risk of developing CVDs (Nomura et al., 2008) and reduced the prevalence of 
metabolic syndrome and its associated CVD risk (Willett, 2010). A meta-analysis of six 
dietary intervention studies comparing Mediterranean-style and low-fat diets confirmed 
that the Mediterranean-style diet was more effective than low-fat diets in improving 
cardiovascular risk factors and inflammatory markers (Manson, 2003). 
 
Adherence to a healthy dietary pattern is likely to reduce the incidence of certain 
cancers, particular those of the gastrointestinal tract. It is less clear, whether changes in 
dietary pattern can reduce or even reverse the progression of pre-existing cancers. There 
are few, highly inconsistent reports of dietary management of cancer. Despite the lack 
of clinical evidence advocating a diet-assisted cancer therapy, our increasing 
understanding of how plant bioactive compounds exert their chemopreventive effects 
could hold some clues to whether these compounds might assist in the therapeutic 
management of prevalent cancers. It has recently emerged that polyphenols are capable 
of modulating epigenetic alterations in cancer cells (Link et al., 2010, Vanden Berghe, 
2012). Epigenetic mechanisms include changes in DNA methylation, histone 
modifications and non-coding RNAs that can drive tumour progression by regulating 
the dynamics of gene expression. Epigenetic modifications occur early and may be 
reversible, making dietary bioactives potentially interesting agents in the long-term 
management of chemoprevention and -therapy.  
 
1.6.5 Incidence of cancer worldwide 
In 2008, cancer was the leading cause of death worldwide and, according to the World 
Health Organization (WHO) estimates, accounted for 7.6 million deaths or 13% of all 
deaths (http://globocan.iarc.fr/). Cancer incidence and mortality is significantly higher 
in Western countries, accounting for ~20% of all deaths, compared to Eastern countries 
or emerging economies (Figure 1.3). The difference in cancer prevalence between 
different geographical regions is most likely the result of different dietary and lifestyle 
habits together with increased life expectancy in Western countries and, thus, higher 
incidences of age-related, degenerative diseases. 
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Figure 1.3: 2008 percentages of all deaths due to cancer, as estimated by the World Health 
Organisation (WHO) for different regions of the world. Cancer was estimated to account for 
around 14% of all deaths (due to any cause) worldwide in 2008. Cancers includes all malignant 
tumours excluding non-melanoma skin cancer. 
 
 
According to GLOBOCAN’s 2008 report, more than 304,200 people were diagnosed 
with cancer every year in the UK. The age-standardised rate (ASR; rate that a 
population would have if it had a standard age structure) for new cancer cases and 
cancer deaths was 266.9 and 115.8 per 100,000 people, respectively. The UK has one of 
highest ASRs, of cancer morbidity in the Western world, which is comparable to that of 
Croatia (115) and Slovenia (113) and but significantly above that of France (94), 
Germany (99), Belgium (93), Switzerland (88) and United States (104). 
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Table 1ii: 2008 estimates of age-standardized rates (ASRs) for regional and gender-
specific incidence of cancer, excluding non-melanoma skin cancer. ASRs were highest 
in the Western countries.  
Region Incidence (ASR) Gender 
   North America 334 men 
Australia/New Zealand 356.8 Men 
Northern 288.9 Men 
Western Europe 335.3 Men 
Middle Africa < 100 Men 
Western Africa < 100 Men 
South-central Asia < 100 Men 
North America 274.4 Women 
Australia/New Zealand 276.4 Women 
Northern 257.8 Women 
Western Europe 250.5 Women 
Middle Africa < 100 Women 
Northern Africa < 100 Women 
 
Data from the Internatioal Agency for Research on Cancer GLOBOCAN 2008 report; www. 
http://globocan.iarc.fr/. ASRs are represented per 100,000. 
 
 
1.6.6 Breast cancer 
Breast cancer is the most frequent cancer among women, accounting for almost a 
quarter of all cancers with an estimated 1.38 million new cancer cases diagnosed in 
2008. It is now the most common cancer both in developed and developing regions. In 
developing countries, rates have been steadily increasing, and are now approaching 
those in Westernized countries (GLOBOCAN 2008 report). Breast cancer is the most 
common cancer in the UK with a lifetime risk of more than 10% and has the second 
highest mortality rate after lung cancer (Figure 1.4). Overall, breast cancer incidence 
rates have levelled off since 1990 and most importantly, during this same time period, 
breast cancer mortality rates have declined by 24%. This reduction in mortality has been 
attributed to the combination of early detection with screening programmes and the 
development of more efﬁcacious, systemic chemotherapy agents.  
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Figure 1.4: Estimated ASRs of incidence and mortality for the seven most common types of 
cancer in the UK. Rates are shown for both sexes combined. Data from the Internatioal Agency 
for Research on Cancer GLOBOCAN 2008 report; www. http://globocan.iarc.fr/. 
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Figure 1.5: 2008 estimates of ASRs for worldwide (A) incidence and (B) mortality from breast 
cancer. Data from the Internatioal Agency for Research on Cancer GLOBOCAN 2008 report; 
www. http://globocan.iarc.fr/. ASRs are represented per 100,000. 
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However, breast cancer incidence rates remain high, especially in Westernized countries 
were they have been traditionally several fold higher than in most developing nations 
(Figure 1.5). 
 
Breast cancer is a highly heterogeneous disease with very diverse, tumour-specific gene 
expression patterns that have complicated disease prognosis and etiology. However, 
DNA microarray profiling studies of breast tumours have identified distinct and 
reproducible subtypes of breast carcinomas that are strongly associated with different 
clinical outcomes. Based on shared genetic characteristics, invasive breast carcinomas 
can be divided into five distinct subtypes: luminal A, luminal B, human epidermal 
growth factor receptor 2 (HER2)
+
/oestrogen receptor (ER)
-
, basal-like (HER2
-
/ ER
-
), 
and normal breast-like (Livasy et al., 2006). The basal-like subtype is often associated 
with mutations in the tumour suppressor genes BRCA1 and p53 and has the highest 
proliferation rates with poor prognosis and high metastasizing potential (Tsuda et al., 
2000). In contrast, the luminal A subtype is associated with the best clinical outcome 
(Voduc et al., 2010). Given the substantial genetic diversity found in tumours belonging 
to the same breast cancer subtypes, identification of those genetic alterations shared by 
tumours of a particular subtype, would greatly facilitate the prognosis of tumorigenic 
potential and ultimately, the disease outcome for the patient by facilitating the 
development of multi-targeted, subtype-specific pharmacological treatments.  
 
Most breast cancers develop sporadically as a result of mutations that have accumulated 
through life or are triggered by exposure to known carcinogens such as radiation or 
tumorigenic chemicals. Only 5-10% of all breast cancer cases are known to have 
underlying hereditary factors. Carriers of heritable mutations in the tumour suppressor 
genes BRCA1 and BRCA2 have an increased risk of developing breast cancer. Mutations 
in these genes have been associated with the hereditary breast-ovarian cancer syndrome 
and affected women have an estimated lifetime risk of breast cancer of >80%, and a 
lifetime risk for developing ovarian cancer of 40- 65% for BRCA1 carriers and 20% for 
BRCA2 carriers (Ford et al., 1998). 
 
Interestingly, a cohort study of  carriers of the BRCA1 and BRCA2 mutation revealed 
two modifiable risk factors that were significantly associated with delayed onset of 
breast cancer in these patients: physical exercise as an adolescent and healthy weight 
(King et al., 2003). Existing data on the relationship between obesity and breast cancer 
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risk and the clinical outcome is complex and often controversial. Most cohort and case-
control studies have reported a distinct, but not always significant, inverse relationship 
between obesity and breast cancer amongst pre-menopausal women and some studies 
even suggested that weight gain can increase the risk for pre-menopausal women to 
develop breast cancer (Protani et al., 2010). Furthermore, obesity at the time of 
diagnosis is seen as a poor prognostic factor of clinical outcome as there is sufficient 
evidence that both pre- and post-menopausal women with breast cancer suffering from 
obesity have poorer survival than normal weight women with breast cancer 
(Carmichael, 2006). The underlying causes of this inverse relationship between obesity 
and breast cancer remain speculative but several mechanisms have been proposed: 
cellular proliferation pathways are upregulated in obese patients (Calle and Kaaks, 
2004) which may lead to increased tumour cell proliferation and metastasis. Adipose 
tissues produce certain growth factors such as leptin, that are known to promote growth 
of breast cancers (Grossmann et al., 2010) together with increased production of 
oestrogens which might lead to more aggressive ER
+
 breast tumours (Tchernof and 
Després, 2000). 
 
The role of diet as a modifiable risk factor in the occurrence and management of breast 
cancer is still debated. In a comprehensive meta-analysis, Michels and colleagues 
(2007) reviewed nearly 1500 articles, including case-control and cohort studies but 
failed to establish a clear association between diet and breast cancer. Some possible 
explanations for the apparent lack of relationship between diet and cancer have already 
been discussed (Chapter 1.6.3) but studies of total breast cancer incidence may not 
detect associations between diet and particular types of breast cancer. In fact, Hung et 
al. (2005) did not observe an association between diet and overall breast cancer 
occurrence but reported a significant inverse relationship between higher consumptions 
of fruits and vegetables and reduced risk for ER
- 
breast cancer. The low incidence of 
breast cancer (in Asian countries incidence is less than a fifth of that in Westernized 
countries (Armstrong and Doll, 1975)) has been the subject of considerable scientific 
interest and speculation (Figure 1.5). The high intake of soy products as a major source 
of phytoestrogens may play a role in lowering the lifetime risk for breast cancer. The 
active components in soy products have been suggested to be isoflavones like genistein, 
which can act as phytoestrogens. However, a meta-analysis of 18 studies regarding soy 
intake and breast cancer risk failed to establish a clear, inverse relationship between soy 
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consumption and breast cancer occurrence (Trock et al., 2006). Some of the 
inconsistencies may be due to variations in the isoflavone contents in the soy products 
and differences in the responsiveness to oestrogenic stimulants between the types of 
cancers studied (ER
+
 and ER
-
 subtypes). Nevertheless, cohort studies monitoring the 
changes in breast cancer risks of Asians migrating to Westernized countries have 
provided some of the most compelling and significant evidence for an inverse 
relationship between diet and breast cancer. Both Deapen (2002) and Ziegler (1993) 
reported that the breast cancer risk of Asians that have migrated to the United States 
(US) increased by several fold over a few generations, rapidly approaching that among 
US Whites. Furthermore, breast cancer incidence in Japan, which has traditionally one 
of the lowest breast cancer rates in the world, has been steadily rising since the 1950s. 
The trend of increasing breast cancer rates coincides with the increased intake of fats 
and adoption of a more Western-style diet over the same period (Kato et al., 1987, Tung 
et al., 1999). The existing epidemiological data from Asian communities are particularly 
valuable to interpreting the relationship between chronic diseases and certain lifestyle 
factors, including dietary patterns and known risk factors such as smoking and alcohol. 
They also offer crucial insight into the consequences of rapid lifestyle changes on the 
prevalence of chronic diseases within one or few generations.  
 
At present, evidence for an inverse relationship between dietary factors and breast 
cancer still remain somewhat inconclusive. However, most studies suggest the existence 
of a beneficial, yet not statistically significant, relationship between healthy dietary 
patterns and breast cancer risk.  
 
1.6.7 Pathology of cancer 
Cancer is, like most non-communicable, chronic illnesses, a disease that is primarily the 
result of environment and lifestyle choices (Anand et al., 2008). While all cancerous 
cells harbour genetic alterations, only 5-10% of all cancers can be directly linked to 
inherited genetic alterations. The causes of cancer are as complex and diverse as the 
types of cancers and the different tissues they can affect but include known risk factors 
such as smoking, alcohol consumption, diet and obesity as well as exposure to radiation 
and mutagenic chemicals. 
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Cancer cells are characterised by unregulated cell growth and failure to undergo 
programmed cell death and may invade neighbouring tissue or spread to distant body 
parts through the lymphatic system or bloodstream. For cells to become cancerous, 
genetic and regulatory alterations of genes involved in growth regulation and initiation 
of senescence and cell death, are required to trigger an imbalance between cell 
proliferation and cell death (Figure 1.6). Mammalian cells have evolved highly 
sophisticated, interlocking mechanisms to detect and repair DNA lesions that could lead 
to genomic instability and loss of genomic integrity (Lord and Ashworth, 2012). These 
mechanisms are collectively known as DNA-damage response (DDR) and encompass a 
set of coordinated processes, such as DNA damage detection, accumulation of DNA 
repair factors and repair of damaged DNA fragments. Somatic mutations in the cancer 
cell genome may include different types of DNA sequence change such as base 
substitutions, insertions or deletions of small or larger sequences of DNA, 
rearrangements of broken DNA that has been inserted in a different location in the 
genome and copy number increases and reductions that may lead to gene amplification 
or deletion, respectively (Stratton et al., 2009). Mutations in the genes involved in DNA 
lesion detection and repair which impact the ability of cells to initiate and carry out the 
DDR, pave the way for additional mutations and the manifestation of alterations in the 
genome of cancer cells. Furthermore, alterations in the cancer genome often involve 
gain-of-function mutations, amplifications, and/or overexpression of key oncogenes and 
the loss-of-function mutations, deletions, and/or epigenetic silencing of key tumour 
suppressors (Hanahan and Weinberg, 2000). Mutations in the genome are divided into 
selectively advantageous “driver” lesions, selectively neutral “passenger” lesions and 
deleterious lesions as well as “mutator” lesions that may accelerate the rate of genetic 
change. Driver lesions can alter cell behaviour and confer a selective advantage over 
neighbouring cells that will promote the development of the disease and have also been 
implicated with reduced sensitivity to anti-cancer agents (Greaves and Maley, 2012, 
Lord and Ashworth, 2012). 
 
Cancer is an evolutionary process that, by analogy to Darwinian evolution, is 
characterized by the continuous accumulation of heritable (passed onto the daughter 
cells) genetic variation by random mutation and natural selection for favourable 
mutations, which provide an evolutionary advantage to the cancer cells over their 
neighbouring cells, such as accelerated proliferation and growth. Most of these 
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evolutionary processes will manifest themselves as benign growths but some of them 
will acquire further advantageous mutations that will allow them to invade tissues and 
metastasize (Ewald and Swain Ewald, 2012).  
 
 
 
 
 
 
 
Figure 1.6: The six hallmarks of cancer (modified from Hanahan and Weinberg, 2011). 
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Tumour suppressor genes such as p53 provide cellular restraints to prevent deregulated 
cell growth and survival or genomic instability. The p53 transcription factor plays a 
central role in inhibiting cell growth and triggering an apoptotic response to a range of 
insults including DNA damage, telomere shortening, environmental stresses and 
oncogene activation. Loss of activity of tumour suppressors removes these restraints 
and can lead to tumourigenesis. In fact, reactivation of p53 in mouse tumour models 
demonstrated that de novo activation of tumour suppressor genes can lead to regression 
of tumours (Martins et al., 2006, Ventura et al., 2007). 
 
Many oncogenes such as extracellular-signal-regulated kinases (ERKs), MYC 
transcription factor (MYC) and rat sarcoma (Ras) are involved in the regulation of cell 
growth, differentiation and survival. Permanent activation or overexpression of these 
proteins in the absence of activated tumour suppressors will inevitably lead to 
uncontrolled cell growth and, ultimately tumourigenesis (Luo et al., 2009). Owing to 
their uncontrolled growth, cancer cells require increased uptake and conversion of 
nutrients but also increased production of nicotinamide adenine dinucleotide phosphate 
(NADPH) as a reducing agent to maintain the cellular redox balance. Increased energy 
requirements are met by an enhanced uptake of glucose and glutamine and even de novo 
fatty-acid biosynthesis by some cancer cells (Schulze and Harris, 2012). Extensive 
metabolic reprogramming is therefore essential to meet the requirements of cancer cells 
to produce large amounts of precursors for subsequent macromolecular biosynthesis 
that allows the accumulation of biomass during tumourigenesis (Schulze and Harris, 
2012). Oncogenes such as MYC have been associated with regulatory changes in the 
transcriptional program leading to energy metabolism along with proangiogenic 
activities, by sustaining the production of vascular endothelial growth factor (VEGF) or 
enhancing neovascularization (Dews et al., 2006). Tumour growth is often accompanied 
by increased vascularization that enhances delivery of nutrients and energy to every cell 
in the solid tumour mass. In fact, lack of vascularity will prevent solid tumours from 
growing indefinitely as internal cells will fail to gain access to essential metabolites. 
Angiogenesis is a fundamental process in both embryogenesis and adult development 
requiring the coordinated action of growth factors and cell adhesion molecules. Key 
signalling pathways of angiogenesis involve members of the VEGF family and platelet-
derived growth factors (PDGFs), which have all been found to activated and 
upregulated by oncogenes in tumours (Ferrara and Kerbel, 2005). Unsurprisingly, 
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antiangiogenic agents have been explored extensively, and with growing success, to 
prevent tumour progression and metastasis (Carmeliet, 2005, Ferrara and Kerbel, 2005). 
 
Traditionally, cancers have been viewed as the result of gradual acquisition of somatic, 
random mutations in the genome that have accumulated though-out the lifetime. Indeed, 
the heterogenic nature of tumours representing a mosaic of cells with unique genetic 
mutation patterns strongly supports the idea that cancer cells have evolved from 
multiple, gradually occurring genetic alterations rather than a single mutation event 
(Stratton et al., 2009). However, 2-3% of all cancers appear to have emerged from a 
one-off cellular catastrophe resulting in tens to hundreds of chromosomal 
rearrangements (Stephens et al., 2011). The agents that cause such dramatic physical 
damages to the chromosome remain largely unknown but result in hundreds of double-
strand breakages of the chromosomes (likely to occur when they are condensed for 
mitosis) leading to chromosomal fragments that circulate unhindered in the nucleus, and 
are pasted together in random order by the DNA repair machinery. Most cells probably 
do not survive such dramatic cellular events but it only requires one surviving cell to 
acquire evolutionary advantageous, cancer-causing lesions followed by additional 
mutations in cancer genes to initiate tumourigenesis. 
 
Our insight and understanding of the highly complex and heterogeneous nature of 
human tumours has expanded substantially over the last decade, leading to the 
recognition that new therapeutic approaches are needed to treat cancer effectively and 
with minimal impact for the patient. Personalized treatments that involve multiple 
therapeutic agents and the increased awareness of environmental and lifestyle factors 
that promote and inhibit cancers, will drive significant advances in the prevention and 
management of the disease in the future. 
 
1.6.8 Mechanisms of mammalian cell death  
Multicellular organisms maintain homeostasis by balancing cell proliferation and cell 
death. Cell death has occurred if at least one of the following criteria has been met: loss 
of plasma membrane integrity, cell fragmentation and/or engulfment by adjacent cells. 
Cell death is a multi-stage process and considered reversible until a “point-of-no-return” 
is passed. In fact, several points-of-no-return have been proposed to define dying cells, 
including the mass activation of caspases, mitochondrial membrane permeabilization 
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and phosphatidylserine (PS) exposure. However, several studies have reported caspase 
activation or PS exposure in non-lethal processes or to have occurred without 
immediate progression to cell death, highlighting the difficulties of defining universal 
criteria for cell death (Boya et al., 2005, Green and Kroemer, 2004). 
 
Cell death can occur via different mechanisms and several types of cell death have been 
described: apoptosis, necrosis, autophagy (characterized by massive autophagic 
vacuolization of the cytoplasm), cornification (specific to the epidermis and leading to 
formation of corneocytes containing an amalgam of proteins and lipids that function as 
a barrier to isolate the body from the external environment) and atypical cell death 
modalities such as mitotic catastrophe (occurs during or shortly after failed/dysregulated 
mitosis as a result of micro- or multinucleation) and anoikis (loss of attachment to the 
substrate or other cells) amongst others. Regardless of the type of cell death, the final 
fate of any dying or dead cell is engulfment by phagocytes. 
 
Apoptosis and necrosis will be discussed in more detail as they are the two most 
common forms of cell death (Table 1iii). Apoptosis is defined as programmed cell 
death. Cells that undergo apoptosis show specific morphological features including the 
rounding-up of cells, retraction of pseudopods, plasma membrane blebbing, chromatin 
condensation and nuclear fragmentation but little or no ultrastructural modifications to 
the organelles. Necrosis occurs following a wide variety of cellular injuries that can be 
caused by exposure to cytotoxic agents. Necrotic cell death is morphologically 
characterized by a gain in cell volume, swelling of organelles, rupture of the plasma 
membrane and loss of intracellular contents. Initially thought to be an uncontrolled or 
accidental form of cell death, necrosis is now believed to be a finely tuned process, 
regulated by signal transduction pathways and catabolic mechanisms involving the 
death domain receptors (Golstein and Kroemer, 2007). Our understanding of the exact 
molecular processes that trigger necrosis remains fragmented. However, induction of 
necrotic cell death has been observed in cells in which both apoptosis and autophagy 
where inhibited, suggesting that necrosis may play a significant role in the highly 
regulated and sophisticated cell death machinery. 
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Table 1iii: Characteristics of necrosis and apoptosis. 
 Necrosis Apoptosis 
Induction 
Non-physiological  disturbances 
(e.g. complement attack, lytic 
viruses, hypothermia, hypoxia, 
toxins) 
Physiological stimuli (e.g. DNA 
damage, lack of growth factors, 
immunomediated) 
Tissue effects 
Acute inflammatory process; 
subsequent scarification 
Non-inflammatory; phagocytosis 
induced by adjacent cells; rapid 
involution without general tissue 
collapse 
 Morphological features 
Onset 
Swelling of cytoplasm and 
mitochondria 
Shrinking of cytoplasm and 
condensation of nucleus 
Plasma 
membrane 
Loss of membrane integrity Membrane blebbing, but no loss 
of integrity 
Chromatin 
 Aggregation of chromatin at the 
nuclear membrane 
Organelles 
Disintegration of organelles Mitochondria become leaky due 
to pore formation involving 
proteins of the bcl-2 family 
Vesicles 
No vesicles formation; complete 
lysis of cell 
Formation of membrane-bound 
vesicles (apoptotic bodies) 
Terminal 
Total cell lysis Fragmentation of cell into 
smaller bodies 
 Biochemical features 
Regulation 
Loss of regulation of ion 
homeostasis 
Tightly regulated process 
involving activation and 
enzymatic steps 
Energy 
requirement 
No energy input Energy (ATP)-dependent 
DNA 
Random digestion of DNA Non-random mono- and 
oligonucleosomal length 
fragmentation of DNA 
Timing Postlytic DNA fragmentation Prelytic DNA fragmentation 
Biochemical 
events 
Involves TNF receptor 1 and the 
recruitment of Fas-associated 
death domain; calpain (protease) 
activation; release of cyclophilin 
D that results in removal of 
transmembrane potential of the 
inner mitochondria 
Release of various factors 
(cytochrome c, AIF) into 
cytoplasm by mitochondria; 
Activation of caspase cascade; 
Alterations in membrane 
asymmetry (i.e., translocation of 
PS from the cytoplasmic to the 
extracellular side of the 
membrane) 
 
  
41 
 
Apoptosis is the regulated destruction of the cell and the result of a highly complex 
process involving a number of different factors and signals. Two key molecular 
signalling pathways exist that lead to apoptotic cell death (Figure 1.7). The first is the 
intrinsic pathway that is activated from inside the cell by proapoptotic members of the 
Bcl-2 protein family that governs downstream mitochondrial signals that that may lead 
to mitochondrial membrane permeabilization. The second is the extrinsic or 
mitochondria-independent death-receptor pathway, that is activated from outside the 
cell by proapoptotic ligands that interact with members of the death-receptor family 
such as tumour necrosis factor receptor I (Ashkenazi, 2002).  
 
Many of the morphological changes that characterize apoptosis are linked to the 
activation of a set of intracellular cysteine proteases called caspases (Kerr et al., 1972). 
Caspases belong to a large family that has been highly conserved through evolution. 
They are central executioners of programmed cell death and activated by both the 
intrinsic and extrinsic apoptotic pathways. Elimination of caspase activity either through 
mutations or pharmacological inhibitors can rescue cells from their apoptotic fate or at 
least slow down the apoptotic process. It is not surprising that cancer-associated 
mutations in caspase-encoding genes have been reported in a number of different cell 
types. Caspases selectively cleave a set of target proteins that in most cases results in 
the inactivation of the target protein but may also activate proteins by cleaving off 
negative regulatory domains or inactivating regulatory subunits.  
 
Caspases are synthesised as zymogens containing three domains (N-terminal 
prodomain, p20 and p10 domain) that require activation by removal of the N-terminal 
prodomain. Downstream caspases are activated through proteolytic cleavage by 
upstream ones, whereas the upstream “initiator” caspases are activated through 
proximity-induced dimerization (Pop and Salvesen, 2009). Caspases-8, -9 and -10 are 
considered the key initiator caspases, that activate the downstream effector caspases-3, -
6 and -7 and which are usually more abundant and active than the other members of the 
caspase family. Over 100 caspase substrates have been identified so far, including those 
inducing chromatin condensation and nuclear fragmentation which are crucial hallmarks 
of apoptosis, highlighting their importance in the regulation of apoptotic 
subprogrammes (Liu et al., 1998, Liu et al., 1997, Sahara et al., 1999). 
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Figure 1.7: Simplefied, schematic representation of the extrinsic and intrinsic apoptosis 
pathways. Apoptotic cell death can be induced through the extrinsic (also called receptor-
mediated) or the intrinsic (mitochondria-mediated) signalling pathways. The extrinsic pathway 
involves ligation to death receptors (e.g. tumor necrosis factor alpha (TNF-α), TNF-related 
apoptosis-inducing ligand (TRAIL), FAS receptor (FasR), also known as cluster of 
differentiation 95 (CD95)) with their ligands through an adaptor molecule, known as Fas-
Associated protein with Death Domain (FADD) that bridges death receptors to caspase-8. Death 
receptors recruit FADD and procaspase-8 to form a death-inducing signalling complex (DISC) 
that activates procaspase-8 and triggers a cascade of caspase activity that cleave target proteins 
leading to apoptosis. This pathway is negatively controlled by the anti-apoptotic proteins c-FLIP 
and Inhibitors of Apoptosis (IAPs). IAPs are a family of functionally and structurally related 
proteins acting as endogenous inhibitors of apoptosis that block activation of caspase-3. Their 
activity is blocked by binding to Smac/Direct IAP Binding protein with Low PI (DIABLO). 
Smac is a mitochondrial protein that promotes cytochrome c dependent activation by 
eliminating the inhibition via IAPs. Intrinsic death stimuli, e.g. reactive oxygen species (ROS), 
DNA-damaging reagents, or Ca
2+
 mobilization directly or indirectly activate the mitochondrial 
pathway by inducing release of cytochrome c and formation of the apoptosome, composed of 
Apoptotic protease activating factor 1 (Apaf-1) and caspase-9. Caspase-9 is activated at the 
apoptosome and, in turn, activates pro-caspase-3. This death pathway is largely controlled by 
pro-apoptotic (e.g. Bcl-2–associated X protein (Bax), Bcl-2 homologous antagonist/killer (Bak), 
BH3 interacting-domain death agonist (BID) and Smac/DIABLO) and anti-apoptotic (e.g. B-
cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-XL), IAPs) proteins. Caspase-8 may 
also induce cleavage of BID, which induces the translocation of Bax and/or Bak to the 
mitochondrial membrane and amplifies the mitochondrial apoptosis pathway. Apoptosis 
inducing factor (AIF) is a mitochondrial protein that triggers chromatin condensation and DNA 
degradation in a cell in order to induce a caspase-independent pathway of apoptosis. The p53 
transcription factor is an essential tumour suppressor and stimulates a wide network of signals 
that act through the two major apoptotic pathways. In the intrinsic pathway, p53 responds to 
stress induction of expression of Bcl-2 pro-apoptotic family members like Bax. p53 can activate 
the extrinsic apoptotic pathway through induction of the genes encoding the transmembrane 
death receptors proteins: Fas, death receptor 5 (DR5) and PMP-22 (PERP). Red: proapoptotic 
signals; blue: antiapoptotic signals. 
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The intrinsic or mitochondrial pathway is triggered by certain extracellular cues and 
severe internal cell stresses, such as DNA or cytoskeletal damage that induces the 
transcription or post-translational activation of proapoptotic Bcl-2 family proteins, 
which constitutes a critical intracellular checkpoint in the intrinsic pathway of 
apoptosis. Bcl-2 family proteins interact extensively with other proteins and it is likely 
that the proapoptotic members induce formation of large pore channels or rupture of the 
mitochondrial membrane either by recruiting other mitochondrial membrane proteins or 
by controlling directly mitochondrial homeostasis. Pore formation in the mitochondrial 
membrane leads to the release of cytochrome c, an important proapoptotic signalling 
protein and a universal feature of apoptotic cells. Cytochrome c is normally located in 
the mitochondrial intermembrane space but upon release into the cytosol it binds to the 
apoptotic protease-activating factor 1 (Apaf-1) whose binding is essential for the 
formation of the apoptosome (Hüttemann et al., 2011; Figure 1.7). 
 
By disabling the specific mechanism that would normally trigger the initiation of 
apoptotic pathways, cancer cells survive and proliferate despite harbouring apoptosis-
inducing changes. Central to the detection of mutations and misreads in the DNA is the 
p53 tumour-suppressor gene. p53 acts as a transcription factor that interacts with  p53-
responsive sequences of genes such as p21 and bax, a proapoptotic member of the bcl-2 
family, which, upon activation, induce cell cycle arrest in aberrant cells (Levine, 1997; 
Figure 1.7). More than 50% of all human tumours harbour missense mutations in at 
least one allele of p53 which allow cells to bypass the intrinsic apoptotic pathway in 
response to their underlying genomic aberrations. 
 
Compounds that can restore apoptosis in cancer cells or increase their sensitivity to 
chemotherapeutic agents are promising candidates for the treatment of tumours. 
 
 
1.7 Aims of the project 
Metabolic engineering of plants offers a unique opportunity to improve the nutritional 
value of existing food crops by increasing their content of health-beneficial 
phytonutrients. During my research for my PhD I aimed to generate two transgenic 
high-anthocyanin tomato lines that accumulated substantial amounts of cyanidins and 
pelargonidins in the fruit. A metabolic engineering strategy was developed to modify 
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the activity of biosynthetic enzymes involved in the formation of separate anthocyanin 
classes. 
 
Using an in vitro breast cancer cell system, I investigated the anti-cancer properties of 
wild type (WT) and high-anthocyanin tomato extracts in order to establish, whether the 
nutritional enhancement of crops with bioactive phytochemicals like anthocyanins, 
could improve their activity against cancer cell proliferation and survival, and whether 
there were differences between different types of dietary anthocyanins in their anti-
cancer properties.  
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2 Developing novel tomato lines with 
increased anthocyanin content 
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2.1 Introduction 
Anthocyanins represent an important group of polyphenolic compounds that are derived 
from the phenylpropanoid biosynthetic pathway (Figure 2.1). Owing to their large 
structural variability they are one of the largest and most abundant groups in the 
flavonoid family. Because they are pigments, anthocyanins often act to attract 
pollinators and seed-dispersing animals but also fulfil other important roles as free 
radical scavengers or protective screens during stress responses to high irradiance and 
low temperatures. Due to their high natural abundance, they are important components 
of the human diet and have been associated with a number of health benefits. Despite 
their near ubiquitous presence in higher plants (they are missing from the order of the 
Caryophyllales that includes the amaranth family members, sugar beet and beetroot, 
which produce betalains instead), anthocyanins are absent from most major food crops. 
Selective breeding strategies focusing predominantly on traits linked to high yield and 
high-energetic values (e.g. starch) have resulted in the loss or reduction of many 
valuable phytonutrients in modern crop varieties. Corn, potatoes, and wheat are some of 
the most important staple crops worldwide but all major varieties produced for human 
consumption are anthocyanin-deficient, despite the existence of anthocyanin-rich 
alternatives. For example, purple corn is a niche crop compared to white, anthocyanin-
free corn varieties. Recent advances in our understanding of the dietary importance of 
these compounds have led to a revival of anthocyanin-pigmented varieties and 
generated a significant research effort into the improvement of existing crop species.  
 
Commercial tomato plants produce a variety of flavonoids in their vegetative tissues, 
including low levels of anthocyanins which are mostly produced in the stems of young 
plants. The fruit contain a number of important phytonutrients, most notably the 
carotenoid lycopene and the flavonoid, rutin (quercetin-rutinoside). Other flavonols 
such as naringenin, kaempferol, quercetin and myricetin and their respective 
dihydroflavonols are produced in small quantities but no anthocyanins are synthesized. 
Several transgenic approaches to modify polyphenol metabolism in tomato have 
succeeded in producing plants with improved polyphenol contents. By introducing a 
Petunia chalcone isomerase (CHI) Muir and colleagues (2001) developed transgenic 
tomato plants with up to 78 fold more flavonols in fruit peel, most notably quercetin 
glycosides. Similarly, overexpression of other structural genes involved in flavonoid 
biosynthesis from different plant sources, also resulted in the accumulation of high 
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levels of deoxychalcones, flavones and flavonols in transgenic tomatoes (Schijlen et al., 
2006). Expression of the maize gene encoding the MYB-type transcription factor C1 
and the LC gene encoding a bHLH transcription factor that together control the 
expression of several structural genes in the pathway leading to anthocyanins, also 
increased accumulation of flavonols in tomato fruit, but not anthocyanins (Bovy et al., 
2002).   
 
Despite their absence from tomato fruit, anthocyanins are found in several closely 
related species such as Solanum chilense or Solanum cheesmanii, where anthocyanin 
pigmentation in the fruit has been associated with the genes Anthocyanin fruit (Aft) and 
Aubergine (Abg) (Mes et al., 2008). The introgression of abg into tomato resulted in 
fruit that produced patches of anthocyanin pigmentation in the peel upon exposure to 
high light (Jones et al., 2003). Introgression is defined as the incorporation of a gene 
from one species into the gene pool of another through repeated backcrossing of the 
interspecific ybrid to one of its parents. 
 
Recently, a more uniform anthocyanin pigmentation in the peel of the fruit has been 
achieved by introgressing Aft and the atroviolaceum (atv) gene into tomato, which 
influences anthocyanin accumulation in the whole plant (Povero et al., 2011). However, 
conventional breeding tools have limitations, as illustrated by the inability to generate 
tomato crosses where anthocyanin pigmentation extends beyond the peel. In 2008, 
tomato fruit with intense anthocyanin pigmentation of both peel and pericarp were 
produced using a transgenic approach (Butelli et al., 2008). Two genes encoding 
transcription factors from snapdragon, Delila (Del) and Rosea1 (Ros1) encoding basic 
helix-loop-helix (bHLH) and R2R3 MYB transcription factors, respectively, were 
introduced into tomato (var MicroTom) under control of a tomato fruit-specific 
promoter (E8). Anthocyanin accumulation in these tomatoes was uniform and light-
independent and reached up to 3 mg/g FW. Butelli’s work demonstrated that activation 
of the existing pathway rather than modification or insertion of structural anthocyanin 
genes was all that was required for anthocyanin accumulation in tomato (Figure 2.1).  
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Figure 2.1: Schematic representation of the biosynthetic pathway leading to production of 
flavonoids. Only the structures of flavonoid classes relevant to this research are shown (boxes). 
PAL, phenylalanine ammonia lyase; 4CL, 4-coumarate:coenzyme A ligase; C4H, cinnamate 4-
hydroxylase; C3H, 4-coumarate 3-hydroxylase; CHS, chalcone synthase; CHI, chalcone 
isomerase; F3H, flavanone-3-hydroxylase; F3'H, flavonoid-3'-hydroxylase; F3'5'H, flavonoid-
3'5'-hydroxylase; FLS, flavonol synthase; DFR, dihydroflavonol reductase; ANS, anthocyanidin 
synthase. 
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Biochemical analyses of the tuber skin and flesh of pigmented potato (Solanum 
tuberosum L.) cultivars showed that the anthocyanins are derived mainly from either 
red, monohydroxylated pelargonidins or purple, trihydroxylated delphinidins but trace 
amounts of dihydroxylated cyanidins have also been reported (Lewis et al., 1998). 
Interestingly, anthocyanin-producing tomato varieties and other closely related 
Solanaceae family members produce predominantly trihydroxylated delphinidins 
indicating the inability to synthesise the other classes of anthocyanins. Dihydroflavonol-
4-reductase (DFR) is the first committed step in the anthocyanin pathway and competes 
with flavonol synthase (FLS) for a group of structurally similar substrates, DHK, DHQ 
and DHM. Synthesis of the three dihydroflavonols is dependent on the activity of two 
hydroxylases: F3’H and F3’5’H which catalyses the conversion of DHK to DHQ and 
DHK to DHM by adding one or two hydroxyl groups, respectively, to phenyl B-ring. 
Most DFRs can effectively catalyse the reduction of all these colourless precursors since 
these compounds differ only in the number of hydroxyl groups on the phenyl B-ring, 
which is not the site of enzymatic action. However, DFRs from some species, such as 
the solanaceous species Petunia hybrida cannot reduce DHK efficiently, and do not 
produce orange-coloured pelargonidins (Johnson et al., 2001b). In Petunia, the substrate 
specificity of DFR has been associated with a region of approximately 40 amino acids 
which is highly variable in the DFRs from different species (Johnson et al., 2001b). 
Similarly, tomato shows a strong DFR substrate specificity for DHM. Tomato DFR may 
be capable of utilizing DHQ to a lesser extent but the absence of pelargonidin-based 
anthocyanins in tomato and its close relatives suggest that tomato DFR cannot use DHK 
as a substrate for the formation of leucopelargonidin and ultimately pelargonidins. 
Whilst absence of activity of either F3’5’H or F3’H in species like Ipomea, Arabidopsis 
and A. majus (Hoshino et al., 2003, Ishiguro et al., 2012, Rausher, 2008, Zufall and 
Rausher, 2004) has accounted for the inability to synthesise all three anthocyanins, the 
presence of all three dihydroflavonols in WT tomato suggests strongly that it is the 
specificity of DFR rather than F3’5’H or F3’H activity that is the limiting step in the 
production of all three anthocyanin classes in tomato.  
 
Failure to produce  anthocyanins with less than three hydroxyl group on the phenyl B-
ring suggest strongly that tomato DFR has strong substrate specificity for DHM. 
Increasing the synthesis of DHM through activation of F3’5’H is therefore a 
prerequisite for making anthocyanin production in tomato possible (Bovy et al., 2002). 
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Consequently, metabolism of mono- and dihydroxylated anthocyanins could be 
facilitated by blocking the activity of F3’5’H.  
 
Because tomato is a member of the Solanaceae family, and DFR has been shown to 
have strong substrate specificity for DHM in other solanaceous species (Johnson et al., 
2001b) we hypothesised that in order to generate tomatoes accumulating high levels of 
monohydroxylated (pelargonidin) or dihydroxylated (cyanidin) anthocyanins we would 
need to inhibit F3’5’H activity and possibly add a DFR from a species that synthesised 
cyanidin/pelargonidin to overcome the substrate specificity of tomato DFR for DHM. 
 
We proposed that complementation of tomato plants with DFR from A. majus, a species 
that produces both pelargonidin- and cyanidin-based anthocyanins in its flowers 
(Sherratt, 1958), could facilitate the Del/Ros1 transcription factor-driven production of 
significant amounts of the two anthocyanins in tomato. In the presence of a functional 
F3’5’H, tomatoes convert DHK to DHM, and ultimately trihydroxylated delphinidins. 
In order to generate dihydroxylated cyanidins in tomato, we hypothesised that inhibition 
of F3’5’H in a DelRos1 background was required to induce cyanidin accumulation. We 
also hypothesised that complementation with DFR from A. majus would significantly 
increase the amount of cyanidins produced in this tomato line by overcoming the 
potential limitations of the tomato DFR in effectively converting DHQ to leucocyanidin 
and ultimately cyanidins. Monohydroxylated pelargonidins are not found in the majority 
of the solanaceous species. The inability of DFR to catalyse the conversion of DHK to 
leucopelargonidin has been well documented in the solanaceous species Petunia (Beld 
et al., 1989, Johnson et al., 2001b) and is likely to explain the absence of pelargonidins 
from tomato. We hypothesised that significant accumulation of pelargonidins in tomato 
could be achieved by following the same approach we proposed to generate large 
amounts of cyanidin, together with inhibition of tomato F3’H activity (F3’H catalyses 
the conversion from DHK to DHQ). In the absence of F3’5’H and F3’H activity, DFR 
from A. majus should convert DHK to leucopelargonidins which would ultimately lead 
to the formation of pelargonidins in tomato. 
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2.2 Aims 
In this chapter the metabolic engineering of steps in the anthocyanin biosynthetic 
pathway are described. Manipulation of the activity of the hydroxylase, F3’5’H and the 
reductase, DFR, allowed us to produce structurally different anthocyanins in tomato. A 
dfr gene sequence from A. majus known to encode a protein active on DHK and DHQ 
was used to overcome tomato DFR substrate specificity for DHM and catalyse the 
production of monohydroxylated pelargonidins and dihydroxylated cyanidins in tomato 
fruit. Using a transgenic approach all three anthocyanin subclasses, delphinidin, 
cyanidins and pelargonidins, were generated in different tomato lines. This work 
confirmed that metabolic engineering is an effective tool for achieving the accumulation 
of novel compounds in important crop species such as tomato. Furthermore, WT and 
transgenic tomatoes producing different anthocyanins can be used as models to 
investigate the health-promoting effects of different anthocyanin classes in the context 
of the same food matrix in comparative nutrition studies.  
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2.3 Experimental Procedures 
 
2.3.1 Supplier details  
Molecular grade chemicals and kits used in this research were obtained from Amersham 
(GE Life Sciences), BioRad, Fisher Scientific Ltd, Invitrogen, Life Technologies, 
Merck Millipore, New England Biolabs, Promega, Roche, Qiagen, Sigma, Thermo 
Scientific and Waters. 
 
2.3.2 Purified Polyphenolics 
The anthocyanin, delphinidin-3-O-glucoside chloride was purchased from 
Extrasynthase and dissolved in DMSO to a final concentration of 200 mM.  
 
2.3.3 Enzymes 
All restriction enzymes used for the generation of constructs for transformation by the 
insertion or removal of sequences, were purchased from New England Biolabs, 
Invitrogen or Roche. The polymerases used for the amplification of PCR products were 
purchased from Qiagen (Taq polymerase) or Thermo Scientific (Phusion® High-
Fidelity DNA Polymerase). BP Clonase™ and LR Clonase™, required for the 
generation of constructs using Gateway® recombination cloning technology were 
supplied with Gateway® BP Clonase® II Enzyme mix and Gateway® LR Clonase® II 
Enzyme mix, respectively (Life Technologies). 
 
2.3.4 Antibiotics 
Ampicillin, carbenicillin, gentamycin, kanamycin, rifampicin, tetracycline and timentin 
were used for the selection of bacteria and transgenic plant material as required. Stock 
and working concentrations for each antibiotic are shown in Table 2i. 
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Table 2i: Concentrations of antibiotics used. 
Antibiotic Purpose Working stock 
concentration 
Original stock 
concentration 
Ampicillin For selection of E. coli 100 µg/mL 100 mg/mL 
Carbenicillin Used for selection of 
Agrobacterium AGL-1 
50 µg/mL 50 mg/mL 
Gentamycin For selection of E. coli 50 µg/mL 50 mg/mL 
Kanamycin For selection of E. coli, 
Agrobacterium, transformed 
plants 
50 µg/mL (E.coli) 
100 µg/mL (plants) 
100 mg/mL 
Rifampicin For selection of 
Agrabacterium 
50 µg/mL 50 mg/mL 
Tetracycline For selection of E. coli 10 µg/mL 10 mg/mL 
Timentin For killing Agrobacterium 
during callus propagation 
320 µg/mL  
 
 
2.3.5 Plant material 
WT tomato (Solanum lycopersicum var. MicroTom) and an f3’5’h-/- mutant, a 
(anthocyaninless; Solanum lycopersicum in VF36 background) were used for plant 
transformation. Tomato seeds were obtained from the seed bank of the Tomato Genetics 
Resource Center (TGRC) at the University of California at Davis, USA. 
 
2.3.6 Plant growth conditions  
WT and transgenic tomato (Solanum lycopersicum var. MicroTom and VF36) plants 
were grown at 23-25°C under 16 h light and 8 h dark cycle. These conditions were 
maintained in the growth room, where the plants were grown on MS agar medium, and 
in the glasshouse. Tomato seedlings were transferred from MS agar medium to soil after 
approximately 3-4 weeks.  
 
2.3.7 Seed isolation and sterilization 
Seeds were extracted from mature tomato fruit and incubated for 10 min in 50% 
hydrochloric acid (HCl; v/v) on a plate shaker at room temperature to separate the 
55 
 
gelatinous coating and any remaining tomato flesh. After the HCl treatment, seeds were 
rinsed with water and incubated in 10% trisodium phosphate (TSP) for another 30 min 
on a plate shaker at room temperature to kill pathogens present on the seed surface. 
After TSP treatment, seeds were rinsed in water and sterilized in 10% commercial 
bleach (v/v) for 3 h with vigorous shaking. Seeds were washed three times with sterile, 
distilled water (dH2O) before being sown out on MS agar (0.8%) plates with or without 
selective antibiotic. 
 
2.3.8 Bacterial strains 
The bacterial strains used for the expression of genes or maintenance of plasmids were 
E. coli DH5α and the Agrobacterium tumefasciens  strain AGL-1. All bacteria were 
grown in medium containing 10g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl and 15g/L 
agar (optional, for plate growth on solid medium). 
 
2.3.9 Molecular methods 
Most methods followed the standard procedures described in MOLECULAR 
CLONING (Sambrook and Russell, 2001) and were modified according to specific 
requirements. Additional protocols were followed according to the product supplier’s 
specific instructions and modified when necessary. 
 
2.3.9.1 Extraction of tomato leaf genomic DNA using CTAB and 
Phenol:Chloroform 
DNA was extracted from tomato leaf material using hexadecyl trimethyl-ammonium 
bromide (CTAB) extraction buffer and purified by phenol:chloroform. CTAB buffer 
was prepared with CTAB (0.2 g/L, 0.1 M Tris pH 8.0, 0.02 M 
ethylenediaminetetraacetic acid (EDTA) pH 8.0, 1.4 M NaCl, 1% polyvinylpyrrolidone 
(PVP 40)) and adjusted to pH 5.0 with HCl. 
Fresh, juvenile plant leaf tissue (200 mg) was ground to a fine powder in liquid N2. 500 
μL of CTAB buffer were added to the plant tissue and homogenized. Tubes were 
transferred to a water bath and incubated for 10 min at 55°C. After incubation, the 
CTAB/plant extract mixture was centrifuged at 12,000 g for 5 min to spin down cell 
debris. The supernatant was then transferred to clean microcentrifuge tubes. An equal 
volume of phenol:chloroform was added to the DNA sample and vortexed until an 
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emulsion formed. The sample was microcentrifuged at 10,000 g for 3 min to achieve a 
separation of the phenol:chloroform and aqueous phase. The aqueous phase from the 
top was transferred to a fresh tube and the washing steps repeated until all protein and 
organic matter were removed from the sample. 
 
2.3.9.2 DNA precipitation with ethanol 
To precipitate the DNA, 2.3 vol of ice-cold 100% ethanol (EtOH) and 0.1 vol NaAc 
(3.0 M; pH 5.3) were added to the sample, and mixed well. The DNA solution was 
incubated at -20°C overnight, before being microcentrifuged for 20 min at 12,000 g. 
The supernatant was removed without disturbing the DNA pellet and the DNA was 
washed with 1 mL 70% EtOH before being microcentrifuged for another 10 min at 
12,000 g. The supernatant was removed carefully and the DNA pellet allowed to air-dry 
to remove all excess EtOH. The DNA pellet was resuspended in sterile, DNAse-free 
water and stored at -20°C until further use. 
 
2.3.9.3 Primer Design and Supply  
For the cloning of genes into various vectors, the confirmation of the presence of genes 
of interest in vectors, bacteria or plant samples and gene expression studies, specific 
primers were designed using the following standard guidelines. For the confirmation of 
gene presence, primers were designed to align at least 100 bp upstream and downstream 
of the start codon and stop codon, respectively. For restriction cloning, restriction site 
sequences preceded by a GC clamp to aid primer alignment were carefully added to the 
gene-specific sequences to ensure the selection of unique restriction sites to avoid 
insertion in non-target regions in the vector. For Gateway cloning™, attB1 and attB2 
sites were added to the 5’ end of the forward and reverse PCR primers, respectively. All 
other primers were designed using Primer3Plus
©
 open web software. The primers were 
synthesized and supplied by Sigma and the PCR Tm values calculated using formula: Tm 
= 2(A/T) + 4(G/C).  
 
2.3.9.4 Polymerase Chain Reaction (PCR)  
PCR reactions were performed using G-Storm and Hybaid Touchdown Thermo Cyclers. 
Taq DNA polymerase (Qiagen) was used for genotyping and colony PCRs. Phusion
®
 
High-Fidelity DNA polymerase (Thermo Scientific) was used for the cloning of 
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gene/cDNA sequences, where high fidelity and high processivity were required. For a 
PCR from cDNA, no more than 100 ng of template were transferred to a sterile PCR 
tube, and 1 μL of each primer (10 mM; synthesised by Sigma-Aldrich, Poole, UK) and 
1 μL dNTP mix were added. dNTP mix contained dATP, dGTP, dTTP and dCTP 
(Promega) each at a final concentration of 10 mM. 5 μL 10x reaction buffer as well as 
0.5 U of polymerase and distilled, sterile water to reach a final reaction volume of 50 μL 
were added. PCR conditions varied depending on the Tm of the primers, the length of 
the expected product size, and the polymerase used in the reaction. 
 
2.3.9.5 Purification of PCR products 
PCR purification was performed using a PCR purification kit (Qiagen) following the 
protocol provided. This purification procedure allows for the removal of primers, 
nucleotides, enzymes, salts, detergents and other impurities from DNA samples. Mixing 
of the PCR solution with binding buffers supplied increases the amount of chaotropic 
salts which alter the structure of water which is required for optimum adsorption of the 
DNA to the QIAquick silica membrane resins. Optimum adsorption occurs at a pH ≤ 7.5 
and was adjusted with 3 M sodium acetate, pH 5.0 if necessary. During DNA 
adsorption, impurities do not bind to the silica membrane but will flow through the 
resin, whilst salts are washed away by an ethanol-containing buffer. 
 
The purified DNA was eluted by adding 30 μL of water directly onto the silica 
membrane and incubating for 1 min before centrifuging at 13,000 g for 1 min.  
 
2.3.10 Methods of construct design 
 
2.3.10.1 Plasmid DNA isolation from E. coli 
Plasmid DNA was isolated from 1-5 mL of liquid, overnight E.coli cultures transformed 
with the vector of interest and grown with the appropriate antibiotic selection.The 
bacterial cells were collected by centrifugation at 12,000 rpm for 2 min and resuspended 
in lysis buffer. Plasmids were isolated using the QIAprep® Spin Miniprep kit (Qiagen) 
following the instructions provided by the manufacturer. Membrane-bound plasmid 
DNA was eluted in 25-50 µL of elution buffer (provided). 
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2.3.10.2 Plasmid and PCR digests  
Restriction digestions of PCR products and vectors were performed using suitable 
restriction enzymes for T4 ligation reactions and the confirmation of cloning. 
Restriction enzymes with matching buffers where chosen when possible and reaction 
mixtures set up with 0.5-1.0 µg of plasmid or PCR DNA, 10-20 units of respective 
restriction enzyme, 1x final concentration of buffer and dH20 to make up to required 
reaction volume. Reactions were incubated for 1 h at 37°C or the temperature specified 
for the enzyme, before loading a small aliquot on a 1.0 % agarose gel to check for 
successful digestion. If digestion was partial, reactions were re-incubated for up to 4 h 
before the reaction was either stopped though heat-inactivation at 65°C for 15 min, or 
the enzyme removed by ethanol precipitation of DNA. 
 
2.3.10.3 Ligation 
Ligation reactions were set up with a concentration ratio of 3:1 for insert to vector DNA 
using approximately 50 ng of insert DNA and 150 ng of vector DNA, 1x ligation buffer, 
5-10 units of T4 DNA ligase and dH20 up to a final volume of 10 µL. The reaction was 
performed overnight at 4 °C. 
 
2.3.10.4 Agarose gel electrophoresis  
PCR and restriction digestion products were run on 1.0 % agarose gels in 1X Tris 
Borate EDTA (TBE 10X: 0.89 mM Boric Acid and 20 mM EDTA; pH 8) buffer. Prior 
to casting, ethidium bromide was added to the agarose gel at a final concentration of 0.1 
µg/mL. Standard DNA markers (100 bp and 1 kb ladders; NEB) were used to identify 
the size of fragments and the ethidium bromide-stained DNA was visualized using a 
long wavelength UV transilluminator. 
 
2.3.10.5 Purification of DNA bands from agarose gels 
After running DNA on a 1% agarose gel containing 0.1 μg/mL ethidium bromide, DNA 
was visualized under UV light and bands of interest cut out using a sharp, sterile scalpel 
blade and transferred to an Eppendorf tube for subsequent DNA purification. 
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DNA was eluted and purified from the gel using the Gel Extraction Kit (Qiagen) and the 
DNA was recovered according to the instruction provided. The DNA was eluted from 
the Qiagen binding column by adding 25-50 µL of elution buffer (provided with kit). 
 
2.3.10.6 Quantification of DNA or RNA  
Purified DNA or RNA samples were quantified using a NanoDrop UV-Vis 
spectrophotometer (Thermo Scientific). Nucleotides absorb at 260 nm (A260), whilst 
proteins have a peak absorbance at 280 nm (A280). A ratio of absorbance at 260 nm and 
280 nm is used to assess the purity of DNA and RNA. A260/A280 ratio of ~1.8 and 
higher is typically suitable for further analysis or downstream applications. Protein 
contamination will lower the A260/A280 ratio. 
 
2.3.10.7 GATEWAY® cloning  
The Gateway
®
 recombination cloning technology (Invitrogen) allows for the transfer of 
DNA sequences between plasmids using a set of recombinant “Gateway® att” sites and 
“BP and LR clonase” enzyme mixes. Cloning is carried out in two steps, requiring the 
BP clonase-mediated insertion of an “att” sequence-flanked DNA fragment into a 
suitable Gateway
® 
entry vector such as pDONR207. The gene cassette in the entry clone 
is then transferred into a suitable Gateway
® 
destination vector using LR clonase. 
Gateway
® cloning was performed according to the manufacturer’s instructions. The 
“att” sequences and a detailed description for the entry vectors are available from 
Invitrogen. 
 
2.3.10.8 Sequencing reactions 
Plasmids that potentially contained the desired sequence or gene inserts were sequenced 
using standard Big Dye Sequencing reactions set up with 100-150 ng of plasmid DNA, 
0.4 μL of desired primer (10 mM), 1 μL of Big Dye 3.1, 2.6 μL of 5x buffer (supplied 
with Big Dye), and dH2O to a final volume of 13 μL. The PCR was performed 
according to the following conditions: initial denaturation at 96°C for 1 min, followed 
by 25 cycles of denaturation at 96°C for 10 sec, annealing at 50°C for 10 sec, and 
elongation at 60°C for 4 min. Samples were commercially sequenced by Genome 
Enterprise Ltd (Norwich, UK) and data obtained as ABI trace files that were analysed 
with Vector NTI® Advance Software version 11 (Invitrogen).  
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2.3.11 Quantifying gene expression 
Expression of key anthocyanin pathway genes was detected using quantitative reverse-
transcriptase PCR (qRT-PCR). 
 
2.3.11.1 RNA extraction 
High quality, intact RNA was essential for analysing the activity of target genes by 
qRT-PCR. RNA was also required for making first strand cDNA in PCR experiments. 
Different RNA extraction techniques were used for tomato fruit tissue and tomato leaf 
tissue. 
 
2.3.11.2 Total RNA extraction from fruit tissue using TRI Reagent® 
Tomato fruit were harvested at different developmental stages, sliced and the seeds 
removed, before being frozen immediately in liquid nitrogen (N2) and stored at -80°C 
until further use. 
 
Total RNA was isolated using TRI Reagent
®
 (Sigma) following the recommended 
protocol with modifications. Tomato fruit tissue (200 mg) was ground in liquid N2 
before adding 1.5 mL of TRI Reagent
®
. The homogenised sample/TRI Reagent
®
 
mixture was incubated at room temperature for 5 minutes shaking, before adding 150 
µL 1-Bromo-3-chloropropane (BCP; Sigma) which acts as a phase-separation agent and 
decreases the possibility of contamination of RNA with DNA. The sample/TRI 
Reagent
®
/BCP mixture was homogenized thoroughly and incubated for another 10 min 
at room temperature. The sample mixture was microcentrifuged for 10 mins at 12,000 g 
at 4°C. Two distinct phases formed and 750 µL of the aqueous, RNA-containing phase 
were transferred to a sterile, RNAse-free tube and mixed with an equal volume of 
isopropanol. The RNA was allowed to precipitate for 5 min at room temperature, before 
being microcentrifuged for 8 min at 12,000 g at 4°C. Then, the supernatant was 
discarded and the RNA pellet washed with 500 µL of isopropanol. Without disturbing 
the pellet the supernatant was carefully removed and the RNA pellet washed with 1.0 
mL of 75% EtOH. The supernatant was discarded and the EtOH washing step was 
repeated before air-drying the RNA pellet at room temperature for approximately 5 min. 
Then, the RNA pellet was resuspended in 40 µL sterile, RNAse-free H20 and allowed to 
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dissolve for 1 h at 4°C. The sample was centrifuged for 5 min at 12,000 g at 4°C to 
separate the soluble RNA solution from remaining contaminants such as sugar that 
formed a pellet at the bottom of the Eppendorf tube. RNA-containing supernatant (32 
µL) was transferred to a new Eppendorf tube and mixed with 4 µL of DNAse1 and 4 µL 
of 10x DNAse1 buffer (Invitrogen™) and incubated at room temperature for 45 min. 
The DNAse reaction was stopped by adding 4 µL of 25 mM EDTA and incubating at 
65°C for 10 min. 
 
2.3.11.3 RNA extraction using Qiagen RNeasy mini kit 
Total RNA was isolated from plant leaves using the Qiagen RNeasy mini kit following 
the manufacturer’s protocol (Qiagen). Plant material was ground in liquid N2, lysed and 
then homogenized with the QIAshredder column. 
 
EtOH was added to the lysate to provide optimum conditions that promote selective 
binding of the RNA to the RNeasy silica-like membrane. Contaminants were washed 
away before eluting the membrane-bound RNA with RNase-free water. 
 
2.3.11.4 cDNA synthesis 
DNAse-treated RNA (3 µg) was mixed with 1 µL of 10 mM primer mix (1:1 oligo-dT 
and random primers), 1 µL of 10 mM dNTPs, and RNAse-free H20 was added to a final 
volume of 20 µL. The RNA/dNTP/primer mix was incubated for 5 minutes at 65°C and 
then chilled on ice. Reverse transcription from RNA was performed with Invitrogen’s  
SuperScript® III Reverse Transcriptase kit by adding 6 µL of 5x first strand buffer, 2 
µL of 0.1 M dithiothreitol (DTT), 1 µL of SuperScript® III Reverse Transcriptase and 1 
µL of RNaseOUT™ (RNase inhibitor, Invitrogen™) to the 20 µL RNA/dNTP/primer 
mix. Samples were mixed gently and reverse transcription was allowed to take place for 
1 h at 50°C. The reaction was inactivated by heating at 70°C for 15 min and samples 
were stored at -20°C. 
 
2.3.11.5 Quantitative PCR  
Three independent biological samples of tomato fruit at breaker stage were pooled and 
RNA was extracted as previously described in Chapter 2.3.11.2. Expression of 
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flavonoid biosynthetic pathway genes (primers shown in Table 2ii) was measured by 
qRT-PCR using SYBR
®
 Green JumpStart™ Taq ReadyMix™ (Sigma) and RNA 
quantity was normalised to Solanum lycopersicum ubiquitin (S. lycopersicum ubiquitin). 
Ubiquitin acts as an internal standard that is required to normalise RNA amount and 
does not change in expression as tomato fruit undergo development. The qRT-PCRs 
were performed in white well PCR plates and for each qRT-PCR reaction 50 ng of 
cDNA were mixed with 5 µM forward and reverse primer (1 µL each) and 10 µL of 
SYBR® Green JumpStart™ Taq ReadyMix™ and RNAse-free H20 was added to a 
final volume of 20 µL. All reactions were performed in triplicate and real-time detection 
was performed using an Opticon™ DNA Engine 2 thermal cycler (MJ research). The 
data was acquired and analysed with MJ Opticon Monitor™ 3.1 analysis software. 
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Table 2ii: Sequences and efficiency values of primers for real-time PCR used to 
investigate anthocyanin biosynthetis gene expression. 
Gene Primer Sequence (5’  3’) Efficiency 
SlUBI 
F GCCAAAGAAGATCAAGCACA 
1.82 
R TCAGCATTAGGGCACTCCTT 
SlPAL 
F AATTGCTTCGAGTCGTGGATAG 
1.91 
R ACAAGGACTTGTCTCAGCTTCTG 
SlCHS-1 
F CCTTTATTTGAACTCGTCTCAGC 
1.71 
R CAGGAACATCCTTGAGTAAGTGG 
SlCHI 
F TTGTCAACTCGGTCTAATGTGTC 
1.98 
R TAAAGTGGGACCTTATTGCACAC 
SlF3H 
F ATGGATGAGCCGATTACATTTG 
1.98 
R TGGCCTCTTCAGTTTGTATCTTC 
SlF3'5'H 
F CTCAACGCCACTAAATCTCCCTA 
1.93 
R TTGCCCATATGTTGACACTAAGC 
SlF3'H 
F TATAGCTGGGACAGACACATCCT 
2.16 
R CTACTTTGTCGATCTCCTGTTGG 
SlDFR 
F GACTTGCCGACAGAAGCAAT 
1.96 
R GTGCATTCTCCTTGCCACTT 
SlANS 
F ACGAACAGGATTTTGCTGCT 
1.97 
R TTTGAGCTCAGCAACTGCAT 
SlFLS 
F TGTCCCATATCACCCTTCTTGTC 
1.71 
R TCACCAATGTGGACAATTATAGCA 
AmDFR 
F TGCAACTGTTCGTGATCCTG 
1.90 
R CATGTCTGCCTTCCACAATG 
AmDel 
F AGATTACTTGAGAGGGCTTGAGAGG 
2.01 
R TGGCATCGTGTAGTTTAGTTTTTGT 
AmRos1 
F TGGTCGCTATTGCTGGTAG 
1.92 
R ATCGTTCTCCATCCATCCTCGCCTA 
 
Am, Antirrhinum majus; F, forward; R, reverse; Sl, Solanum lycopersicum.  
 
 
2.3.12 Construction of binary vectors for Agrobacterium-mediated plant 
transformation  
Stably transformed tomato plants were generated using Agrobacterium tumefasciens (A. 
tumefasciens)-mediated transformation. Agrobacterium-mediated DNA transfer is an 
efficient technique to deliver plasmids into many different plant species. A. 
tumefasciens causes crown gall disease and infects plants by transferring virulence 
genes into the nucleus of infected cells. The disarmed A. tumefasciens strains used in 
plant transformation have lost the genes that cause the symptoms of crown disease but 
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retained their ability to transfer plasmid DNA into infected plant cells. Binary vectors 
are shuttle vectors that can replicate in multiple hosts. 
 
2.3.12.1 Construction of binary vector SLJ.E8.DFR 
The cDNA sequence encoding for the A. majus DFR was cloned into a suitable binary 
vector allowing for expression in both E.coli and A. tumefasciens. 
 
2.3.12.1.1  Digestion of binary vector SLJ.E8.60 
The binary destination vector SLJ.E8.60 was provided by Eugenio Butelli. SLJ.E8.60 
has been modified from the SLJ7292 plant expression vector (generated by Prof 
Jonathan Jones, The Sainsbury Laboratory, Norwich, UK. Plasmid list available from 
http://www.tsl.ac.uk/research/jonathan-jones/plasmids.htm) by insertion of sequences 
encoding the S. lycopersicum E8 promoter (GenBank accession: DQ317599.1) and the 
A. majus Rosea1 gene (GenBank accession: DQ866652.1). In order to place the A. 
majus dfr (AmDfr) cDNA sequence under control of the E8 promoter, the Rosea1 gene 
was removed from SLJ.E8.60 by selecting suitable restriction sites downstream and 
upstream of the Rosea1 sequence and digesting SLJ.E8.60 with BamHI and SmaI 
(Figure 2.4 A) 
 
2.3.12.1.2 Addition of restriction sites to AmDfr cDNA 
Dfr cDNA from A. majus (size 1,341 bp; GenBank accession: X15536.1) was kindly 
provided by Cathie Martin and reamplified using primers designed to introduce BglII 
and SmaI restriction sites (Figure 2.2). BamHI and BglII generate compatible cohesive 
ends that allow for ligation of the BglII-flanked DFR cDNA sequence into the BamHI-
digested destination vector. Primer sequences are reported in Table 2iii and their 
respective positions in the cDNA highlighted in Figure 2.2. The PCR reaction to add 
these restriction sites was performed with proof-reading Pfu
®
 DNA polymerase 
(Stratagene) according to the following conditions: initial denaturation at 95°C for 2 
min, followed by 30 cycles of: denaturation at 95°C for 45 sec, annealing at 65°C for 45 
sec, elongation at 72°C for 90 sec and a final elongation step of 10 min at 72°C.  
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DfrSmaI_RE 
DfrBglII_FA 
 
CGAGAAGATCTATGAGTCCCACTTCACTAAATACGAGTTCGGAAACCGCACCACCATCCTCAACCACCGT
ATGTGTCACAGGAGCTGCCGGCTTCATAGGCTCATGGCTTGTCATGAGGCTTCTCGAACGTGGCTACACC
GTTCGTGCAACTGTTCGTGATCCTGGTAATATGAAGAAGGTAAAACACCTAATAGAACTGCCAAAAGCAG
ACACGAACTTGACATTGTGGAAGGCAGACATGACAGTAGAAGGAAGCTTCGACGAAGCAATTCAAGGTTG
CGAAGGAGTGTTTCACTTGGCCACGTCTATGGAATTTGATTCCGTGGATCCTGAGAATGAAGTGATCAAG
CCAACAATTGACGGTATGTTGAACATCATTAAATCATGCGTGCAAGCAAAAACCGTCAAGAAATTCATCT
TCACCACATCCGGTGGGACTGTAAATGTTGAAGAACACCAGAAACCAGTCTATGATGAAACAGATTCCAG
TGACATGGATTTCATTAACTCCAAAAAAATGACTGGATGGATGTATTTTGTGTCAAAAATCTTGGCAGAG
AAAGCTGGAATGGAAGCAGCAAAAGAGAATAACATTGATTTTATCAGCATTATACCACCCCTGGTGGTTG
GTCCATTTATCATGCCAACATTCCCACCTAGCCTAATCACTGCACTTTCTCCCATTACTGGGAATGAGGC
TCACTACTCAATCATAAAGCAATGTCAATATGTGCATTTGGATGATCTGTGTGAGGGTCATATATTCTTG
TTTGAGTATCCTAAGGCAGAAGGAAGATACATTTGCTCCTCTCATGACGCAACAATTTATGATATCGCTA
AATTGATCACAGAGAACTGGCCCGAATATCATATCCCTGACGAATTTGAGGGCATTGACAAGGACATACC
GGTGGTGAGTTTCTCCTCCAAGAAAATGATCGGAATGGGTTTTATATTCAAGTACACATTAGAGGACATG
TTCAGGGGTGCGATTGACACTTGCCGCGAGAAAGGAATGCTCCCGTATTCTACTAAGAATAACAAGGGAG
ACGAGAAGGAACCCATTTTGAATTCCCTAGAAAACAATTACAATATTCAAGACAAAGAACTGTTTCCAAT
TTCGGAGGAAAAACACATCAATGGACAAGAGAATGCCCTGCTTTCAAATACTCAAGACAAAGAACTGCTT
CCAACTTCAGAAGAAAAACGTGTTAATGGACTAGAGAGCGCCCTGCTTTCAAAGATTCAAGACAAAGAAG
TGCTTCCAACTTCAGGGGTTAAGCATGCCAACGGACAAGAAAATGCGCTGCTTCCAGACATTGCAAACGA
TCATACTGATGGCAGAATCTAGCCCGGGGGACTG 
 
Figure 2.2: A. majus pallida cDNA sequence with PCR primer positions and sequences. 
Restriction site sequences highlighted in red were added to the 3’ and 5’ end of the cDNA 
sequence for subsequent cloning into the binary vector SLJ.E8.60. 
 
 
Table 2iii: Primers for the addition of restriction sites to the cDNA sequence of the 
DFR cDNA from A. majus. 
Primer name Sequence (5’ 3’) 
DfrBglII_FA CGAGAAGATCTATGAGTCCCACTTCACTAAATACGAG 
DfrSmaI_RE CGATCATACTGATGGCAGAATCTAGCCCGGGGGACTG 
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2.3.12.1.3 Ligation of A. majus dfr sequence into binary destination vector 
The BglII/SmaI-flanked A. majus dfr PCR product was digested with the restriction 
enzymes BglII and SmaI and ligated into the BamHI and SmaI digested binary vector 
SLJ.E8.60 (Figure 2.3 B) using T4 DNA ligase generating the binary 
vector, SLJ.E8.DFR (Figure 2.3 C). The ligation reaction was incubated overnight at 
4°C and was subsequently used to transform E. coli Dh5α cells as described in section 
2.3.14.1. 
 
Transformed E. coli cells containing SLJ.E8.DFR plasmid were selected on agar plates 
with the selective antibiotic tetracycline. The presence of the A. majus dfr gene 
sequence in the plasmid carried by positive transformed cells was confirmed by colony 
PCR using the primers DfrBglII_FA and DfrSma1_RE (Table 2iii). With a pipette tip, a 
small number of E. coli cells from individual colonies were transferred into a PCR tube 
containing the PCR master mix. Colonies containing the A. majus dfr gene were 
selected and grown at 37°C overnight with shaking in 10 mL of L-medium with 
tetracycline at 10 µg/mL. Plasmid DNA from SLJ.E8.DFR containing E. coli was 
extracted using the Qiagen Spin Miniprep kit following the instructions in section 
2.3.10.1. In order to confirm the correct sequence of the A. majus dfr gene, a sequencing 
reaction using the primers shown in Table 2iii was performed following the instructions 
in 2.3.10.8. 
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Figure 2.3: Cloning strategy to generate SLJ.E8.DFR. (A) Map of T-DNA region of the binary 
vector SLJ.E8.60 with restriction sites BamHI and SmaI. (B) Cloning of BglII/SmaI flanked A. 
majus dfr sequence into SLJ.E8.60 after removal of Rosea1. (C) Map of T-DNA region of the 
binary vector SLJ.E8.DFR used for transformation of tomato plants. AmDfr, A. majus dfr cDNA 
sequence; E8, ethylene-responsive fruit ripening E8 promoter; Kan
r
, LB, left T-DNA border 
region; nptII gene conferring kanamycin resistance under the control of the nos promoter; RM 
right T-DNA border region; Rosea1, A. majus Rosea1 transcription factor cDNA sequence; 
Term, terminator region of cauliflower mosaic virus. 
 
  
LB Kan
r
 E8 Term RB 
BamHI SmaI 
Rosea1 
  
A 
BamHI SmaI 
LB Kan
r
 E8 
AmDfr 
Term RB 
  
BglII SmaI 
 
  
B 
LB Kan
r
 E8 AmDfr Term RB 
C 
68 
 
2.3.12.2 Construction of binary vector pFRN.F3’H.RNAi 
Fragments of the f3’h gene encoding for the S. lycopersicum F3’H was cloned into a 
suitable binary double-stranded RNA vector allowing for expression in both E.coli and 
A. tumefasciens. 
 
2.3.12.2.1 Addition of Gateway® att sites to the f3’h gene sequence fragment 
The mRNA sequence of f3’h from S. lycopersicum (size 1,785 bp; GenBank accession: 
XM_004235959.1) was obtained from the National Center for Biotechnology 
Information (NCBI) Genbank and an f3’h fragment was reamplified using primers 
designed to introduce Gateway
®
 attB1 and attB2 sites (Figure 2.4 A). The att-flanked 
f3’h sequence fragment was inserted into the Gateway® entry clone pDONR207 by 
Gateway
® 
BP clonase-mediated recombination (Figure 2.4 B). Primer sequences are 
reported in Table 2iv. The PCR reaction to add these restriction sites was performed 
with GoTaq™ DNA Polymerase (Promega) according to the following conditions: 
initial denaturation at 95°C for 2 min, followed by 30 cycles of: denaturation at 95°C 
for 45 sec, annealing at 65°C for 45 sec, elongation at 72°C for 120 sec and a final 
elongation step of 10 min at 72°C.  
 
 
Table 2iv: Primers for the addition of Gateway
®
 att sites to the f3’h gene sequence 
fragment from S. lycopersicum. 
Primer name Sequence (5’ 3’) 
Slf3’h_FA_Gate
way 
GGGGACAAGTTTGTACAAAAAAGCAGGCTGGTGGCGTAT
GCTAAGGAAA 
Slf3’h_RB_Gate
way 
GGGGACCACTTTGTACAAGAAAGCTGGGTTCTTTCGGGCC
TGAACTCTA 
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Figure 2.4: Cloning strategy to generate pFRN.F3’H.RNAi. (A) Map of T-DNA region of the 
Gateway
®
 entry clone pDONR207 with entry sites attL1/attL2 and attB1/attB2 flanked S. 
lycopersicum f3’h sequence fragment (B) Gateway® entry clone pDONR207 containing S. 
lycopersicum f3’h sequence fragment (C) Map of T-DNA region of the binary Gateway® 
destination clone pFRN (modified from the destination clone pFGC5941 expressing dsRNA) 
containing a 35S promoter (D) Map of T-DNA region of the binary vector pFRN.F3’H.RNAi 
used for transformation of tomato plants. 35S, 35S constitutive promoter sequence of the 
cauliflower mosaic virus; CHSA, chalcone synthase A intron; Cm
r
, chloramphenicol resistance 
gene; f3’h, S. lycopersicum f3’h sequence fragment; Gentr, gentamycin resistance gene; Kanr, 
nptII gene conferring kanamycin resistance under the control of the nos promoter; LB, left T-
DNA border region; RM right T-DNA border region; Term, terminator region. 
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2.3.12.2.2 Generation of binary destination vector pFRN.F3’H.RNAi 
The gene cassette in the entry clone, containing the f3’h sequence fragment, was 
transferred into a suitable double-stranded RNA Gateway
® 
destination vector pFRN 
(Figure 2.4 C) using Gateway
® 
LR clonase-mediated recombination (see Chapter 
2.3.10.7 for description of Gateway
®
 cloning technology). The recombination resulted 
in the formation of the binary pFRN.F3’H.RNAi vector suitable for silencing of the f3’h 
gene in tomato (Figure 2.4 D). 
 
Transformed E. coli cells containing pFRN.F3’H.RNAi plasmid were selected on agar 
plates with the selective antibiotic kanamycin. The presence of the S. lycopersicum f3’h 
gene sequence fragment in the plasmid, carried by positive transformed cells, was 
confirmed by colony PCR using the primers Slf3’h_FA_Gateway and 
Slf3’h_RB_Gateway (Table 2iv). With a pipette tip, a small number of E. coli cells 
from individual colonies were transferred into a PCR tube containing the PCR master 
mix. Colonies containing the S. lycopersicum f3’h gene were selected and grown at 
37°C overnight with shaking in 10 mL of L-medium with kanamycin at 50 µg/mL. 
Plasmid DNA from SLJ.E8.DFR containing E. coli was extracted using the Qiagen Spin 
Miniprep kit following the instructions in section 2.2.10.1. No sequencing reaction 
confirming the correct insertion of the S. lycopersicum f3’h gene fragment into the 
pFRN.F3’H.RNAi binary vector was carried out because the opposite orientation of the 
two S. lycopersicum f3’h gene fragments made correct alignment and contig assembly 
very difficult and misreads in the sequence of the S. lycopersicum f3’h gene fragment 
were unlikely to impact the RNA interference (RNAi) leading to the silencing of F3’H 
in pFRN.F3’H.RNAi-transformed plants. 
 
2.3.13 Sequencing of constructs  
All clones designed for transformation of tomato with AmDfr cDNA were sequenced 
before being used for transformation of plants. Several Big Dye (3.1) sequencing 
reactions with a maximum read length of 500 bp were carried out spanning the whole 
region of the gene of interest. The sequencing data was analysed using Vector NTI
®
 and 
contigs generated from sequences obtained with individual primers using 
ContigExpress. The assembled contigs were aligned with the original sequence obtained 
from NCBI using AlignX
®
. Both ContigExpress and AlignX
®
 are part of the Vector 
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NTI
®
 software package (Invitrogen). The three primer pairs used to confirm the correct 
sequence of the AmDfr clones are reported in Table 2v. Plasmids with the correct A. 
majus dfr sequence were used for subsequent transformation of tomato. 
 
 
Table 2v: Primers for the sequencing of the dfr cDNA sequence of A. majus pallida. 
Primer name Sequence (5’ 3’) 
DFR_F1 ACCACCGTATGTCACAGGA 
DFR_F2 GAGAAAGCTGGAATGGAAGCA 
DFR_F3 AAGGGAGACGAGAAGGAACC 
DFR_R1 GGAAGGCAGACATGACAGTAGA 
DFR_R2 TGGATGATCTGTGTGAGGGTCA 
DFR_R3 CGTGTTAATGGACTAGAGAGCG 
 
 
 
2.3.14 Transformation of organisms  
 
2.3.14.1 Transformation of E. coli  
E. coli cells were transformed using the heat shock method. Competent Dh5α cells were 
thawed on ice. After 10 min 1.5 μL of the ligation reaction or plasmid construct 
containing approximately 300-500 ng/μL DNA were added to 100 μL of thawed, 
competent Dh5α cells and mixed gently. The competent cell/construct mix remained on 
ice for 30 min before heat-shock by incubating the cells at 42°C for 45 sec, and then 
transferring them immediately back onto ice for another 2 min. Pre-warmed LB broth (1 
mL) was added and the cells were allowed to recover at 37°C for 1 h shaking in the 
incubator. Aliquots of transformed cells were the plated on LB agar plates containing 
appropriate selective antibiotics and incubated at 37°C overnight. 
 
2.3.14.2 Transformation of A. tumefasciens by triparental mating 
Triparental mating was chosen to transform the binary vectors to A. tumefasciens 
because plasmids ranging from between 25 and 30 kb in size proved too large to enter 
A. tumefasciens by electroporation. Triparental mating relies on the co-cultivation of A. 
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tumefasciens AGL-1 (recipient strain), E. coli Dh5α containing the desired construct 
(donor strain), and E. coli pRK2013 (helper strain), which facilitates the transfer of the 
construct of interest from the transformed E. coli to the untransformed A. tumefasciens. 
All three strains were grown separately to an optical density (OD)600 of between 0.5-0.9 
with their respective antibiotics (A. tumefasciens at 28°C with rifampicin 50 µg/mL, E. 
coli Dh5α at 37°C with construct-specific antibiotic, and E. coli pRK2013 at 37°C with 
kanamycin 50 µg/mL). 
 
Aliquots of a the E. coli donor, E. coli helper and A. tumefasciens recipient strains were 
added to a sterile tube in a ratio of 1:1:2 and mixed thoroughly before spreading 0.5 mL 
of this mix on L agar plates containing no antibiotics. After incubation of the plate at 
28°C for 1 to 2 days, the bacterial film was washed off with 0.5 mL of LB broth. The 
bacterial solution was plated onto LB agar plates containing the plasmid selective 
antibiotic, 50 µg/mL rifampicin as well as 100 µg/mL carbenicillin to which A. 
tumefasciens AGL-1 is resistant and which allows selection against E. coli. After 
incubation for 2-3 days at 28 °C individual A. tumefasciens AGL-1 colonies were 
selected and the presence of the desired plasmid was confirmed by colony PCR. 
 
2.3.15 Stable transformation of Tomato 
 
2.3.15.1 Growth media and supplements 
Regeneration and shooting medium for the propagation of transformants were prepared 
freshly on the day of use (recipes can be found in the Appendix). 
 
2.3.15.2 A. tumefasciens mediated tomato transformation 
A 24 h culture of A. tumefasciens AGL-1 containing the binary vector for 
transformation of tomato was set up at 28°C with shaking. The same day, feeder plates 
were set up by evenly spreading 1 mL of fine tobacco suspension culture onto plates 
containing the MS medium with 0.5 mg/L 2,4-dextrose, and 0.6% agarose. Plates were 
placed unsealed and stacked in the cell culture room in 1ow light, overnight. Cotyledons 
from ten-day old, sterile grown tomato seedlings were harvested the next morning and 
placed in sterile water. After removing the outer cotyledon tips with clean, sterile razor 
blades the cotyledons were cut transversely into 3-4 mm pieces and placed onto sterile 
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filter paper. Up to 40 cotyledon pieces were then transferred onto a feeder plate with 
their abaxial surface uppermost. The feeder plates had been covered with a sterile filter 
paper to prevent direct contact between the tobacco cell culture and the tomato 
cotyledons. The feeder plates together with the cotyledons were placed at 25°C under 
low light for 8 h. The 24 h Agrobacterium culture was centrifuged to remove the culture 
medium before resuspending the pellet in MS medium containing 3% sucrose to a final 
OD600 of 0.4-0.5. After the 8 h incubation on feeder plates the cotyledons were 
immersed in the Agrobacterium solution for 1-30 min, before being blotted dry and 
transferred back onto the original feeder plates. The feeder plates with the cotyledons 
were then moved back to the culture room and co-cultivated at 25°C under low light for 
40 h. 
 
After the co-cultivation period the cotyledon pieces were transferred onto regeneration 
medium. Twelve cotyledon pieces were placed on each 100 mm Petri dish with the leaf 
ends curling into the medium to ensure good contact between the leaf and nutrients and 
antibiotics. The cotyledon pieces were allowed to generate calli and leaves and were 
transferred onto fresh medium every 2-3 weeks for approximately three months. Shoots 
from each callus structure were then excised and transferred to labelled, individual jars 
containing fresh rooting medium. Once the shoots had developed a well-branched root 
system they were removed from the shooting medium and transferred to soil and moved 
to the glasshouse. Positive transformants were identified by PCR using primers specific 
for the nptII gene conferring kanamycin resistance to explants carrying the 
transformation construct. 
 
2.3.16  Tomato crosses  
Transgenic parental lines were crossed to generate a T1 plant population with the genes 
of interest. In the T2 plants the allele pairs segregated leading to some T2 plants 
carrying the desired combination of genes. The Mendelian principle of segregation 
defines the separation of pairs of alleles in the reproductive cells, resulting in offspring 
with new allele combinations different from those of the parents’. Tomato crosses were 
performed by emasculating (removal of stamens) the flowers of the female parents 
before the flower opened up and the stamens reached full maturity. One day after 
emasculation the female parents were pollinated by carefully brushing the male parents’ 
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pollen containing stamens against the stigma. Seeds were collected once the developing 
tomato fruit had reached their full maturity and excess tomato flesh was removed by 
washing the seeds for 10 min with 50% HCl. Clean seeds were stored in a dry, cold 
place. 
 
2.3.16.1 Generation of E8::Del/Ros1/f3’5’h-/- 
Tomatoes (Solanum lycopersicum var. MicroTom) expressing Delila (Del; GenBank 
accession: M84913.1) and Rosea1 (Ros1) under the control of an ethylene-responsive, 
fruit-specific E8 promoter (E8) were referred to as Del/Ros1 (see Figure 2.5 for map of 
T-DNA region of the binary vector pDEL.ROS; a detailed description of the primers 
and cloning strategy are available in the supplementary materials of Butelli et al., 2008) 
and crossed to an f3’5’h (a) mutant (f3’5’h-/-, Solanum lycopersicum var. VF36) 
carrying a stop codon mutation in the gene encoding F3’5’H (de Jong et al., 2004). The 
seeds were obtained from the Tomato Genetics Resource Centre at the University of 
California, Davis, California and had been generated through chemical-induced 
mutation. Del/Ros1 were used as male parents to pollinate emasculated flowers of 
f3’5’h-/-/a mutant plants. The resulting cross developed purple-coloured fruit from 
which seeds were extracted and sown on kanamycin-containing selective medium. The 
seedlings of the T2 generation were selected by visual analysis, as lack of pigmentation 
in the seedling stem base was a visual characteristic of f3’5’h-/-/a mutant plants. 
Therefore, seedlings with two mutated alleles of the F3’5’H/A gene were easily 
distinguished from plants with functional copies of the F3’5’H/A gene by their 
unpigmented stems. These seedlings were selected and allowed to mature and set fruit. 
The presence of Delila and Rosea1 transcription factors was confirmed by PCR. The 
resulting plants developed normally and produced plants of orange/red hue. 
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Figure 2.5: Map of T-DNA region of the binary vector pDEL.ROS used for the transformation 
of tomato plants to induce activation of the anthocyanin biosynthetic pathway (Butelli et al., 
2008). LB, left T-DNA border region; Kan
r
, nptII gene conferring kanamycin resistance under 
the control of the nos promoter; E8, ethylene-responsive fruit ripening E8 promoter; Del, A. 
majus Delila transcription factor; Ros1, A. majus Rosea1 transcription factor; Term, terminator 
region of cauliflower mosaic virus; RM right T-DNA border region. 
 
 
2.3.16.2 Generation of E8::Del/Ros1/E8::AmDfr/f3’5’h-/- tomato plants 
Del/Ros1 tomato plants were used as male parents to generate progeny with 
pelargonidin and cyanidin accumulation. A minimum of ten independent transgenics 
expressing E8::AmDfr (T0 generation) were used as female parents. In order to generate 
tomato lines producing high levels of mono- and dihydroxylated anthocyanins, 
Del/Ros1 transcription factors mediated activation of the anthocyanin biosynthetic 
pathway was required. Del/Ros1 plants (carrying two functional alleles of F3’5’H/A) 
were selected as male parents and crossed to E8::AmDfr/f3’5h-/- plants. The resulting T1 
generation seeds were sown out on MS agar medium containing 100 µg/mL kanamycin 
and the plants were analysed for the presence of Del, Ros1 and AmDfr. All T1 plants 
carried at least one functional allele of the F3’5’H/A gene resulting in the production of 
delphinidins and purple colouration of the fruit. In the T2 generation, plants with 
different genotypes emerged as a result of allelic segregation, with some carrying the 
desired E8::Del/Ros1/E8::AmDfr/f3’5’h-/- genotype. 
 
2.3.17 Analysis of T2 transgenic tomato plants 
Before transferring kanamycin-resistant seedlings to soil, plants were screened by 
genotyping to confirm the presence of AmDfr and Del/Ros1. Positive seedlings were 
transferred to soil and allowed to develop fruit, from which seeds were collected and 
sown out on agar containing 100 µg/mL of kanamycin. The resulting T2 generation 
seedlings underwent an initial visual screen. A functional allele of the F3’5’H/A gene is 
LB Kan
r
 E8 Term RB E8 Term Del Ros1 
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required for delphinidin production and seedlings with at least one functional copy of 
F3’5’H/A gene were easily recognized by the purple pigmentation in the roots and base 
of the stem of young seedlings. Seedlings with unpigmented roots and stems were 
selected and analysed by PCR for the presence of AmDfr and Del/Ros1. Seedlings 
carrying AmDfr and Del/Ros1 were allowed to mature and develop fruit. Plants with the 
target genotype E8::Del/Ros1/E8::AmDfr/f3’5’h-/- were easily identified by their 
distinctly dark red, brick coloured fruit and referred to as AmDfr/Del/Ros1/f3’5’h-/-. 
Tomato fruit were harvested at the ripe stage and further analysed by HPLC-MS to 
confirm the identity of the anthocyanins present. 
 
 
2.3.18 Metabolite analyses 
 
2.3.18.1  Anthocyanin and flavonoid extraction 
Tomato fruit samples (fresh or frozen) from which anthocyanin samples were extracted 
were either homogenized using a commercial blender (fresh fruit) or ground to a fine 
powder using liquid nitrogen (frozen samples). The extraction solution, 50% MeOH 
(v/v) with 0.7% HCl, was added to the fruit samples at 1 mL per 1 g tomato fruit 
material, vortexed and incubated overnight at 4°C with shaking. After overnight 
incubation the tomato fruit samples were centrifuged at 4,000 g for 15 min at 4 °C. The 
supernatant was collected and stored at -20 °C for further analysis. 
 
2.3.18.2 HPLC-LC-MS analysis and quantification of polyphenolic compounds 
Tomato extracts were run on a 100 x 2 mm internal diameter Phenomenex
®
 3 μm Luna 
C18 column using a Surveyor HPLC attached to DecaXPplus ion trap MS (Thermo 
Fisher). Separation was achieved using a linear gradient (Table 2vi) of acetonitrile 
(ACN) versus 0.1% formic acid (FA) in water, run at 300 μL/min and 30 ºC. The 
elution products were monitored with a photo diode array (PDA) detector over the range 
of 200-600 nm. Anthocyanins or flavonoids were detected by light absorbance using 
collecting channels at 500-550 nm or 340-360 nm, respectively. They were also 
detected by positive mode electrospray MS, collecting full spectra from m/z 100-2000. 
The runs were performed by Dr. Lionel Hill. Polyphenol masses and fragmentation 
patterns were determined using Quant browser. Anthocyanins and other flavonoids were 
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quantified using the standards kaempferol-3-rutinoside, rutin, cyanidin-3-glucoside, 
delphinidin-3-glucoside and chlorogenic acid. For the quantification of resveratrol in the 
high-resveratrol tomato fruit, flavonoid standards and the stilbenes, resveratrol and 
resveratrol-glucoside (polydatin), were used. Calibration curves were run before and 
after the samples. The quantification of polyphenolic compounds was performed by Dr. 
Lionel Hill.  
 
 
Table 2vi: Solvent gradient for separation of polyphenolic compounds. 
Time (min) % ACN 
0 1 
4 1 
23 30 
30 70 
30.5 1 
37 1 
 
 
 
2.3.18.3 Purification of anthocyanins from Del/Ros1 tomato fruit 
Anthocyanins were purified from delphinidin-producing Del/Ros1 tomato fruit using 
preparative HPLC as part of a collaborative project with Prof Hans-Peter Mock in the 
department of Applied Biochemistry at the Leibniz Institute of Plant Genetics and Crop 
Plant Research (IPK) in Gatersleben in Germany. 
 
2.3.18.3.1 Pre-purification of anthocyanins on a solid phase C18 column 
Polyphenolic compounds were extracted from tomato fruit by adding 25 ml of 2% FA 
in 50% MeOH (v/v) to 1 g lyophilized tomato fruit material, followed my 
ultrasonication for 20 min. Tomato debris was removed using Whatman paper No. 1 or 
comparable filter system. Filtered polyphenol extracts were transferred to a rotary 
evaporator to remove all MeOH for subsequent transferral to a solid phase 5000 mg 
Chromabond
® 
C18 column (Machery-Nagel). Removal of MeOH was required as 
MeOH interferes with the retention ability of the C18 material and may prevent the 
polyphenolic compounds from binding to the C18 resin. Solid phase C18 columns were 
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equilibrated with acidified H2O before addition of the aqueous polyphenol extract. The 
polyphenol extract from up to 15 g of lyophilized tomato fruit was loaded onto a 5000 
mg Chromabond
® 
C18 column. Polyphenols, but not sugars, were bound by the C18 
silica material allowing for the removal of sugars by the addition of water (30 mL). 
Flavonols and anthocyanins were eluted in a sequential manner: First, flavonols 
(yellow-coloured) were eluted with 2% FA in 60% MeOH (v/v; 60 mL), followed by 
the elution of anthocyanins with 10 mL of 2% FA in 100% MeOH. The separation of 
anthocyanins from other polyphenols on a solid phase C18 silica column was necessary 
in order reduce contamination of anthocyanin fractions with other polyphenols obtained 
by subsequent preparative HPLC. 
 
2.3.18.3.2 Separation of total anthocyanins from other polyphenols by medium-scale 
preparative HPLC 
Tomato extracts were run on a 250 x 30 mm internal diameter Phenomenex
®
 5 µm 
Gemini
®
 NX-C18 110 Å column using a Varian ProStar 210 preparative HPLC (Agilent 
Technologies) connected to a Varian ProStar 410 AutoSampler (Agilent Technologies). 
Separation was achieved using a linear gradient (Table 2vii) of ACN versus 1.9% FA 
and 0.1% ammonium formate in water, run at 10 mL/min and 25 ºC. The elution 
products were moitored with a photo diode array PDA detector over the range of 200-
600 nm. Anthocyanins and flavonoids were detected by light absorbance using 
collecting channels at 535 nm and 280 nm, respectively.  
 
 
Table 2vii: Solvent gradient for separation of polyphenolic compounds on the 
Phenomenex
®
 5 µm Gemini
®
 C18 column using a Varian ProStar 210 preparative 
HPLC. 
Time (min) % ACN 
0 3 
8.5 3 
100 20 
133.5 30 
150 30 
153.5 97 
165 97 
167 3 
170 3 
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The anthocyanins eluted after 50 min and 10 mL fractions were collected every min 
between minute 50 and 120. A representative HPLC chromatogram of the separation of 
polyphenolic compounds of Del/Ros1 tomato fruit obtained by Varian ProStar 210 
preparative HPLC equipped with a 250 x 30 mm internal diameter Phenomenex
®
 5 µm 
Gemini
®
 NX-C18 110 Å column is shown in Figure 2.6 A. 
 
2.3.18.3.3 Identification of individual anthocyanins by LCT analysis 
All anthocyanin fractions were analysed on a liquid chromatography (LC)/mass 
spectrometer (MS)/TOF mass spectrometer (LCT premier; Waters) in order to 
determine the purity and type of the anthocyanins present in the individual fractions 
collected by preparative HPLC (Chapter 2.2.18.3.2). Samples were run on a Waters 2.1 
mm X 100 mm internal diameter ACQUITY UPLC
®
 1.7 µm BEH Phenyl column, 130 
Å, using a LCT premier mass spectrometer. Separation was achieved using a linear 
gradient (Table 2viii) of 0.1% FA in ACN versus 0.1% FA in water, run at 500 μL/min 
and 25 ºC. 
 
 
Table 2viii: Solvent gradient for separation of polyphenolic compounds on the LCT 
premier. 
Time (min) % (ACN + 0.1% FA) 
0 0 
10 40 
10.1 95 
10.6 95 
10.7 0 
13.5 0 
 
 
 
Single peak fractions containing only one major anthocyanin were considered as highly 
pure. However, some anthocyanins coeluted or eluted very closely together and resulted 
in fractions containing two or more anthocyanins. After LCT analysis of each fraction, 
Varian ProStar 210 preparative HPLC fractions containing the same anthocyanins were 
pooled together and concentrated using a nitrogen evaporator. 
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2.3.18.3.4 Separation of individual anthocyanins by smale-scale preparative HPLC 
Anthocyanin fractions obtained by Varian ProStar 210 preparative HPLC were further 
purified using a small-scale preparative HPLC equipped with a smaller C18 column to 
achieve better separation. Samples were run on a 19 mm x 150 mm internal diameter 
Waters 5 µm XBridge™ BEH C18 prep column, 130Å connected to a Prep 2000 HPLC 
system (Waters) with a UV/Vis detector (Waters). 
 
Separation was achieved using a linear gradient (Table 2ix) of ACN versus 1.9% FA 
and 0.1% ammonium formate in water, run at 4 mL/min and 25 ºC. The elution products 
were monitored with a photo PDA detector over the range of 200-600 nm. 
Anthocyanins were detected by light absorbance using the collecting channel at 535 nm. 
 
 
Table 2ix: Solvent gradient for separation of polyphenolic compounds on the Waters 5 
µm XBridge™ C18 prep column using a Waters Prep 2000 HPLC system. 
Time (min) % ACN 
0.01 3 
5 3 
60 20 
80 30 
90 30 
92 97 
99 97 
100 3 
 
 
 
The Waters 5 µm XBridge™ C18 prep column allowed a very good separation of 
anthocyanin fractions that had previously run too closely together to be separated on the 
Phenomenex
®
 5 µm Gemini
®
 C18 column (Figure 2.6 B). However, the different 
purifications steps were important in order to remove other polyphenols effectively 
from the fractions. The purified anthocyanins were concentrated using a nitrogen 
evaporator and resuspended in 50% MeOH (v/v) at 200 mM and stored at -80 °C until 
further use to investigate their biological efficacy on human breast cancer cells in vitro 
(Chapter 3).  
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Figure 2.6: Preparative HPLC to purify anthocyanins from the fruit of delphinidin-producing 
Del/Ros1 tomatoes. (A) Chromatogram of the preparative HPLC of total anthocyanins (535 nm) 
and other polyphenols (280 nm) run on the Phenomenex
®
 5 µm Gemini
®
 C18 column using a 
Varian ProStar 210 preparative HPLC. (B) Chromatogram of the preparative HPLC of a single 
anthocyanin fraction previously separated in (A) and corresponding to delphinidin 3-
(coumaroyl)-rutinoside-5-glucoside with a mass of 919 run on the Waters 5 µm XBridge™ C18 
prep column using a Waters Prep 2000 HPLC system. 
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2.3.19 TEAC antioxidant assay 
The Trolox equivalent antioxidant capacity (TEAC) measures the antioxidant capacity 
of substances by comparing them to the standard, 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox). Antioxidant capacity is measured using 
the 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) decolourisation 
assay (7 mM ABTS
 
and 2.45 mM potassium persulfate in dH2O). ABTS, a blue-green 
chromophore
 
with a characteristic absorption at 734 nm, is quenched by antioxidants 
resulting in decolourisation of the solution. The ABTS working solution was obtained 
by diluting the stock solution in EtOH to an absorbance of 0.70 ± 0.02 AU at 734 nm. A 
standard curve was obtained by mixing 1 mL ABTS working solution with 10 µL 
Trolox (0.2 mM, 0.4 mM, 0.6 mM, 0.8 mM, 1.0 mM, 1.2 mM, 1.4 mM, 1.6 mM 1.8 
mM, 2mM; see Figure 2.7) and measuring the  absorbance after 5 min at 734 nm at 
room temperature using a 8453 Diode Array spectrophotometer (Hewlett-Packard). 
 
 
 
 
 
Figure 2.7: Standard curve for the measurement of the Trolox total antioxidant capacity 
according to is concentration (mM). Conditions: 1000 µL ABTS, 10 µL Trolox, 25 °C, time of 
reaction: 5 minutes. 
 
 
2.3.19.1 Polyphenol extraction for TEAC analysis 
Polyphenols were extracted from tomato fruit using water and acetone in a sequential 
manner. Ripe tomato fruit were ground to a fine powder using liquid N2. Water-soluble 
polyphenols were extracted from 1 g of tomato powder using 6 mL of dH2O and TEAC 
measured following the procedure used to obtain the standard curve. To determine the 
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TEAC of any remaining, water-insoluble compounds the extraction was repeated with 6 
mL ACN. The antioxidant capacity of the polyphneol fraction was measured by mixing 
900 µL ABTS working solution with 100 µL polyphenol extract before measuring the 
absorbance after 5 min at 734 nm at room temperature. The TEAC of each polyphenol 
fraction was expressed as mmol Trolox per kg FW. 
 
2.3.20 Statistical methods 
The statistical significance was determined using Student’s t-test. P-values ≤ 0.05 were 
considered statistically significant. 
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2.4 Results  
2.4.1 Production of cyanidins in tomato through inactivation of f3’5’h 
Delila (Del) and Rosea1 (Ros1) are two genes from snapdragon (Antirrhinum majus) 
that encode for a basic helix-loop-helix and a MYB-like transcription factor, 
respectively. Both Del and Ros1 are crucial in regulating anthocyanin production in 
snapdragon flowers (Goodrich et al., 1992, Schwinn et al., 2006). Work by Butelli et al. 
(2008) showed that these two transcription factors, placed under the control of a fruit-
specific E8 promoter, can be used to induce production of trihydroxylated anthocyanins 
(predominantly delphinidins and petunidins) in tomato. These plants were referred to as 
Del/Ros1 plants, and displayed an intense purple colouration of the fruit but not of the 
vegetative tissue. The substrate preference of the native tomato DFR for DHM results in 
the production of trihydroxylated anthocyanins only. The production of other classes of 
anthocyanins in tomato therefore, requires inhibition of the synthesis of the delphinidin 
precursor DHM combined with an engineering strategy to overcome the DHM substrate 
specificity of the native tomato DFR. F3’5’H is the key enzyme that catalyses the 
formation of DHM from DHK through the addition of two hydroxyl groups at the 3’ 
and 5’ position on the phenyl B-ring. To determine, whether Del/Ros1-induced 
production of anthocyanins other than delphinidins is possible, Del/Ros1 plants were 
crossed with an f3’5’h-/- (a-/-) double mutant. The resulting plants had the 
E8::Del/Ros1/f3’5’h-/- (a-/-) genotype and were referred to as Del/Ros1/f3’5’h-/-. The 
plants developed normally but produced few fruit that contained few seeds compared to 
WT or Del/Ros1 plants. This observation was already made in the f3’5’h-/- homozygous 
parental plants suggesting that F3’5’H may play a role in pollen development. 
Del/Ros1/f3’5’h-/- fruit had orange/red skin colour with red to pink flesh displaying a 
distinctive purple venation that originated at the fruit stalk base (Figure 2.8 B). HPLC 
analysis confirmed the presence of five major peaks in the absorbance range of 500-550 
nm, at which anthocyanins absorb most strongly (Figure 2.8 A). Mass spectrometry 
(MS) identified the peaks labelled as 1, 2 (merged peak corresponding to two 
compounds), 3, 4 and 5 in Figure 2.8 A as cyanidin 3-(caffeoyl)-rutinoside-5-glucoside 
(m/z 919), peonidin 3-(caffeoyl)-rutinoside-5-glucoside (peak 2; m/z 933), cyanidin 3-
(coumaroyl)-rutinoside-5-glucoside (peak 2; m/z 903), cyanidin 3-(feruloyl)-rutinoside-
5-glucoside (m/z 933), peonidin 3-(coumaroyl)-rutinoside-5-glucoside (mass 917) and 
peonidin 3-(feruloyl)-rutinoside-5-glucoside (m/z 947), respectively. The mass spectra 
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of the fragmentation pattern of the two predominant anthocyanin compounds identified 
as cyanidin 3-(coumaroyl)-rutinoside-5-glucoside with a corresponding m/z of 903 (part 
of peak 2 in Figure 2.8 A) and peonidin 3-(coumaroyl)-rutinoside-5-glucoside with an 
m/z of 917 (peak 4 in Figure 2.8 A) are shown in Figure 2.8 C1 and C2. HPLC-MS data, 
including fragmentation patterns, are summarized in Table 2x. The total anthocyanin 
content in the fruit of Del/Ros1/f3’5’h-/- was ~40 fold lower than the amount reported 
for the Del/Ros1 tomatoes (2-3 mg/g FW). 
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Figure 2.8: Analysis of anthocyanins from the fruit of cyanidin-producing E8::Del/Ros1/f3’5’h-
/-
 line. (A) HPLC analysis of anthocyanins of E8::Del/Ros1/f3’5’h-/- shows the presence of  five 
major new anthocyanin compounds. (B) Fruit of WT and cyanidin-producing E8::Del/Ros1 
/f3’5’h-/- line. (C) Mass analysis of new products at corresponding to peak 2 and 4 were 
identified as (1) cyanidin 3-(coumaroyl)-rutinoside-5-glucoside and (2) peonidin 3-(coumaroyl)-
rutinoside-5-glucoside, respectively. 
WT  
Del/Ros1/ 
f3’5’h-/- 
time in min 
B 
RT: 8.00 - 35.50
8 10 12 14 16 18 20 22 24 26 28 30 32 34
Time (min)
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
24000
26000
28000
30000
32000
34000
36000
38000
40000
42000
uA
U
NL:
4.38E4
nm=500.0-
550.0  
PDA 06a32
a
b
so
rb
a
n
ce
 
1 
2 
3 
4 
5 
A 
500-550 
nm 
449 
741 
06a32 #1111-1130 RT: 18.41-18.72 AV: 10 NL: 5.72E8
F: + c ESI Full ms [100.00-2000.00]
200 400 600 800 1000 1200 1400 1600 1800 2000
m/z
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
 A
bu
nd
an
ce
903.2
904.2
369.1
933.2
1050.5
287.3 1268.4394.0163.1 741.2 1806.0935.2611.1 1432.51066.5813.2465.0258.2 1698.9 1970.41557.4
re
la
ti
v
e 
a
b
u
n
d
a
n
ce
 
m/z 
06a32 #1126-1128 RT: 18.67-18.70 AV: 2 NL: 3.42E8
T: + c d Full ms2 903.21@cid35.00 [235.00-1820.00]
300 400 500 600 700 800 900 1000
m/z
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
 Ab
un
da
nc
e
741.1
742.0
449.0
287.3
449.9
288.1
593.4269.1 353.3 412.7 456.3 886.3742.7
re
la
ti
v
e 
a
b
u
n
d
a
n
ce
 
m/z 
287 
903 
C 
1 
cyanidin 3-(coumaroyl)-
rutinoside-5-glucoside 
re
la
ti
v
e 
a
b
u
n
d
a
n
ce
 
06a32 #1199-1216 RT: 20.01-20.28 AV: 9 NL: 4.13E8
F: + c ESI Full ms [100.00-2000.00]
200 400 600 800 1000 1200 1400 1600 1800 2000
m/z
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lat
ive
 A
bu
nd
an
ce
917.3
611.1
918.3
1268.6
303.3
465.1 1432.6
1050.7
812.5 1300.6755.2
287.3 449.0 976.6633.2595.0 1880.11065.1 1581.9247.0 1792.4
06a32 #1221-1224 RT: 20.41-20.44 AV: 2 NL: 8.00E7
T: + c d Full ms2 917.24@cid35.00 [240.00-1845.00]
300 400 500 600 700 800 900 1000 1100
m/z
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
el
at
iv
e 
Ab
un
da
nc
e
755.2
756.1
301.2
463.0
302.2
433.0 463.9286.0 579.3 900.3625.1309.2 416.3 953.6817.4 1031.0722.7
re
la
ti
v
e 
a
b
u
n
d
a
n
ce
 
m/z 
m/z 
917 
755 
301 
463 
C 2 
peonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
87 
 
Table 2x: Characterisation of anthocyanin peaks identified in the fruit of the 
E8::Del/Ros1/f3’5’h-/- tomato line. 
Rt (min) peak 
ESI-MS 
(m/z) 
MS/MS fragments Compound 
16.87 1 919 
757[Cy+Rut+Glc], 
449[Cy+Glc], 287 [Cy]+ 
cyanidin 3-(caffeoyl)-
rutinoside-5-glucoside 
18.47 2 933 
771[Pe+Rut+Glc], 
463[Pe+Glc], 301 [Pe]+ 
peonidin 3-(caffeoyl)-
rutinoside-5-glucoside 
18.47 2 903* 
741[Cy+Cou+Rut], 
449[Cy+Glc], 287[Cy]+ 
cyanidin 3-(coumaroyl)-
rutinoside-5-glucoside 
18.98 3 933 
771[Cy+Fer+Rut], 
449[Cy+Glc], 287[Cy]+ 
cyanidin 3-(feruloyl)-
rutinoside-5-glucoside 
20.07 4 917 
755[Pe+Cou+Rut], 
463[Pe+Glc], 301[Pe]+ 
peonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
20.6 5 947 
785[Pe+Fer+Rut], 
463[Pe+Glc], 301[Pe]+ 
peonidin 3-(feruloyl)-
rutinoside-5-glucoside 
 
Rt, retention time; Cy, cyanidin; Pe, peonidin; Glc, glucose; Cou, coumaroyl; Rut, rutinoside; 
Fer, feruloyl; ESI-MS, Electro spray ionization mass spectra; m/z, molecular mass of 
compound. 
* Peak 2 corresponds to two compounds of which cyanidin 3-(coumaroyl)-rutinoside-5-
glucoside (mass 903 and RT 18.47) is the most abundant. 
 
 
 
2.4.2 Towards engineering tomatoes with increased cyanidin content 
 
2.4.2.1 Overcoming DFR substrate specificity 
The levels of anthocyanins reported from the Del/Ros1/f3’5’h-/- tomato plants were 
extremely low. In order to increase the amount of cyanidins in tomato, we hypothesised 
that overcoming the substrate specificity of the native tomato DFR was essential. By 
generating tomato plants with a E8::Del/Ros1/E8::AmDfr/f3’5’h-/- genotype that also 
expressed a DFR from A. majus, a species that does produce both cyanidin and 
pelargonidins, we expected to increase cyanidin content in these tomatoes. Screening of 
~ 200 plants resulted in twenty-four positive T2 plants expressing the three transgenes 
Del, Ros1, AmDfr and that were homozygous for f3’5’h-/- (a-/-). Of these twenty-four 
plants, five independent transgenics showed the accumulation of a distinctive, brick red 
colour in their fruit indicating the presence of novel anthocyanins (Figure 2.9 B). The 
other transgenic individuals resembled a WT. As previously observed in f3’5’h-/- double 
mutant plants, E8::Del/Ros1/E8::AmDfr/f3’5’h-/-, referred to as AmDfr/Del/Ros1/f3’5’h-/-
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, produced less fruit and set less seeds compared to WT tomatoes. HPLC-MS analysis 
and identification of the anthocyanins present in AmDfr/Del/Ros1/f3’5’h-/- fruit are 
shown in figure 2.9. 
 
2.4.3 AmDfr triggers pelargonidin production in tomato  
The HPLC analysis of the AmDfr/Del/Ros1/f3’5’h-/- fruit revealed the presence of 
several novel anthocyanin peaks in addition to the peaks found in Del/Ros1/f3’5’h-/- 
tomato fruit (Figure 2.9 A). The identity of these anthocyanin peaks was confirmed by 
mass spectrometry and revealed the presence of several monohydroxylated 
pelargonidin-type anthocyanins in addition to the dihydroxylated cyanidin-type 
anthocyanins found in Del/Ros1/f3’5’h-/- tomato fruit.  More than ten anthocyanins were 
identified in the fruit of AmDfr/Del/Ros1/f3’5’h-/- and a full list of anthocyanins 
identified is presented in Table 2xi. The most abundant peak, labelled as peak 9, was 
identified as pelargonidin 3-(coumaroyl)-rutinoside-5-glucoside with an m/z value of 
887. MS analysis of this compound revealed a major fragment of m/z 725, 
corresponding to pelargonidin 3-(coumaroyl)-rutinoside due to the loss of glucose with 
m/z 162. Further fragmentation of pelargonidin 3-(coumaroyl)-rutinoside (m/z 725) 
resulted in fragments of m/z 433 due to the loss of coumarate and rhamnose and m/z 271 
due to the loss of glucose. Pelargonidin has a molecular weight of 271 confirming that 
the compound corresponding to peak 9 and identified as pelargonidin 3-(coumaroyl)-
rutinoside-5-glucoside is indeed a pelargonidin derivative (Figure 2.9 C1). The second 
most prevalent anthocyanin in the fruit of AmDfr/Del/Ros1/f3’5’h-/- was labelled as peak 
7 and corresponded to cyanidin 3-(coumaroyl)-rutinoside-5-glucoside with an m/z of 
903 (Figure 2.9 C2). This compound was also the most abundant dihydroxylated 
anthocyanin found in the fruit of Del/Ros1/f3’5’h-/- (peak 2; Figure 2.8 A). Whilst all the 
cyanidins originally identified in the Del/Ros1/f3’5’h-/- (Chapter 2.3.1) were also present 
in AmDfr/Del/Ros1/f3’5’h-/-, the total amount of cyanidins did not change dramatically 
in response to A. majus DFR activity. The presence of large amounts of novel 
pelargonidins in the fruit of AmDfr/Del/Ros1/f3’5’h-/- show that in tomatoes lacking 
F3’5’H function, A. majus DFR drives the production of predominantly 
monohydroxylated anthocyanins, suggesting a substrate preference for the pelargonidin 
precursor DHK. 
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Figure 2.9: Analysis of anthocyanins from the fruit of the E8::Del/Ros1/E8::AmDfr/f3’5’h-/- line 
producing predominantly pelargonidins and low amounts of cyanidins. (A) HPLC analysis of 
anthocyanins of E8::Del/Ros1/E8::AmDfr/f3’5’h-/- shows the presence of  at least 11 new 
anthocyanin compounds. (B) Fruit of WT and pelargonidin- and cyanidin-producing 
E8::Del/Ros1/E8::AmDfr/f3’5’h-/- line. (C) Mass analysis of new products corresponding to peak 
9 and 6 were identified as (1) pelargonidin 3-(coumaroyl)-rutinoside-5-glucoside and (2) 
cyanidin 3-(coumaroyl)-rutinoside-5-glucoside, respectively. 
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Table 2xi: Characterisation of anthocyanin peaks identified in the fruit of the 
E8::Del/Ros1/E8::AmDfr/f3’5’h-/- tomato line. 
Rt 
(min) 
Peak ESI-MS 
(m/z) 
MS/MS fragments Compound 
11.27 1 757 595[Cy+Rut], 449[Cy+Glc], 
287[Cy]+ 
cyanidin 3-rutinoside-5-
glucoside 
12.03 2 741 579[Pl+Rut], 433[Pl+Glc], 
271[Pl]+ 
pelargonidin 3-rutinoside-5-
glucoside 
13.63 3 433 271[Pl]+ pelargonidin 5-glucoside 
14.02 4 579 433[Pl+Glc], 271[Pl]+ pelargonidin 3-rutinoside 
16.77 5 919 757[Cy+Rut+Glc], 
449[Cy+Glc], 287 [Cy]+ 
cyanidin 3-(caffeoyl)-
rutinoside-5-glucoside 
17.77 6 903 741[Pl+Rut+Glc], 
433[Pl+Glc], 271[Pl]+ 
pelargonidin 3-(caffeoyl)-
rutinoside-5-glucoside 
NV  933 771[Pe+Rut+Glc], 
463[Pe+Glc], 301[Pe]+ 
peonidin 3-(caffeoyl)-
rutinoside-5-glucoside 
18.35 7 903 741[Cy+Cou+Rut], 
449[Cy+Glc], 287[Cy]+ 
cyanidin 3-(coumaroyl)-
rutinoside-5-glucoside 
18.35 8 933 771[Cy+Fer+Rut], 
449[Cy+Glc], 287[Cy]+ 
cyanidin 3-(feruloyl)-
rutinoside-5-glucoside 
19.57 9 887 725[Pl+Cou+Rut], 
433[Pl+Glc], 271 
pelargonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
19.98 10 917 755[Pe+Cou+Rut], 
463[Pe+Glc], 301[Pe]+ 
peonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
NV  947 785[Pe+Fer+Rut], 
463[Pe+Glc], 301[Pe]+ 
peonidin 3-(feruloyl)-
rutinoside-5-glucoside 
20.77 11 N/A N/A unknown pelargonidin 
derivative 
 
Rt, retention time; N/A, not applicable; NV, not visible in UV; Cy, cyanidin; Pe, peonidin; Pl, 
pelargonidin; Glc, glucose; Cou, coumaroyl; Rut, rutinoside; Fer, feruloyl; ESI-MS, Electro 
spray ionization mass spectra; m/z, molecular mass of compound. 
 
 
2.4.4 Cyanidins but no pelargonidins are produced in the peel of 
E8::Del/Ros1/E8::AmDfr/f3’5’h-/- tomato fruit 
Analysis of the anthocyanins in peel and flesh of anthocyanin-enriched transgenic 
tomato lines revealed differences in the classes of anthocyanins produced in the tissues 
of AmDfr/Del/Ros1/f3’5’h-/- (Figure 2.10). Cyanidin 3-(coumaroyl)-rutinoside-5-
glucoside and peonidin 3-(coumaroyl)-rutinoside-5-glucoside, corresponding to peaks b 
1 and b 3 (Table 2xii) were the most abundant compounds in the peel, and no 
monohydroxylated anthocyanins were detected in the peel of AmDfr/Del/Ros1/f3’5’h-/-. 
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In the flesh, pelargonidin 3-(coumaroyl)-rutinoside-5-glucoside (peak b 6, Table 2xii) 
was the predominant anthocyanin but we also identified all dihydroxylated 
anthocyanins that were also present in the peel. Equal amounts of freeze-dried plant 
material were used for the anthocyanin extraction procedure and it was evident that the 
skin accumulated approximately four times more anthocyanins than the flesh (Figure 
2.10 B). The peel of the tomato fruit accounts for less that 5% of the total fresh weight 
of the fruit. Therefore, the monohydroxylated anthocyanins found in the flesh, even at 
lower relative concentrations, still account for the majority of anthocyanins present in 
the whole fruit. 
 
There was no significant difference in the amount of anthocyanins that accumulated in 
the peel or flesh of Del/Ros1 tomato fruit, in which petunidin 3-(coumaroyl)-rutinoside-
5-glucoside (peak a 2) and delphinidin 3-(coumaroyl)-rutinoside-5-glucoside (peak a 1) 
were the most and second most abundant compounds in that tomato line (Table 2xii). 
Del/Ros1/f3’5’h-/- fruit contained three- to fourfold more anthocyanins in the peel than 
in the flesh and both tissues accumulated the same dihydroxylated anthocyanins (Figure 
2.10 C and Table 2xii). The dihydroxylated anthocyanins found in Del/Ros1/f3’5’h-/- 
were identical with those identified in the peel of AmDfr/Del/Ros1/f3’5’h-/-. 
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Figure 2.10: HPLC analysis of anthocyanins in the peel and flesh of fruit of (A) delphinidin-
producing E8::Del/Ros1, (B) cyanidin- and pelargonidin-producing 
E8::Del/Ros1/E8::AmDfr/f3’5’h-/-, (C) cyanidin-producing E8::Del/Ros1/f3’5’h-/- line, (D) WT. 
HPLC analysis of anthocyanins of E8::Del/Ros1/f3’5’h-/- shows the presence of  five major new 
anthocyanin compounds. Peaks corresponded to the following compounds: a 1, delphinidin 3-
(coumaroyl)-rutinoside-5-glucoside; a 2, petunidin 3-(coumaroyl)-rutinoside-5-glucoside; b 1, 
cyanidin 3-(coumaroyl)-rutinoside-5-glucoside; b 2, cyanidin 3-(feruloyl)-rutinoside-5-
glucoside; b 3, peonidin 3-(coumaroyl)-rutinoside-5-glucoside; b 4, peonidin 3-(feruloyl)-
rutinoside-5-glucoside; b 5, pelargonidin 3-(caffeoyl)-rutinoside-5-glucoside; b 6, pelargonidin 
3-(coumaroyl)-rutinoside-5-glucoside; c 1, cyanidin 3-(coumaroyl)-rutinoside-5-glucoside; c 2, 
cyanidin 3-(feruloyl)-rutinoside-5-glucoside; c 3, peonidin 3-(coumaroyl)-rutinoside-5-
glucoside; c 4, peonidin 3-(feruloyl)-rutinoside-5-glucoside. 
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Table 2xii: Characterisation of major anthocyanin peaks identified in the peel and flesh 
of the fruit of three anthocyanin tomato lines. 
Tomato line Peak 
ESI-MS 
(m/z) 
Peel Flesh Compound 
E8::Del/Ros1 a 1 919 yes yes 
delphinidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1 a 2 933 yes yes 
petunidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/E8::Am
Dfr/f3’5’h-/- 
b 1 
903 
 
yes yes 
cyanidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/E8::Am
Dfr/f3’5’h-/- 
b 2 933 yes yes* 
cyanidin 3-(feruloyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/E8::Am
Dfr/f3’5’h-/- 
b 3 917 yes yes* 
peonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/E8::Am
Dfr/f3’5’h-/- 
b 4 947 yes yes* 
peonidin 3-(feruloyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/E8::Am
Dfr/f3’5’h-/- 
b 5 903 no yes 
pelargonidin 3-(caffeoyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/E8::Am
Dfr/f3’5’h-/- 
b 6 887 no yes 
pelargonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/f3’5’h-/- c 1 903 yes yes 
cyanidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/f3’5’h-/- c 2 933 yes yes 
cyanidin 3-(feruloyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/f3’5’h-/- c 3 917 yes yes 
peonidin 3-(coumaroyl)-
rutinoside-5-glucoside 
E8::Del/Ros1/f3’5’h-/- c 4 947 yes yes 
peonidin 3-(feruloyl)-
rutinoside-5-glucoside 
 
Compounds marked with (*) are not annotated in the corresponding chromatogram. Rt, 
retention time; Cy, cyanidin; Dp, delphinidin; Mv, malvidin; Pt, petunidin; Caf, caffeoyl; Glc, 
glucose; Cou, coumaroyl; Rut, rutinoside; Fer, feruloyl; ESI-MS, Electro spray ionization mass 
spectra; m/z, molecular mass of compound.  
 
 
2.4.5 Inactivation of F3’5’H and F3’H enzyme activity dramatically 
impacts plant fertility 
Silencing of the f3’h gene in an f3’5’h (a) mutant resulted in plants that developed 
normally but did not produce any fruit that contained viable seeds. The plants developed 
flowers but most of them did not result in the setting of fruit and the few fruit that 
developed on these plants did not contain any seeds. Attempts to generate crosses using 
AmDfr/Del/Ros1/f3’5’h-/- as a male parent also failed. Several flavonoid metabolism 
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enzymes have been implicated in plant development and growth. For example, 
mutations or suppression of the cinnamate 4-hydroxylase (c4h) and dihydroflavonol 4-
reductase-like gene (DRL1) have been reported to lead male sterility in Arabidopsis 
(Schilmiller et al., 2009, Tang et al., 2009) and co-suppression of dfr or f3’5’h genes 
resulted in ovule abortion in Petunia hybrida (Jorgensen et al., 2002). 
 
These results show that alterations in the expression of flavonoid biosynthetic genes can 
impact vital developmental processes in the plant and may pose a limitation to 
metabolic engineering targeting specific branches in the polyphenol metabolism through 
inactivation or suppression of key biosynthetic genes.  
 
 
2.4.6 Comparison of major polyphenolic compound composition and 
antioxidant capacity between WT and transgenic high-anthocyanin 
tomato lines 
Flavonoid and anthocyanin compositions were compared between the transgenic 
Del/Ros1 and AmDfr/Del/Ros1/f3’5’h-/- lines and WT fruit (Figure 2.11). The amount of 
flavonols in ripe fruit did not dramatically differ between the WT and transgenic lines. 
Total flavonol content was slightly reduced by ~10% in AmDfr/Del/Ros1/f3’5’h-/- 
tomatoes and increased by ~20% in Del/Ros1 compared to the WT control (Figure 2.11 
A). Quercetin-3-O-rutinoside also referred to as rutin was the most abundant flavonol in 
all three tomatoes but was proportionally more abundant in WT compared to the two 
transgenic high-anthocyanin tomato lines. The amount of chlorogenic acid (CGA) was 
increased threefold from 40 µmol/kg FW in the WT control to 120 µmol/kg FW in 
AmDfr/Del/Ros1/f3’5’h-/- but reduced to 20 µmol/kg FW in Del/Ros1. In the two 
transgenic lines, levels of kaempferols and quercetins were higher than in the WT fruit. 
Most notably, kaempferol-3-rutinoside (kae-3-rut) was increased by 2.5 fold compared 
to WT fruit. Kaempferol-rutinoside-glucoside (Kae-rut-glu) was almost undetectable in 
both WT and Del/Ros1 but was present at 25 µmol/kg FW in the fruit of 
AmDfr/Del/Ros1/f3’5’h-/- where F3’5’H was inactive. Levels of quercetin-coumaroyl-
rutinoside (que-cou-rut) and quercetin-rutinoside-feruloyl (que-rut-fer) were also higher 
in the transgenic lines compared to WT. 
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Figure 2.11: Comparative analysis of (A) flavonoid and (B) anthocyanin content and 
composition of WT and transgenic lines Del/Ros1 and AmDfr/Del/Ros1/f3’5’h-/-. HPLC 
analysis, recorded at (A) 340-360 nm or (B) 500-550 nm, of 50% methanol (v/v) extracts of ripe 
tomato fruit. Classiﬁcation and identiﬁcation of compounds was performed on the basis of PDA 
absorbance and mass spectrometry.  
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Myricetin-rutinoside-coumarate (myr-rut-cou) was the only trihydroxylated flavonoid 
that was detected and quantified with fidelity. Myr-rut-cou was present at extremely low 
levels of ~5 µmol/kg FW in both WT and AmDfr/Del/Ros1/f3’5’h-/- fruit but increased 
to 30 µmol/kg FW in Del/Ros1. 
 
Similarly, anthocyanins were identified and quantified in the three tomato lines (Figure 
2.11 B). As expected, anthocyanins were absent from the WT tomato fruit. The 
identification of anthocyanins in the fruit of the transgenic high-anthocyanin lines had 
shown that Del/Ros1 produces only trihydroxylated anthocyanins and 
AmDfr/Del/Ros1/f3’5’h-/- synthesises predominantly monohydroxylated anthocyanins 
and low levels dihydroxylated anthocyanins. Del/Ros1 contained 2.5 times more 
anthocyanins that AmDfr/Del/Ros1/f3’5’h-/-. The most abundant anthocyanins found in 
Del/Ros1 fruit was delphinidin-coumaroyl-rutinoside-glucoside (del-glu-cou-rut) and in 
the fruit of AmDfr/Del/Ros1/f3’5’h-/- was pelargonidin-coumaroyl-rutinoside-glucoside 
(pel-glu-cou-rut). 
 
Differences in the antioxidant activity between WT and transgenic anthocyanin 
tomatoes were measured using the TEAC assay. The activity of the water-soluble 
fraction (containing anthocyanins) of Del/Ros1 tomatoes (var. MicroTom) was fourfold 
higher than that of WT tomatoes (var. MicroTom; Figure 2.12 A). The water-soluble 
fraction of AmDfr/Del/Ros1/f3’5’h-/- tomatoes resulted in a threefold increase in 
antioxidant activity compared to the WT tomatoes (Figure 2.12 A).  
 
In all three tomato samples, the antioxidant activity observed in the acetone-soluble 
fraction (containing lipophilic antioxidants) was fourfold lower compared to the water-
soluble fractions. In agreement with the results from the hydrophilic fraction, the 
antioxidant capacity of lipophilic fractions of Del/Ros1 and AmDfr/Del/Ros1/f3’5’h-/- 
were increased by four- and threefold, respectively, compared to the WT tomato 
fraction (Figure 2.12 B). Both transgenic anthocyanin tomatoes have significantly 
higher antioxidant capacities than the WT control with Del/Ros1 displaying the most 
pronounced increase. 
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Figure 2.12: Analysis of (A) hydrophilic and (B) lipophilic antioxidant activity in ripe tomato 
fruit from WT and transgenic lines Del/Ros1 and AmDfr/Del/Ros1/f3’5’h-/-. Values are 
expressed relative to Trolox antioxidant activity. Histograms represent mean values ± standard 
error (n=3). * p<0.05; ** p<0.01; *** p<0.001. 
 
 
2.4.7 Alteration in the anthocyanin pathway gene expression in response to 
AmDfr activity 
Expression of the key genes involved in the biosynthetic pathway of anthocyanins in the 
transgenic, anthocyanin-producing lines Del/Ros1 and AmDfr/Del/Ros1/f3’5’h-/- were 
investigated by quantitative qRT-PCR and compared to the WT control (Figure 2.14). 
Fruit were selected at different stages of maturity for subsequent RNA extraction and 
cDNA synthesis (Figure 2.13). Expression levels for plant polyphenol biosynthetic 
genes changed dramatically during fruit development, being lowest in ripe fruit and 
showing highest levels of induction in the early breaker stage. Therefore, I selected fruit 
at early breaker stage, at which the peel of the fruit would start to turn from green to 
yellow/orange (Figure 2.13). The expression of the genes was normalized to SlUbi, 
encoding for the tomato ubiquitin and gene expression levels were expressed relative to 
SlUbi. Expression levels of early biosynthetic genes (Figure 2.14 A) varied dramatically 
between the different tomato lines no general trend between the presence of the 
transgenes and the changes in gene expression. pal, chs-1 and f3’h were expressed at 
highest levels in WT fruit, whereas expression of f3’5’h and f3h was significantly 
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upregulated in AmDfr/Del/Ros1/f3’5’h-/- compared to WT and chi was most strongly 
expressed in Del/Ros1 tomato. 
 
However, a clear correlation between the presence of the transgenes Del, Ros1 and 
AmDfr and the upregulation of late biosynthetic genes was observed (Figure 2.14 B). 
The fls gene encoding flavonol synthase which catalyses the conversion of 
dihydroflavonols to flavonols was expressed most strongly in WT but both Sldfr and 
Slans, coding for enzymes that are crucial for performing the structural modifications 
that are required for the conversion of dihydroflavonols to anthocyanins, were strongly 
upregulated in the transgenic lines but higher in AmDfr/Del/Ros1/f3’5’h-/- than in 
Del/Ros1. The transcription factor genes Del and Ros1 were more strongly expressed in 
AmDfr/Del/Ros1/f3’5’h-/- than in Del/Ros1, and unsuprsingly showed no expression in 
the untransformed WT control. High expression of the AmDfr transgene expression was 
detected only in the fruit of AmDfr/Del/Ros1/f3’5’h-/- and confirmed that AmDfr was 
indeed active in AmDfr/Del/Ros1/f3’5’h-/- tomatoes and catalysing the formation of 
predominantly monohydroxylated anthocyanins in the fruit. 
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Figure 2.13: Anthocyanin production in various developmental stages of the different 
anthocyanin tomato genotypes. Photographs of (A) WT, (B) Del/Ros1 and (C) 
AmDfr/Del/Ros1/f3’5’h-/- tomato fruit. 
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Figure 2.14: Expression profiles of key anthocyanin pathway genes of the transgenic Del/Ros1 
and AmDfr/Del/Ros1/f3’5’h-/- tomato lines were compared to WT. Tomatoes were harvested at 
breaker stage. Expression of (A) early biosynthetic pathway genes and (B) late biosynthetic 
pathway genes and transgenes were represented relative to S. lycopersicum ubiquitin (SlUbi). A. 
majus Rosea1, AmRos1;  A. majus Delila, AmDel; A. majus dihydroflavonol reductase, AmDfr; 
S. lycopersicum anthocyanidin synthase, LeAns; S. lycopersicum chalcone synthase-1 (SlChs-1); 
S. lycopersicum chalcone isomerase (SlChi); S. lycopersicum dihydroflavonol reductase; S. 
lycopersicum flavanone-3-hydroxylase (SlF3h); S. lycopersicum flavonoid-3'-hydroxylase 
(SlF3’h); S. lycopersicum flavonoid-3'5'-hydroxylase (SlF3’5’h); S. lycopersicum flavonol 
synthase (SlFls); S. lycopersicum phenylalanine ammonia lyase (SlPal). Data shown as mean ± 
standard error (n=3). * p<0.05; ** p<0.01. 
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2.5 Discussion  
Plant metabolic engineering is an indispensable tool in molecular biology and has 
contributed significantly to increasing our knowledge of the fundamental biochemical 
processes that govern primary and secondary metabolism in plants. By understanding 
the molecular mechanisms that underlie their development, growth or unique 
biochemical characteristics, this technology can be applied to modify crop species to 
improve their nutritional composition or resistance to biotic and abiotic stresses.  
 
Increasing awareness of the health benefits of plant compounds such as carotenoids and 
polyphenols, has led to increased research efforts using both conventional breeding and 
transgenic approaches to enhance their content or composition in important crop species 
including maize, rice, wheat and tomato (Bai et al., 2011, Schijlen et al., 2004). The 
tissue-specific accumulation of many of these compounds is often regulated by MYB 
and/or bHLH transcription factors, or their tertiary complexes, that can activate general 
pathways (e.g. Vitis vinivera MYB5a–mediated regulation of anthocyanins, flavonols, 
tannins, and lignins (Deluc et al., 2006)) or induce highly specific branches in a 
biosynthetic pathway (proanthocyanidin regulation in strawberry fruit is regulated by 
FaMYB9, FabHLH3 and WD40 FaTTG1 (Schaart et al., 2013)). The modification of 
plant secondary metabolism through transcriptional regulation of biosynthetic pathways 
has resulted in the accumulation of polyphenolic compounds in several crop species 
(Davies, 2010, Dixon, 2005, Gray et al., 2012).  
 
Commercial tomato varieties accumulate significant amounts of the carotenoid, 
lycopene, but contain only low levels of flavonols and no anthocyanins in the fruit. 
Several transgenic approaches have successfully increased the content of carotenoids in 
in tomato by modulating the expression of regulatory genes (Davuluri et al., 2005) or 
introducting novel genes (Rosati et al., 2000). Non-transgenic introgression with wild 
relatives of tomato that accumulate anthocyanins, resulted in tomatoes producing  
anthocyanins in the peel but not in the flesh (Povero et al., 2011). Transgenic 
approaches that involved the addition of transcription factors regulating flavonoid 
biosynthesis in heterogenous species, resulted in tomatoes that accumulated high levels 
of flavonols (Bovy et al., 2002, Luo et al., 2008) and anthocyanins (Butelli et al., 2008) 
in peel and flesh. This demonstrates that transcription factors play a critical role in the 
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regulation of genes implicated with the general flavonoid biosynthetic pathway or 
specific branches leading to flavonols, anthocyanins and proanthocyanidins. 
 
To date, many transcription factors or MBW complexes regulating flavonoid 
biosynthesis have been identified in commercially important crops and ornamental 
plants, but mainly in model species such as Arabidopsis and Antirrhinum and Petunia, 
which have contributed to most of our understanding of anthocyanin. Our increasing 
knowledge of the regulatory and structural genes involved in the biosynthetic pathways 
has allowed targeting of specific branches in the pathway in order to accumulate 
specific compounds. This has important implications for the development of novel 
crops with enhanced nutritional qualities through the addition of new compounds, e.g. 
β-carotene-enriched rice (Paine et al., 2005), or the reduction and elimination of toxic or 
undesirable compounds like cyanogen in cassava (Siritunga and Sayre, 2003).  
 
Butelli et al. (2008) demonstrated that the addition of the two transcription factors, 
Delila and Rosea1, which jointly regulate anthocyanin production in A. majus, lead to 
the accumulation of large amounts of anthocyanins when placed under the control of a 
fruit-specific E8 promoter. Transgenic Del/Ros1 tomatoes accumulated between 2 and 3 
mg of trihydroxylated anthocyanins per gram FW. The Del/Ros1 tomato line 
accumulated only trihydroxylated anthocyanins but produced all three classes of 
flavonols, Kae, Que and Myr (Figure 2.11 A), which strongly suggested that the 
structural enzymes, required for the conversion of the dihydroflavonol, DHK, to either 
DHQ or DHM were active in the fruit. These dihydroflavonols act as substrates for 
FLS, which catalyses the conversion to flavonols or as substrates for DFR that forms 
leucoanthocyanidins and subsequently, lead to the production of anthocyanins or 
proanthocyanidins (Figure 2.1). The presence of mono-, di- and trihydroxylated 
flavonols but absence of mono- or dihydroxylated anthocyanins in Del/Ros1 fruit was 
strongly indicative of the substrate preference of DFR for trihydroxylated DHM. 
 
In order to generate mono- and dihydroxylated anthocyanins we pursued a dual 
metabolic engineering strategy to overcome DFR substrate-specificity by introducing a 
non-specific DFR from A. majus and controlling the formation different classes of 
dihydroflavonols by inhibiting the activity of the hydroxylases, F3’5’H and F3’H that 
catalyse the formation of DHM and DHQ, respectively. The accumulation of low levels 
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of dihydroxylated anthocyanins in the Del/Ros1/f3’5’h-/- line confirmed our hypothesis 
that in the absence of a functional F3’5’H, tomato DFR could bind to the cyanidin 
precursor DHQ (Figure 2.8 and Table 2x). The low amounts of cyanidin-type 
anthocyanins indicated however, that tomato DFR could not efficiently convert DHQ to 
leucocyanidins. In order to overcome the substrate-specific limitations of DFR and 
increase the amounts of dihydroxylated anthocyanins in the fruit, we introduced a gene 
from A. majus encoding a DFR that produces both mono- and dihydroxylated 
anthocyanins in the flowers of A. majus (Martin et al., 1991).  
 
Somewhat unexpectantly, the resulting line, AmDfr/Del/Ros1/f3’5’h-/-, produced both 
mono- and dihydroxylated anthocyanins in the fruit and had a total anthocyanin content 
of 2.5-fold lower than that of the Del/Ros1 line (Figure 2.11 B). Separate analysis of the 
peel and flesh revealed however, that only dihydroxylated cyanidins and peonidins were 
produced in the peel whereas both dihydroxylated and monohydroxylated anthocyanins 
were produced in the flesh of ripe tomato fruit of AmDfr/Del/Ros1/f3’5’h-/- (Figure 2.10 
B). This was an interesting observation as no monohydroxylated anthocyanins were 
detected in the Del/Ros1/f3’5’h-/- line, which produced low levels of cyanidins in both 
peel and flesh. The absence of monohydroxylated pelargonidins from the fruit peel of 
AmDfr/Del/Ros1/f3’5’h-/- suggests that in the peel, F3’H is active and converts DHK to 
DHQ, which is then converted by DFR into leucocyanidin. The presence of both mono- 
and dihydroxylated anthocyanins in the flesh, shows that some DHK is converted to 
DHQ by F3’H but a substantial proportion of the available DHK is directly converted 
into leucopelargonidin by the A. majus DFR.  
 
This observation might indicate that the transcription factors Delila and Rosea1 strongly 
induce expression of F3’H in the peel but less effectively in the flesh of tomato fruit. 
Gene expression analysis of tomato f3’h in the whole fruit at the early breaker stage 
showed that expression of f3’h was lower in the anthocyanin-producing lines, Del/Ros1 
and AmDfr/Del/Ros1/f3’5’h-/- compared to WT (Figure 2.14 A). F3’5’H, F3’H and DFR 
compete for the same substrate, DHK. In the delphinidin-producing Del/Ros1 line, 
F3’5’H is substantially increased in response to Del/Ros1, and binds more effectively 
than F3’H to their common substrate, DHK. This might lead to negative feedback on 
the expression of F3’H and could explain why expression levels of f3’h are reduced in 
Del/Ros1. In the AmDfr/Del/Ros1/f3’5’h-/- line, activity of F3’5’H has been blocked as a 
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result of a stop mutation in the gene encoding F3’5’H. Gene expression analysis of 
f3’5’h in the fruit of the AmDfr/Del/Ros1/f3’5’h-/- line showed that transcript levels of 
f3’5’h were significantly increased (Figure 2. 14 A). However, the absence of 
trihydroxylated dihydroflavonols or delphinidins in these tomatoes illustrated that f3’5’h 
transcripts were not translated into a functional enzyme due to the stop mutation in its 
sequence.  
 
In AmDfr/Del/Ros1/f3’5’h-/-, F3’H competes with DFR but not F3’5’H for DHK 
substrate binding. Whilst tomato DFR cannot use DHK as a substrate, A. majus DFR 
can effectively convert DHK to leucopelargonidin. Both tomato and A. majus DFR 
(LeDfr and AmDfr; Figure 2.14 B) were significantly upregulated in the fruit of 
AmDfr/Del/Ros1/f3’5’h-/- resulting in the production of both di- and monohydroxylated 
anthocyanins in the fruit. However, the high amounts of cyanidins found in the peel of 
AmDfr/Del/Ros1/f3’5’h-/- and the absence of pelargonidins suggest that in this tissue, 
F3’H is activate and converts all DHK to DHQ. Separate gene expression analysis of 
F3’H in peel and flesh is required to confirm whether F3’H is differentially regulated in 
the peel and the flesh of tomato fruit.  
 
Our current observations confirm that in the fruit of transgenic AmDfr/Del/Ros1/f3’5’h-/- 
tomatoes, A. majus DFR effectively converts both DHK and DHQ to leucopelargonidin- 
and –cyanidin, respectively. The failure to substantially increase the accumulation of 
dihydroxylated anthocyanins in the flesh of AmDfr/Del/Ros1/f3’5’h-/-, however, 
suggests that in this tissue, F3’H is insufficiently activate. The transcription factors, 
Delila and Rosea1, effectively activate general phenylpropanoid metabolism and result 
in the upregulation of late biosynthetic pathway genes, dfr and ans, which are required 
for the formation of anthocyanins (Figure 2.14 B). Compared to f3’5’h, total expression 
of f3’h in the developing fruit is not increased as a result of Delila and Rosea1 
activation. This indicates that in the flesh, which accounts for most of the DW of the 
fruit, the f3’h gene does not respond effectively to Del/Ros1-mediated transcriptional 
activation. Not all transcriptional regulators may work equally well in every species or 
some may fail to control expression of all structural flavonoid genes (Schwinn et al., 
2006). In maize, for example, the R and C1 genes encode transcription factors that 
regulated anthocyanin production in the maize kernels. The expression of R and C1 in 
transgenic tomato fruit resulted in the accumulation of high levels of flavonols but not 
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anthocyanins (Bovy et al., 2002). Delila and Rosea1 regulate biosynthesis of mono- and 
dihydroxylated anthocyanin in A. majus and effectively induced the genes such as 
f3’5’h, required for the production of trihydroxylated anthocyanins in tomato (Butelli et 
al., 2008). However, the failure to significantly upregulate the expression of f3’h in 
AmDfr/Del/Ros1/f3’5’h-/- tomatoes might indicate that Delila and Rosea1 do not 
activate this structural gene effectively and thus, are unsuitable for increasing the 
amount of dihydroxylated cyanidins in tomato. 
 
Tissue-specific expression of flavonoid genes in tomato as well as other species is well 
documented and the amount of major flavonoids such as naringenin that accumulate in 
the peel may account for around 90% of total flavonoids present in the tomato fruit 
(Torres et al., 2005). The weak expression of structural flavonoid genes in the flesh has 
limited previous transgenic attempts to accumulate high amounts of flavonoids in the 
whole fruit of tomato (Muir et al., 2001) but also explains the skin-specific 
accumulation of anthocyanins in the fruit of non-transgenic anthocyanin tomatoes 
(Povero et al., 2011). However, this limitation was overcome by placing transgenes 
under the control of a fruit-specific E8 promoter, which successfully activated the 
expression of flavonoid biosynthetic genes that led to the accumulation of flavonols or 
anthocyanins in all fruit compartments (Bovy et al., 2002, Butelli et al., 2008, Luo et al., 
2008). 
 
I demonstrated, that by blocking F3’5’H activity and introducing a substrate-
independent DFR, novel branches in the anthocyanin biosynthetic pathways were 
activated that led to the formation of cyanidins and pelargonidins. My work also 
demonstrated the complexity and difficulty of controlling several structural enzymes in 
order to target specific compounds in a pathway.  
 
Failure to upregulate f3’h activity significantly and increase cyanidin production in the 
flesh of AmDfr/Del/Ros1/f3’5’h-/- tomatoes, could potentially be overcome by 
introducing a novel F3’H from A. majus or Chrysanthemum, which both accumulate 
significant amounts of cyanidins in their flowers under the control of their native 
promoters (AmF3’H is responsive to Del and Ros1) or an E8 promoter.  
 
The development of a high-pelargonidin line that produces exclusively pelargonidins in 
both peel and flesh might be even more challenging. The silencing of f3’h in the a 
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(f3’5’h-/-) mutant resulted in plants that were unable to self-fertilise. Cross-pollination 
attempts also failed in these plants suggesting that both pollen and anther development 
could be affected in these plants. Flavonoid biosynthesis and metabolism have been 
implicated with a number of developmental processes such as auxin transport and 
pollen development (Taylor and Grotewold, 2005). The CHS is the first committed step 
in the synthesis of flavonoids and chs-deficient plants fail to accumulate flavonoids in 
their tissues and organs. Antisense inhibition of chs in Petunia resulted in flavonoid-
deficient anthers that were male sterile due to an arrest in male gametophyte 
development (van der Meer et al., 1992). Conditional male fertility was also reported in 
CHS-deficient maize (Pollak et al., 1995) but Arabidopsis plants harbouring a null 
mutation in their chs gene and were deficient in flavonoid biosynthesis but fully fertile 
(Burbulis et al., 1996). Schijlen et al. (2007) reported the development of parthenocarpic 
(seedless) fruit with impaired pollen tube growth in a chs RNAi tomato lines suggesting 
that flavonoids are essential for pollen development. CHS and flavonoid accumulation 
appears to be essential for pollen and anther development in some species such as 
maize, Petunia and tomato but not in others. So far, there are no definite reports of other 
flavonoid biosynthetic genes to impact male or female fertility. However, Suzuki et al. 
(2000) reported male and female sterility as a result of co-suppression of CHS and DFR 
in the ornamental plant Torenia hybrida but did not report whether suppression of DFR 
alone impacted plant fertility. Despite normal flower development, the f3’h RNAi (in a 
f3’5’h-/- background) tomato line failed to self-pollinate and set fruit. Similarly, cross-
pollination with pollen from fertile tomato lines failed to produce fruit in these plants 
suggesting that inhibition of both f3’h and f3’5’h severely impacted male and female 
fertility in tomato. Compared to WT plants, a reduction in the number of fruit developed 
was observed in the a mutant. Additional loss of F3’H activity resulted in complete 
failure to self-pollinate. Further studies, investigating pollen tube and anther 
development, are required to investigate underlying causes of the apparent infertility of 
F3’H/F3’5’H co-suppressed tomatoes. Inhibition of F3’H and F3’5’H activity is a 
requirement to generate a tomato line that produces monohydroxylated anthocyanins 
only. However, generating tomatoes which produce only pelargonidins in both peel in 
flesh may not be possible if concurrent inhibition of F3’H and F3’5H leads to 
irreversible sterility. 
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3 Anthocyanin-enriched tomato extracts 
induce apoptosis in breast cancer cells 
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3.1 Introduction 
Numerous studies have reported that pure plant polyphenols as well as polyphenol-rich 
extracts of fruit and vegetables can inhibit the proliferation of multiple cancer cell types 
in vitro. Several studies have provided evidence that exposure to these compounds can 
alter the apoptotic response through modulation of key components of the apoptotic 
pathway suggesting that anthocyanins and other plant polyphenols possess certain anti-
cancer or chemotherapeutic properties. The mechanisms by which these biological 
effects are exerted are still not fully elucidated but are thought to be the result of 
combinatorial induction of the apoptotic program, changes in the cellular oxidative 
state, alterations in the cell cycle, and reduced DNA synthesis.   
 
Plant polyphenols such as resveratrol and anthocyanins have been shown to induce 
arrest of the cell cycle in G0/G1 (Bai et al., 2010) or alternatively in the S-phase 
depending on the individual cancer cell type, through effects on cell cycle regulator 
proteins such as p53, p21, cyclin D1, cyclin A and others (Joe et al., 2002, Pozo-
Guisado et al., 2002, Lazze et al., 2004, Malik et al., 2003). Cell cycling is central to 
cell division and cell proliferation and cell cycle profiles are often altered or accelerated 
in cancer cells, making cell division a common target for many chemotherapeutic 
agents. 
 
The development and growth regulation of normal cells is strongly interlinked with 
apoptosis, a complex cellular process relying on the coordinated activation and 
execution of various subprogrammes. Many chemopreventive agents target inducers of 
apoptosis in malignant cells. A number of studies have shown that anthocyanins and 
resveratrol along with many other phytochemicals exhibit strong proapoptotic activity 
through both the intrinsic, mitochondria-dependent (Feng et al., 2007)) and extrinsic, 
mitochondria-independent pathways. Both apoptotic pathways have unique component 
mechanisms but almost always involve the activation of caspase proteases. 
 
Caspases are a family of cysteine proteases that play a crucial role in the activation of 
the morphological changes associated with apoptosis.  Loss of function or alterations in 
caspase activity can prevent cells from assuming their apoptotic fate (Earnshaw et al., 
1999). Thus, alterations in caspase functionality, as a result of mutations, are frequently 
observed in different types of cancer, including MCF-7 breast cancer cells which do not 
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express detectable levels of caspase-3 due to a partial deletion within exon 3 of the 
CASP-3 gene (Jänicke et al., 1998). Activation of caspases after exposure to 
anthocyanin-rich extracts has been observed in different cell lines (Hui et al., 2010, Lee 
et al., 2009, Reddivari et al., 2007). In order to understand the anti-cancer activity of 
phytochemicals, it is vital to study at least some of the markers indicative of cell death.  
 
Most of our current understanding of the health-beneficial effects of these dietary 
phytonutrients is derived from studies involving the use of isolated compounds. 
However, over the last few years, results have emerged suggesting that isolated 
polyphenols do not have the same health-promoting effects as the same compounds in a 
food matrix environment (Prior et al., 2008, Titta et al., 2010). It is now believed that 
the dietary components alone do not explain the health benefits of diets that are rich in 
fruit and vegetables. Taking the nutritional context into account and assessing the 
importance of the food matrix are likely to increase our understanding of the 
mechanisms by which phytochemicals contribute towards reduced disease risks and 
incidences. Consequently, comparison of high-anthocyanin or high-resveratrol tomato 
lines with WT tomatoes deficient in these phytonutrients may provide a good model to 
study the health benefits of these compounds in a food context. 
 
3.1.1 Aims 
In this chapter the effects of a high-resveratrol and several anthocyanin-enriched tomato 
extracts on metabolic activity and apoptosis of MCF-7 and MDA-MB-231 breast cancer 
cells are described. A comparison of purified, dietary supplements compared to whole 
tomato extracts containing the same phytochemicals allowed me to study their 
biological effects in the context of a food matrix. WT tomato extracts provided a 
matched matrix control in the experiments using high- resveratrol or high-anthocyanin 
tomatoes. This allowed me to link any differences in the biological effects between the 
different tomato extracts to the compounds that are unique to the individual tomato 
lines. A comparative analysis of the chemopreventive effects of a high-delphinidin and 
a high-pelargonidin tomato extracts was conducted in order to understand whether the 
structure of different anthocyanin molecules affects their biological activity. 
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3.2 Experimental procedures  
 
3.2.1 Cell culturing 
 
3.2.1.1 Description of cell lines 
All cell lines were purchased from the American Type Culture Collection (ATCC
®
). 
Both MCF-7 (Figure 3.1 A) and MDA-MB-231 (Figure 3.1 B) are adherent cell lines 
that were derived from breast adenocarcinomas. MCF-7 in non-invasive and ER
+
 and 
responds to oestradiol via a cytoplasmic oestrogen receptors. The MDA-MB-231 human 
cell line has an invasive phenotype and is ER
-
.  
 
HMT-3522-S1 or HMT-3522/wt is a human breast epithelial cell subline derived from 
HMT-3522. The parent line was established from a benign breast tumour. HMT-3522-
S1cell line has remained non-tumourigenic for more than 400 passages. 
 
 
 
Figure 3.1: Images of (A) MCF-7 and (B) MDA-MB-231 human breast cancer cell lines. 
 
 
3.2.1.2 Media and selection  
Both MCF-7 and MDA-MB-231 cells were maintained in GlutaMAX
TM
 Dulbecco’s 
Modified Eagle medium (DMEM) cell culture medium (GIBCO, Life technologies) 
supplemented with 1% non-essential amino acids (GIBCO, Life technologies) and 10% 
heat inactivated fetal calf serum (FCS; GIBCO, Life technologies) at 37°C and 5% CO2. 
A B 
Scale Bar = 100 µM Scale Bar = 100 µM 
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DMEM GlutaMAX
TM
 has a glucose concentration of 1 g/L and contains 110 mg/L 
pyruvate. Cells were sub-cultured twice a week or when reaching 80% confluence. 
 
HMT-3522-S1 cells were maintained in collagen-coated flasks in serum-free 
DMEM/Ham's F12 (1:1) cell medium (GIBCO, Life technologies) containing 2 mM 
glutamine supplemented with 250 ng/mL insulin, 10 µg/mL apo-transferrin, 2.6 ng/mL 
sodium selenite, 0.1 nM estradiol, 1.4 µM hydrocortisone, 5 µg/mL ovine prolactin and 
10 ng/mL Epidermal Growth Factor (EGF). Collagen is an extracellular matrix protein 
that is used in cell culture to facilitate cell attachment growth, differentiation, migration, 
and tissue morphogenesis. Cell culture flask were coated with collagen and incubated 
for 1 h at 37°C and 5% CO2 before the addition of cells and cell culture medium. 
 
3.2.1.3 Passage and maintenance of cells  
For experimental analyses MCF-7 and MDA-MB-231 cells were used at passages 
between 6 and 20. Passaging or subculturing refers to the transfer of a small numbers of 
cells into a new culture vessel. Regular subculturing is required to avoid the induction 
of transcriptional changes or senescence associated with prolonged high cell density.  
 
3.2.1.4 Trypsinisation 
Both MCF-7 and MDA-MB-231 cells form monolayers that require dissociation from 
each other and the culture flasks, in order to be transferred to new culture vessel. 
Trypsinizing refers to the use of the proteolytic enzyme trypsin to break adhesion 
proteins in cell-cell and cell-matrix interactions and results in the detachment of cells. 
Prior to trypsinisation, cell medium was removed and cells were washed twice with 
PBS. Washed cells were incubated with 2 mL of 0.05% Trypsin-EDTA (Gibco, Life 
Technologies) for two to three minutes at 37°C and 5% CO2 or until cells had detached. 
The proteolytic activity of trypsin was inactivated by addition of complete medium 
containing FCS that acts as a trypsin inhibitor. 
 
3.2.2 Plant secondary metabolites 
All plant secondary metabolites were purchased. The anthocyanin, delphinidin-3-O-
glucoside chloride was purchased from Extrasynthase and dissolved in DMSO to a final 
concentration of 200 mM. The stilbenes, resveratrol (3,4', 5-trihydroxy-trans-stilbene) 
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and polydatin (reservatrol-3-β-mono-D-glucoside) were purchased from Sigma and 
dissolved to a final concentration of 200 mM in ethanol and DMSO, respectively.  
 
3.2.3 Tomato extract preparation for human cell studies 
Crude tomato extracts were prepared from ripe high-anthocyanin, high-resveratrol and 
WT tomato fruit. Tomatoes were harvested at the ripe stage and immediately transferred 
into liquid N2 before being freeze-dried and powdered. The freeze-dried tomato powder 
was then stored protected from light at -20°C (short term) or -80°C (long term). A crude 
tomato extract was prepared by extracting water- and methanol-soluble compounds with 
an 80% methanol (v/v) containing 0.75% HCl from the freeze-dried tomato powder. 1 g 
of freeze-dried plant material and 50 mL of 80% MeOH (v/v) were incubated overnight 
at 4°C in the dark with shaking, before being centrifuged at 4,000 g at 4°C for 15 min to 
separate the polyphenol-containing solvent extract from the plant material. The clear 
extract was then concentrated using a rotary evaporator. The solvent was evaporated at 
37°C for approximately 40 min or until extracts were almost dry and had reached a gel-
like composition. Tomato-derived extracts were dissolved in 50% MeOH (v/v) at a ratio 
of 0.67 g (DW) of tomato powder used to 1 mL of 50% MeOH (v/v). The re-solubilized 
extracts were stored at -20°C for no more than one month. Anthocyanin and resveratrol 
content was quantified as described in Chapter 2.3.18. 
 
 
Table 3i: Final concentration of tomato extract and the molar equivalents of their main 
active compounds. 
Extract 
Active 
compound 
0.1% 0.3% 0.4% 0.5% 0.6% 0.7% 0.8% 0.9% 1% 
high-
del 
anthocyanin 
10 
µM 
30 
µM 
40 
µM 
50 
µM 
60 
µM 
70 
µM 
80 
µM 
90 
µM 
100 
µM 
high-
pel 
anthocyanin 4 µM 
12 
µM 
16 
µM 
20 
µM 
24 
µM 
28 
µM 
32 
µM 
36 
µM 
40 
µM 
high-
res 
resveratrol 2 µM 
6 
µM 
8 µM 
10 
µM 
12 
µM 
14 
µM 
16 
µM 
18 
µM 
20 
µM 
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3.2.4 Cell viability 
3.2.4.1 Trypan Blue exclusion assay 
After incubation, cell viability was assessed by Trypan Blue exclusion. Trypan Blue is 
derived from toluidine. The stain is not absorbed by viable, healthy cells but can enter 
damaged or dead cells, allowing for them to be counted. 20 μL of cell suspension were 
mixed with an equal volume of 0.4% Trypan Blue solution (Sigma). Cells were counted 
on a dual-chamber haemocytometer under the light microscope. 
 
3.2.4.2 WST-1 cell metabolic activity assay 
3.2.4.2.1 Assay principle 
The water-soluble tetrazolium (WST)-1 assay contains 2-(4-Iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, and is based on the reduction of 
water soluble, red WST-1 tetrazolium salt to water soluble, orange formazan salt a 
tetrazolium. Tetrazolium salts are widely used to measure spectrophotometrically the 
proliferation, growth, viability and chemosensitivity of cell populations. The assay 
principle relies on the cleavage of tetrazolium salt to tetrazolium by cellular enzymes. 
Growth and expansion of cells results in an increase in the overall activity of 
mitochondrial dehydrogenase which leads to an augmentation of formazan dye formed 
that correlates to the number of metabolically active cells in the sample. The reaction 
depends on the glycolytic production of NAD(P)H in viable cells and the concentration 
of orange formazan dye formed correlates to the number of metabolically active cells. 
The amount of formazan dye produced can be measured using a spectrophotometer with 
a test wavelength at 450 nm. Although the assay is described as a proliferation assay, I 
used it to determine the metabolic status, specifically the mitochondrial activity of the 
cells. The metabolic activity of the cells is related directly to their ability to grow and 
proliferate (application details can be found on http://www.roche-applied-science.com). 
 
3.2.4.2.2 Wst-1 cell metabolic activity assay: Dose-dependency experiment 
Human breast cancer cell lines MCF-7 and MDA-MB-231 and the normal breast 
epithelial cell line HMT-3522-S1 were grown as described previously (Chapter 3.2.1). 
MCF-7 and MDA-MB-231 cells were split and seeded into 96-well plates at 5,000 cells 
per well, whereas HMT-3522-S1 cells were seeded at 12,500 cells per well and cultured 
115 
 
in 100 µL complete medium for 24 h to allow cells to adhere. Cells were then treated 
for 24 h with complete medium containing various concentrations of purified 
compounds or tomato extracts. Purified compounds dissolved in EtOH or DMSO were 
diluted to a final concentration of 0.1% in the culture media. Tomato extracts dissolved 
in 50% MeOH (v/v) were diluted to a final concentration of 1% in the culture media. 
After 24 h incubation in complete medium containing the desired treatment conditions, 
the treatment medium was removed and replaced with 100 µL complete medium 
containing 10% WST-1 reagent (Roche). The samples were incubated for another 2 h at 
37 ° and 5% CO2 to allow the cells to metabolize the WST-1 reagent. The formazan dye 
produced was quantified by measuring the absorbance at 450 nm with a reference 
wavelength of 600 nm using a FLUOstar Omega multi-mode microplate reader (BMG 
Labtech). Absorbance data were expressed as the percentage of metabolic activity 
relative to the solvent-treated control. 
 
3.2.5 Flow cytometry  
Flow based cytometry or fluorescence-activated cell sorting (FACS) are techniques that 
allow the analysis, identification and isolation of individual cells in a fluidic channel. 
Addition of fluorochrome-labelled antibodies or fluorescent dyes to the cell suspension 
allows targeting of specific markers present in the cell population. 
 
Flow cytometry is based on the principle of light scattering, light excitation, and 
emission of light from a fluorochrome molecule at a certain wavelength to create multi-
parametric data from cells within the size range of 0.5 μm and 40 μm diameter. In the 
process of single cell analysis, cells pass individually through a highly focused laser 
beam by a continuous flow of a fine stream of the suspension. The light scattering or 
fluorescence emission intensity of individual cells labelled with fluorochromes will 
provide information about the cell’s properties. Flow cytometers use separate 
fluorescence (FL-) channels that are equipped with optical filters that will block certain 
wavelengths while permitting others and are capable of detecting light emission at 
specific wavelengths.  This allows for simultaneous analysis of more than one cell 
parameter monitored by different fluorochromes, provided that those fluorochromes 
emit light at different wavelengths. 
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3.2.5.1 Flow cytometry data analysis 
Histograms represent the intensity of either scatter or fluorescence of a specific 
parameter per histogram. Dot plots quantify the percentages of cells with various 
properties. Distinct subpopulations of cells with different properties can be identified 
with both histograms and dot plots. In a dot plot, each cell is represented by a dot and 
positioned on the x and y scales according to their intensity. Scatter dot plots (x = 
forward scatter, y = side scatter) are often useful in assessing the overall state of the cell 
population. Cell debris often accumulates at the axis intersection and along the y axis. 
Intact cells usually form a distinct population clearly separated from cell debris and 
other contaminants (Figure 3.2 A) which can be selected through “gating” and studied 
separately for other parameters.  
 
Fluorescein (FITC)-conjugated Annexin-V and propidium iodide (PI) are two 
fluorescent stains that are frequently used to different parameters of apoptosis and cell 
cycle. They emit light at different excitation wavelengths which requires the use of two 
distinct fluorescence channels (eg. FL-1 and FL-3). Quadrants allow for the separation 
and quantification of distinct cell subpopulations based on their light emission intensity 
(Figure 3.3). Annexin-V is detected by FL1 and Annexin-V positive cells scatter at the 
far end of the x axis, whereas PI is detected by FL-3 and PI-positive cells accumulate at 
the top end of the y axis (Table 3ii). 
 
 
Table 3ii: Interpretation of fluorescence detection of Annexin-V/PI stained cells and the 
distribution of subpopulations in a gated scatter plot based the light emission intensity 
of a given cell. 
 
  
Quadrant Fluorescence 
channel 
Annexin-V Propidium 
Iodide 
Cell stage 
D-- - negative negative healthy 
D+- FL1 positive negative early apoptotic 
D++ FL-1/FL-3 positive positive late apoptotic 
D-+ FL-3 negative positive necrotic 
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Figure 3.2: Examples of scatter plots and histograms of flow cytometric analysis of the cell 
cycle of (A) a normal cell cycle of MCF-7 cells after 24 h treatment with 1% WT tomato extract 
and (B) an altered cell cycle of MCF-7 cells in response to 24 h treatment with 1% high-pel 
tomato extract. (1) Data acquisition scatter plot demonstrating the selection of intact cells by 
“gating”. (2) Scatter plot of the cell population selected through gating in (1) and selection of 
single cells through second gating. (3) Histogram representing the distinct cell cycle phases 
corresponding to the DNA content of individual cells in the population selected through gating 
in (2). 
  
A A A 
G1 
G2 
S 
G2/M 
S 
G0/G1 
singlet
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B 1 B 3 B 2 
G0/G1 
G2/M 
S 
sub-G1 sub-
G1 
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Cell cycle profiles are usually represented as histograms showing the distinct 
distribution of DNA content within a population of cells measuring the fluorescence 
intensity per individual cell (Figure 3.2 A3 and B3). Cells in G0/G1 will have one copy 
of the genomic DNA and therefore 1x fluorescence intensity, cells in G2/M phase of the 
cell cycle will have two copies of the genomic DNA and 2x fluorescence intensity. 
Cells in the S phase are synthesizing DNA and will accordingly have fluorescence 
values between the 1x and 2x. Fluorescence intensity will also double if cells are 
present as doublets or aggregates. Aggregates and simultaneously read events are 
unavoidable during the acquisition part of cell cycle analysis but must be omitted from 
single cells in order to maintain data fidelity. Aggregates will have a higher area to 
height ratio (FL2-A to FL2-H) and can be excluded from later analysis by gating the 
singlet population (Figure 2 A2 and B2). A cell cycle histogram representing the DNA 
content in single cells of a given population which is produced by plotting cell count 
against total cell fluorescence (FL2-A; see Figure 3.2 A3 and B3).  
 
3.2.5.2 Cell cycle detection by Propidium Iodide 
Cell cycle analysis is a method that allows the distinguishing of cells in different phases 
of the cell cycle. Cell cycle alterations can be the result of cell damage, including DNA 
damage that causes cells to pause at certain checkpoints in order to prevent the 
proliferation of aberrant cells. Flow cytometric analysis allows the accurate 
determination of whether and where drugs or xenobiotic compounds operate in the cell 
cycle. 
 
PI was one of the first fluorescent dyes to be used in FACS assisted cell cycle analysis 
and allows for quantification of DNA content and binds in proportion to the amount of 
nucleic acid present in an individual cell. PI does not discriminate between DNA and 
RNA, making the removal of RNA prior to cell cycle analysis an essential requirement 
in order to maintain data fidelity. The DNA content of cells doubles as they progress 
from G0/G1 to G2/M phase, which is reflected in a doubling in the fluorescent signal 
emitted by PI-stained cells. 
 
3.2.5.2.1 Sample preparation, data acquisition and analysis 
MCF-7 and MDA-MB-231 cells were seeded into 6-well plates at 150,000 cells per 
well for cell cycle analysis and incubated for 24 h prior to treatment. Cells were exposed 
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to tomato extracts at a final concentration of 1% in the medium for 0 h, 3 h, 6 h, 12 h or 
24 h. After exposure to treatment, cell medium containing detached cells was 
transferred to a labelled 15 mL tube. Cells that remained attached to the well were 
washed twice with PBS (PBS washing solution was also transferred to the labelled tube) 
before being trypsinised and pooled with the detached cells in the 15 mL tube. After 
centrifuging at 300 g for 5 min and washing once with PBS, cells were resuspended in 
500 µM 70% EtOH (v/v) to permeabilize the cell membranes and incubated overnight 
in the dark at -20°C. Samples were centrifuged at 600 g for 5 min, EtOH was removed 
and cells were washed with PBS before being resuspended in 60 µL RNA-degrading 
solution containing 0.1% Triton X-100, RNAse A 0.5mg/mL in PBS and incubated at 
37°C for 30 min. Aliquots of 3 μl of 1 mg/mL PI were added to the cell suspension and 
samples immediately analysed with a flow cytometer. 
 
Data acquisition was performed with a BD Biosciences Accuri™ C6 Flow Cytometer 
equipped with a 488 nm laser. 10,000 events were collected in the gated population of 
single cells for each sample. Figure 3.2 show representative plots of PI stained cells 
demonstrating the gating strategies and data acquisition procedure. Cell debris was 
excluded from the analysis. Data acquisition and analysis was carried with BD CFlow
®
 
Software. 
 
3.2.5.3 Apoptosis detection by Annexin-V 
3.2.5.3.1 Assay principle  
Apoptosis is a normal genetic process by which cells undergo a tightly regulated 
programme leading to controlled cell death. In apoptotic cells, the membrane 
phospholipid phosphatidylserine (PS) translocates from the inner to the outer membrane 
leaflet exposing itself to the external cellular environment. Annexin-V is a 35-36 kD 
phospholipid-binding protein characterized by a high affinity for PS. Annexin-V is 
conjugated to fluorochromes and acts as a highly sensitive probe for flow cytometry 
analysis of cells undergoing apoptosis. Translocation of PS precedes the loss of 
membrane integrity which takes place at the later stages of apoptosis. That loss of 
integrity results from either apoptosis or necrosis. In order to distinguish between early 
and late stages of the cell death, Annexin-V is used in conjunction with PI, a fluorescent 
molecule with a high affinity for nucleic acids. Viable cells exclude PI, whilst the 
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membranes of damaged or dead cells become permeable to PI. Apoptosis is a gradual 
process that may take hours to even days to develop; this allows for cells to be tracked 
over time moving from Annexin-V negative and PI negative (viable cells, with intact 
membranes) to Annexin-V positive and PI negative (early apoptotic cells, PS becomes 
exposed but cellular membranes remain impermeable) to Annexin-V positive and PI 
positive (late apoptotic or dying cells, PS is exposed and membrane permeable to PI). 
Annexin-V negative and PI positive cells are necrotic. See Table 3ii for summary of the 
stain combinations and their interpretations.  
 
3.2.5.3.2 Sample preparation, data acquisition and analysis 
MCF-7 and MDA-MB-231 cells were seeded into 12-well plates at 50,000 cells per 
well and treated with tomato extracts as described in Chapter 3.2.5.2.1. After exposure 
to treatment, cell medium containing detached cells was transferred to a labelled 15 mL 
tube. Cells attached to the well were washed twice with PBS (PBS washing solution 
was also transferred to the labelled tube) before being trypsinised and pooled with the 
detached cells in the 15 mL tube. After centrifuging at 300 g for 5 min and washing 
twice with PBS, cells were resuspended in 97.2 µL of 1x binding buffer before adding 
2.5 µL of Annexin-V and 5 µL PI, which were all provided with the Annexin-V FITC 
assay kit (eBioscience). Samples were incubated for 10 min in the dark prior to analysis 
with a flow cytometer. 
 
Data acquisition was performed as described in Chapter 3.2.5.2.1. Figure 3.3 A and B 
show representative scatter plots of Annexin-V/PI stained cells and demonstrate the 
gating strategies applied to select the intact cells in the population. Cell debris including 
dead cells was excluded from the apoptosis analysis. 
 
Data acquisition was carried with BD CFlow® Software and data analysed with 
Kaluza® Flow Analysis Software (Beckman Coulter).  
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Figure 3.3: Example of scatter plots and gating strategy of the flow cytometry analysis of 
apoptotic stages in (A) healthy MCF-7 cells after 24 h treatment with 1% WT tomato extract 
and (B) apoptotic MCF-7 cells in response to 3 h treatment with 1% high-del tomato extract. (1) 
Data acquisition scatter plot demonstrating the selection of intact cells by “gating”. (2) Scatter 
plot of the cell population selected through gating and identification of subpopulations through 
use of fluorescence channels FL-1 and FL-3. 
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3.2.6 Detection of protein levels by western blot analysis  
 
3.2.6.1 Antibodies 
The primary antibodies caspase-3 (#9662), caspase-7 (#9492) and caspase-9 (#9502) 
were purchased from Cell Signaling Technology and stored and used according to the 
manufacturer’s instructions. Antibodies were used at a final concentration of 1:1000. 
The secondary, HRP-conjugated was purchased from Cayman Chemical stored and 
used according to the manufacturer’s instructions. The secondary antibody was used at a 
final concentration of 1:10000. 
 
3.2.6.2 Preparation of protein extracts from human cells  
MCF-7 and MDA-MB-231 cells were exposed to various stimuli. Cells were washed 
twice with ice-cold PBS and lysed with ice-cold RIPA buffer (50 mM TrisHCl pH7.4, 
150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS), supplemented with protease 
inhibitors (complete mini protease inhibitor cocktail tablet, Roche). Samples were 
incubated for 20 min on ice, before pelleting the cell debris by centrifugation (20 min, 
13,000 g, 4°C) and the supernatant protein was collected and stored at -20°C until 
further use. 
 
3.2.6.3 Gels and running conditions  
SDS-PAGE separation of protein samples was performed using 10% precise Tris-
Glycine gels Thermo Scientific) or home-made 10% PAGE gels at 185 V in XCell 
SureLock™ Mini-Cell (Life Technologies) at room temperature. 30 µg of protein, 
previously quantified using the bicinchoninic acid assay, was mixed with 4x loading 
dye (Laemmli loading buffer,  250 mM Tris-HCl pH 6.8, 8% SDS, 40% Glycerol, 8% 
betamercaptoethanol, 0.02%  bromophenol blue) and boiled for 3 min before being 
loaded on the gel along with a prestained, broad range protein marker (7-175 kDa; New 
England BioLabs).  
 
3.2.6.4 Transfer and blotting conditions 
Proteins were transferred from the gel to a nitrocellulose membrane (Whatman™, GE 
Healthcare). The transfer was performed at 100 V for 1 h at 4°C using the Mini Trans-
Blot
®
 Module (Bio-Rad) following the manufacturer’s instructions. 
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3.2.6.5 Immunoblotting and development 
The unspecific binding antibodies to the membrane was prevented by incubating the 
membrane in 20 mL of blocking solution that consisted of 5% (w/v) fat-free milk 
powder in TBS-T (50 mM Tris-Buffered saline pH 7.5 (TBS)  and 0.1% (v/v) Tween-20 
(Sigma) for a minimum of 1 h at room temperature. The membrane was then incubated 
the blocking solution containing the primary antibody specific for the protein of interest. 
Antibodies were diluted in blocking solution according to the manufacturer’s 
recommendations. Incubation with primary antibody was performed overnight at 4°C 
with shaking. The next day, the primary antibody solution was removed and the 
membrane washed three times at room temperature with TBST before being incubated 
with horseradish peroxidase-conjugated (HRP), secondary antibody diluted 1:10,000 
(v/v) in blocking solution, for 1-4 h at room temperature. 
 
Membrane-bound protein bands were visualized on an ImageQuant™ LAS 500 or 4000 
camera (GE healthcare) after the addition of Pierce
®
 ECL Western Blotting Substrate 
(Thermo Scientific), a nonradioactive, highly sensitive luminol-based chemiluminescent 
substrate for the detection of HRP.  
 
 
3.2.7 Bicinchoninic Acid Assay 
Total protein content was quantified using the bicinchoninic acid assay (BCA) assay kit 
(Thermo Scientific). The assay relies on the formation of a Cu
2+
-protein complex under 
alkaline conditions, followed by reduction of the Cu
2+
 to Cu
1+
. The amount of the 
reduction is proportional to the amount of protein present. In alkaline conditions, BCA 
forms a purple complex with Cu
1+
. The reduction of Cu
2+
 by proteins can be determined 
colorimetrically by measuring the at an absorbance maximum of 562 nm. 
 
  
3.2.8 Statistical methods 
The statistical significance was determined using Student’s t-test. P-values ≤ 0.05 were 
considered statistically significant. 
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3.3 Results  
 
3.3.1 Purified polyphenols have little effect on cell viability  
The effects of exposure to resveratrol, polydatin, and rutin on MCF-7 and MDA-MB-
231 cell metabolic activity were investigated. After 24 h exposure to resveratrol a 
significant dose-dependent reduction in cell proliferation was observed in MCF-7 but 
not in MDA-MB-231 cells (Figure 3.4 A). Incubation with 50 µM and 100 µM 
resveratrol reduced MCF-7 cell metabolism by 20 % (p<0.05) and 40 % (p<0.001), 
respectively, relative to the solvent-treated control (Figure 3.4 A). In contrast, 
resveratrol induced a metabolism-stimulating effect in MDA-MB-231 cells, increasing 
cell proliferation significantly in a dose-dependent manner by up to 20% after exposure 
to 50 µM and 100 µM resveratrol. 
 
Plants produce a significant proportion of their resveratrol in glucosylated forms. In 
order to compare the biological efficacy of both trans-resveratrol and glucosylated 
resveratrol we performed the same experimental procedure with the commercially 
available resveratrol glycoside, polydatin. Polydatin treatment resulted in a decrease in 
metabolism of both MCF-7 and MDA-MB-231 cells (Figure 3.4 B). At 100 μM, 
polydatin reduced metabolic status of MCF-7 and MDA-MB-231 cells by ~15%. At the 
highest concentration tested, 200 μM of polydatin induced a statistically significant 
inhibition of metabolism of ~30% in both cell types relative to the untreated control 
(Figure 3.4 B). Interestingly, intermediate concentrations (50 μM) of polydatin resulted 
in a statistically significant increase in the metabolic status of ~10% in the MCF-7 cells. 
 
We also investigated the inhibitory effect of rutin, a highly abundant flavonoid present 
in tomatoes. Rutin displayed some weak biological activity in both cell lines; at the 
highest treatment concentration (200 µM), rutin treatment resulted in a reduced 
metabolic status of MCF-7 and MDA-MB-231 cells by 10% and 15% (p<0.05), 
respectively (Figure 3.4 C). 
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Figure 3.4: Dose response effects on the metabolic status of MCF-7 und MDA-MB-231 cells 
after 24 hour treatment with polyphenols. Cells were exposed to (A) resveratrol at 0 µM, 10 
µM, 20 µM, 50 µM and 100 µM, (B) polydatin at 0 µM, 50 µM, 100 µM, 150 µM and 200 µM 
and (C) rutin at 0 µM, 50 µM, 100 µM, 150 µM and 200 µM. Results are expressed as a 
percentage of metabolic activity after treatment relative to the untreated control. Data shown as 
mean ± standard error (n=3 technical replicates. Experiments were performed at least twice).  
* p<0.05; ** p<0.01; *** p<0.001. 
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3.3.2 Commercially available and purified anthocyanins from high-del 
tomatoes have little effect on the cell metabolic status. 
The dose-dependent effects of delphinidin-3-glucoside (del-3-glu), a commercially 
available anthocyanin, on the cell viability of MCF-7 and MDA-MB-231 cells were 
studied after 24 h incubation with complete medium containing del-3-glu at different 
concentrations (Figure  3.5 A). At the maximum concentration of 200 µM, no 
significant reduction in the metabolic status of either cell line was observed. However, 
at the respective concentrations 100 µM and 150 µM, the metabolic status of MCF-7 
and MDA-MB-231 cells, was significantly (p<0.05) reduced by 10% relative to the 
untreated control. This reduction in cell metabolism was only transient and no longer 
observed at the highest treatment concentration of 200 µM, leading to the conclusion 
that del-3-glu does not lastingly affect the metabolic activity of both cell lines at the 
treatment concentrations and durations chosen.  
 
The effects on MCF-7 and MDA-MB-231 cell survival following exposure to up to 200 
µM of the two most prevalent anthocyanins delphinidin 3-(coumaroyl)-rutinoside-5-
glucoside (del-3-cou-rut-5-glu) and petunidin 3-(coumaroyl)-rutinoside-5-glucoside 
(pet-3-cou-rut-glu) in the high-delphinidin tomato (purified as described in Chapter 
2.2.18.3) were studied following the same experimental procedure as used for the 
analysis of del-3-glu (Figure 3.5 A). The purified anthocyanins del-3-cou-rut-5-glu and 
pet-3-cou-rut-5-glu exerted weak inhibitory effects on the metabolic status in a dose-
dependent manner in both breast cancer cell lines.  
 
In response to 24 h treatment with del-3-cou-rut-5-glu, both MCF-7 and MDA-MB-231 
showed a ~ 10% decrease in cell metabolic status at the lowest concentration tested (50 
µM). After treatment with 200 µM of the compound, metabolic activity was further 
decreased by 20% and 10% in MCF-7 and MDA-MB-231 cells, respectively (Figure 3.5 
B). These data indicate that del-3-cou-rut-5-glu exerts its cytotoxic effects in a dose-
dependent manner but administration of relatively high molar concentrations is required 
to reduce metabolic status significantly. 
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Figure 3.5: Dose response effects on the metabolic status of MCF-7 and MDA-MB-231 cells 
after 24 hour anthocyanin treatment at 0 µM, 50 µM, 100 µM, 150 µM and 200 µM. Cells were 
exposed to (A) delphinidin-3-glucoside, (B) delphinidin 3-(coumaroyl)-rutinoside-5-glucoside 
and (C) petunidin 3-(coumaroyl)-rutinoside-5-glucoside. Results are expressed as a percentage 
of metabolic activity after treatment relative to the untreated control. Data shown as mean ± 
standard error (n=3 technical replicates. Experiments were performed at least twice).  
* p<0.05; ** p<0.01. 
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The second most prevalent anthocyanin in the high-delphinidin tomatoes was pet-3-cou-
rut-5-glu. Exposure to purified pet-3-cou-rut-5-glu significantly reduced cell metabolic 
status of MCF-7 cells by approximately 20% after 24 h treatment with 150 µM (P<0.01; 
Figure 3.5 C). At 200 µM, cell metabolic activity was only 10% reduced (statistically 
not significant) relative to the untreated control, suggesting that the statistically 
significant pet-3-cou-rut-5-glu-induced reductions in the cell viability at concentrations 
lower than 200 µM may have been a result of biological variability rather than lasting 
growth-inhibitory activity. No statistically significant effects on the metabolic activity 
of MDA-MB-231 cells were observed as a result of pet-3-cou-rut-5-glu treatment 
(Figure 3.5 C). 
 
3.3.3 Anthocyanin and high-resveratrol tomato extracts reduce the 
metabolic activity of breast cancer cells 
The dose-dependence of tomato extract effects on the metabolic activity of MCF-7 and 
MDA-MB-231 breast cancer cells was investigated following the cell culture and 
metabolic activity assay procedures outlined in chapters 3.2.1.2 to 3.2.1.4. Cells were 
exposed to different concentrations of various tomato extracts for 24 h before measuring 
their metabolic activity using Roche’s WST-1 cell assay.  
 
No cytotoxic effects on MCF-7 or MDA-MB-231 cells were observed in response to 
incubation with WT tomato extracts (Figure 3.6 A). On the contrary, the metabolic 
activity of both breast cancer cell lines increased in a dose-dependent manner in 
response to increasing WT tomato extract supplementation. At the highest WT tomato 
extract concentration I observed a statistically significant 20% increase (p<0.05) in 
metabolic status of both cell lines compared to the untreated control. 
 
The dose-dependent effects of high-resveratrol (high-res) tomato extract on the 
metabolic activity of breast cancer cells were tested. High-res extract dramatically 
reduced cell metabolic status of MCF-7 and MDA-MB-231 cells (Figure 3.6 B). Cell 
metabolic activity started to decrease after exposure to 0.4% of extract in the medium. 
After incubation with 0.8% extract, which contained approximately 16 µM of total 
resveratrol (Table 3i), the percentage of viable MCF-7 and MDA-MB-231 cells was 
reduced to almost 0% (p<0.001, Figure 3.6 B).  
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Figure 3.6: Dose response curves for 24 hour treatment of MCF-7 und MDA-MB-231 cells 
with (A) WT tomato extract and (B) high-resveratrol tomato extract. Cells were exposed to 
extract concentrations ranging from 0.1% to 1% of the total medium and results are expressed as 
a percentage of metabolic activity after treatment relative to the untreated control. Data shown 
as mean ± standard error (n=3 technical replicates. Experiments were performed at least twice). 
* p<0.05; ** p<0.01; *** p<0.001.  
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A dramatic reduction in breast cancer cell metabolic activity was also observed in 
response to treatment with high-delphinidin (high-del) tomato extracts (Figure 3.7 A). 
In MCF-7 cells, high-del tomato extract had a statistically non-significant stimulatory 
effect up to an extract concentration of 0.6%, stimulating cell metabolic activity by up 
to 30% compared to the untreated control. However, metabolic activity of MCF-7 cells 
was strongly inhibited once high-del extract concentrations surpassed 0.6% in the 
medium. At 1% high-del extract concentration in the medium, which contained 
approximately 100 µM of total trihydroxylated anthocyanins (Table 3i), metabolic 
activity of MCF-7 cells was significantly reduced to ~5% (p<0.001) relative to the 
activity of the untreated control (Figure 3.7 A). 
 
In MDA-MB-231 cells, a strong correlation between high-del extract concentration and 
cell metabolic activity was observed (Figure 3.7 A). High-del tomato extract did not 
stimulate cell growth of MDA-MB-231 cells at low treatment doses but resulted in a 
gradual concentration-dependent decrease in cell viability. Extract concentrations of 
0.8% and higher led to an almost complete inhibition of metabolic activity (p<0.001; 
Figure 3.7 A). 
 
Similarly, the dose-dependence of exposure to extract from the high-pelargonidin (high-
pel) tomatoes by MCF-7 and MDA-MB-231 cells was investigated (Figure 3.7 B). The 
exposure to high-pel extract concentrations of 0.9 % and 1 %, which contained 
approximately 36 and 40 µM of mono- and dihydroxylated anthocyanins (Table 3i),  
resulted in a significant reduction (P<0.05) of 30 % and 40 % in the metabolic activity 
of MCF-7 cells.  
 
MDA-MB-21 cell activity was significantly reduced by 20% in response to treatment 
with 0.5% high-pel extract (p<0.05) and cell metabolic activity continued to decrease 
with increasing concentrations of high-pel extract. After 24 h incubation with 1% 
extract, metabolic activity of MDA-MB-231 cells had been reduced to only 30% 
compared to the of the solvent-treated control (Figure 3.7 B). 
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Figure 3.7: Dose response curves for 24 hour treatment of MCF-7 und MDA-MB-231 cells 
with (A) high-delphinidin tomato extract, and (B) high-pelargonidin tomato extract. Cells were 
exposed to extract concentrations ranging from 0.1% to 1% of the total medium and results are 
expressed as a percentage of metabolic activity after treatment relative to the untreated control. 
Data shown as mean ± standard error (n=3 technical replicates. Experiments were performed at 
least twice). * p<0.05; ** p<0.01; *** p<0.001. 
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3.3.4 Effects of WT and high-del extracts on the viability of normal HMT-
3522-S1 breast cells 
HMT-3522-S1 cells are derived from a benign breast tumour but are considered a 
“normal” breast epithelial cell line. They are sometimes used in comparative studies 
investigating the differential behaviour of normal and cancerous cells (Bissell et al., 
2002, Kenny et al., 2007). Dose-dependency effects of either WT or high-del tomato 
extracts on the metabolic activity of HMT-3522-S1 cells in response to 24 h exposure 
were investigated (Figure 3.8). WT tomato extract induced a stimulatory effect of up to 
20% which is in agreement with the observations made in MCF-7 and MDA-MB-231 
cells (Figure 3.6 A). 
 
Exposure to high-del extract reduced metabolic activity of HMT-3522-S1 cells in a 
dose-dependent manner, resulting in a 70% reduction in cell proliferation at the highest 
concentration tested (1% extract). 
 
 
 
Figure 3.8: Dose response curves for 24 hour treatment of HMT-3522-S1 cells with WT tomato 
extract or high-delphinidin tomato extract. Cells were exposed to extract concentrations ranging 
from 0.1% to 1% of the total medium and results are expressed as a percentage of metabolic 
activity after treatment relative to the untreated control. Data shown as mean ± standard error 
(n=3 technical replicates. Experiments were performed at least twice). * p<0.05; ** p<0.01; *** 
p<0.001. 
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3.3.5 Comparison of the biological efficacy of delphinidin and pelargonidin 
in food matrix background 
In order to determine whether delphinidins and pelargonidins differ in their biological 
efficacy, a comparative study using delphinidin and pelargonidin tomato extracts was 
conducted. The high-del tomato extracts contained ~2.5 times more anthocyanins than 
the high-pel tomato line and their biological efficacy not directly comparable with one 
another. In order to compare directly the biological effects of delphinidins and 
pelargonidins, the high-del tomato extracts were diluted 2.5 times with WT tomato 
extract to achieve an equimolar anthocyanin concentration (40 µM) comparable to that 
present in the high-pel tomato extracts. Diluted high-del extracts equally reduced 
metabolic activity of MCF-7 (p<0.05) and MDA-MB-231 (p<0.01) cells by 40% after 
24 h exposure to the highest extract concentration of 1% (Figure 3.9 B). There was no 
notable difference between the two cell lines in their response to high-del treatment. 
 
MCF-7 and MDA-MB-231 cells responded differently to pelargonidin-containing high-
pel extracts (Figure 3.9 A). At the highest concentration tested, 1% of high-pel extract 
which contained 40 µM of anthocyanins, inhibited the metabolic activity of MCF-7 
cells by 40% (p<0.01) and of MDA-MB-231 cells by 70% (p<0.01). Diluted high-del 
and high-pel extracts, each containing 40 µM of delphinidins or pelargonidins, induced 
an equal inhibitory effect in MCF-7 cells, reducing their metabolic activity by 40% 
(Figure 3.9 A and B). In contrast, high-pel tomato extract was more effective than 
diluted high-del extract in reducing the metabolic activity of MDA-MB-231 cells 
(Figure 3.9 A and B). 1% of high-pel extract reduced MDA-MB-231 cell metabolic 
activity by 70% compared to only 40% after treatment with 1% high-del tomato extract, 
indicating that MDA-MB-231 cells are more sensitive to pelargonidins than to 
delphinidins. 
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Figure 3.9: Comparative study of the 24 hour exposure effects of (A) high-pelargonidin and (B) 
high-delphinidin tomato extracts on the metabolic activity of MCF-7 und MDA-MB-231 cells. 
High-delphinidin tomato extract was diluted to the equimolar concentration of anthocyanins 
found in the high-pelargonidin tomato extract. Cells were exposed to extract concentrations 
ranging from 0.1% to 1% of the total medium and results are expressed as a percentage of 
metabolic activity after treatment relative to the untreated control. Data shown as mean ± 
standard error (n=3 technical replicates. Experiments were performed at least twice). * p<0.05; 
** p<0.01; *** p<0.001. 
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3.3.6 Alterations to the cell cycle after exposure to tomato extracts  
The cell cycle is a central component of cell proliferation and division in which DNA is 
replicated, divided and passed on to daughter cells. Many chemotherapeutic agents 
target the cell cycle by interfering with key genes that participate in and control cell 
cycle checkpoints and which are often targets of genetic alterations in cancer. 
 
The effects of high-anthocyanin tomato extracts on the cell cycle of the breast cancer 
cell lines were measured after exposure to 1% tomato extracts between 3 h and 24 h. 
The 24 h exposure to 1% WT tomato extract had no effect on the distribution of cells in 
the cell cycle (Figure 3.10 A). This result confirmed the findings of the metabolic status 
assays where WT tomato extract did not interfere with the survival and growth of MCF-
7 and MDA-MB-231 cells. 
 
In contrast, short-term exposure (3 h and 6 h) to 1% high-del extract resulted in a 
dramatic alteration of the cell cycle profile of both cell lines (Figure 3.10 A). 3 h 
exposure to high-del extract reduced the MCF-7 cell population in G0/G1 significantly 
and resulted in an increased population in the S and G2 phases. After 6 h treatment, the 
cell cycle of high-del extract treated MCF-7 cells was severely disturbed; a sub-G1 
population, indicative of highly apoptotic cells, had formed and the populations in the 
G1, S and G2 phases were significantly decreased. In the 6 h treatment, cell debris 
accounted for approximately 90% of the cell sample, indicative of the severely 
cytotoxic effects of high-del. No cell cycle data could be recorded beyond the 6 h time 
point as no intact cells remained in the sample. 
 
In MDA-MB-231 cells, there was also a significant high-del extract-induced increase in 
the cells in the G1 population and also led to the formation of a sub-G1 peak, 
representative of late apoptotic cells (Figure 3.10 A). As a result of the severe 
cytotoxicity of high-del extracts no more cell cycle data could be collected beyond the 6 
h time point due to the absence of sufficient intact cells to generate reliable data. The 
amount of damaged cells and cell debris increased dramatically with exposure duration 
to high-anthocyanin extracts and the proportions of cell debris were comparable to those 
reported in Table 3iii for the Annexin-V/PI apoptosis assay. 
 
Breast cancer cells were also exposed to 1% high-pel extract for 3 h to 24 h (Figure 3.10 
B). A reduction in the cell population in the G0/G1 phased was observed in both MCF-7 
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and MDA-MB-231 after 6 h and was further reduced in a time-dependent manner until 
the 24 h time point. A sub-G1 population started to form after an incubation period of 
12 h in the MCF-7 cells and after 24 h in the MDA-MB-231 cells. At the 24 h time 
point, the number of cells in the G0/G1 phase had decreased significantly with a 
simultaneous increase in the G2/M population (Figure 3.10 B).  
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Figure 3.10: Effect of anthocyanin tomato extracts on the distribution of cells in different 
phases of cell cycle in MCF-7 and MDA-MB-231 cells. The cells were treated with either (A) 
WT tomato extract for 0h and 24 h or high-delphinidin tomato extract for 0 h, 3 h and 6 h, or 
(B) high-pelargonidin tomato extract for 0 h, 3 h, 6 h, 12 h, 24 h, before being collected and 
stained with PI. Following the FACS analysis, cellular DNA histograms were further analysed 
by BD CFlow® software. The data are a representative example for duplicate tests.  
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3.3.7 Time-dependent induction of apoptosis after exposure to high-
polyphenol tomato extracts 
 
3.3.7.1 Exposure to extracts of WT tomatoes did not induce apoptosis 
The time-dependent effects of WT tomato extracts on apoptosis of MCF-7 and MDA-
MB-231 cells after exposure to 1% extract were investigated using Annexin-V/PI 
staining and FACS analysis. WT tomato extract did not induce apoptosis in either cell 
line confirming the previous observations made in the metabolic status assays (Figure 
3.6 A) that WT tomato extracts do not exert cytotoxic effects on the cell lines. A small, 
yet statistically significant increase in healthy cells compared to the solvent-treated 
control was observed in both MCF-7 and MDA-MB-231 cells in response to prolonged 
exposure to WT tomato extract (Table 3iii A). The amount of cell debris detected in WT 
extract-treated cell samples was negligible and hence not shown in Table 3iii A. 
 
3.3.7.2 Dependence of induction of apoptosis by high-pel extract on the length of 
exposure  
MCF-7 and MDA-MB-231 cells were treated with 1% high-pel tomato extract for a 
maximum duration of 24 h to investigate the extract-induced time-dependent effects on 
apoptosis. High-pel extracts exerted pro-apoptotic effects on MCF-7 and MDA-MB-231 
cells in a time-dependent manner, gradually reducing the proportion of healthy cells as 
they shifted quickly into the late apoptotic stage (Table 3iii B). In the MCF-7 cell 
population, the effects were most significant after a 24 h exposure when more than 80% 
(p<0.001) of the cells had entered late apoptosis and less than 10% of cells were 
healthy. A similar, yet less dramatic trend was observed in MDA-MB-231 which 
responded to increased high-pel exposure with a gradual transition into apoptosis and 
necrosis. The apoptotic response of MDA-MB-231 was most acute after 24 h treatment 
exposure where 50% and ~20% of the cell population were undergoing apoptosis and 
necrosis, respectively (Table 3iii B). The amount of cell debris, representative of 
severely damaged cells that have been excluded from the apoptosis analysis, increased 
dramatically with extract exposure times to 88.4% for MCF-7 cells and 91.7% for 
MDA-MB-231 cells after 24 h exposure. 
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Table 3iii: Time-dependent effect of different tomato extracts on the apoptosis of MCF 
and MDA-MB-231 cells. Cells were treated for 0 h, 3 h, 6 h, 9 h, 12 h, and 24 h with 
1% extract of (A) WT, (B) high-pelargonidin and (C) high-delphinidin tomatoes before 
being collected and stained with Annexin-V and PI. Following the FACS analysis and 
data were further analysed with BD Kaluza software. No cell debris was detected (not 
applicable; N/A). Results are expressed as the percentage of the cell population in each 
state. Data shown as mean ± standard error. * p<0.05; ** p<0.01; *** p<0.001. 
 
A  MCF-7 
extract duration Healthy early 
apoptotic 
late apoptotic necrotic cell debris 
in % 
wt 0h 93.4 0.6 1.1 4.9 N/A 
wt 3h 95.9 1.4 1.7 1.1** N/A 
wt 6h 97.0 0.8 0.9 1.3*** N/A 
wt 9h 96.5 0.8 0.6 2.1 N/A 
wt 12h 96.9* 0.9 1.5 0.7** N/A 
wt 24h 97.9* 0.8 0.8 0.5** N/A 
 
MDA-MB-231 
extract duration Healthy early 
apoptotic 
late 
apoptotic 
necrotic cell debris 
in % 
wt 0h 94.7 2.3 0.1 2.9 N/A 
wt 3h 99.1** 0.3** 0.5 0.1* N/A 
wt 6h 98.8** 0.6* 0.3 0.3* N/A 
wt 9h 99.0** 0.5** 0.3 0.3* N/A 
wt 12h 98.9** 0.4** 0.5** 0.2* N/A 
wt 24h 95.6 2.7 0.9 0.9* N/A 
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B  MCF-7 
extract duration healthy early 
apoptotic 
late 
apoptotic 
necrotic cell debris 
in % 
high-pel 0h 96.0 2.2 1.1 0.7 11.8 
high-pel 3h 90.5 0.9** 3.4 5.2 82.7 
high-pel 6h 86.4 2.0 8.9 2.8 88.6 
high-pel 9h 73.9 5.3 16.2 4.6 85.2 
high-pel 12h 68.2* 2.0 22.3* 7.6 84.7 
high-pel 24h 9.3*** 7.5** 81.2** 1.9 88.4 
 
MDA-MB-231 
extract duration healthy early 
apoptotic 
late 
apoptotic 
necrotic cell debris 
in % 
high-pel 0h 95.4 0.8 3.0 0.9 15.1 
high-pel 3h 90.0 5.4 3.5 1.1 75.2 
high-pel 6h 83.2* 8.8* 6.2 1.9 87.5 
high-pel 9h 71.5* 5.0 20.6* 3.0 82.4 
high-pel 12h 62.4* 5.2** 30.9* 1.6 76.0 
high-pel 24h 27.6*** 3.8* 49.5** 19.1** 91.7 
 
 
C  MCF-7 
extract duration healthy early 
apoptotic 
late 
apoptotic 
necrotic cell debris 
in % 
high-del 0h 89.6 3.0 5.4 2.0 18.3 
high-del 3h 56.2 5.4 29.6 8.8** 81.8 
high-del 6h 1.9*** 25.6*** 72.5*** 0.0** 93.0 
high-del 9h 3.8** 21.3*** 75.0** 0.0** 98.7 
high-del 12h 0.6*** 10.6** 88.7*** 0.1** 93.3 
high-del 24h 0.7*** 8.9 90.4** 0.0** 98.0 
 
MDA-MB-231 
extract duration healthy early 
apoptotic 
late 
apoptotic 
necrotic cell debris 
in % 
high-del 0h 94.7 4.8 1.7 0.2 17.9 
high-del 3h 23.0*** 16.5* 55.3*** 5.3* 87.5 
high-del 6h 2.5*** 25.9** 71.5*** 0.1 94.7 
high-del 9h 1.4*** 24.2* 74.4* 0.0 92.8 
high-del 12h 1.2*** 18.1 80.7* 0.0 88.8 
high-del 24h 0.7*** 6.5 92.8*** 0.0 96.6 
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3.3.7.3 Dependence of induction of apoptosis by high-del extract on the length of 
exposure  
The cell metabolic activity assays and cell cycle analysis demonstrated that high-del 
tomatoes had the highest cytotoxic effects compared to the other anthocyanin tomatoes. 
A significant induction of apoptosis in both breast cancer cell lines was observed after 
as little as 3 h of incubation with medium supplemented with 1% high-del extract 
(Table 3iii C). MDA-MB-231 responded more quickly to high-del treatment than MCF-
7 cells; at the 3 h time point less than 25% (p<0.001) of MDA-MB-231 cells were 
healthy compared to more than 50% (p<0.05) of MCF-7 cells. However, after 6 h 
exposure there was no difference in the apoptotic response between the two cell lines. 
After 6 h of treatment ~25% of MCF-7 and MDA-MB-231 cells were undergoing early 
apoptosis and almost 75% of cells had reached a late apoptotic stage. The percentage of 
cells undergoing cell death was further increased with prolonged incubation periods, 
and after the maximum exposure period of 24 h, more than 90% of cells were in late 
apoptosis and the remaining cells in the early stages of apoptosis (Table 3iii C). The 
amount of cell debris, representative of severely damaged or dead cells that were 
excluded from the apoptosis analysis, increased dramatically with extract exposure 
times. 
 
3.3.8 Anthocyanin-rich tomato extracts trigger activation of apoptotic 
proteins 
Levels of select proteins involved in the activation or execution of apoptosis in 
mammalian cells were assayed by western blot. Members of the caspase family are 
activated by proapoptotic signals and play a crucial role in the activation of the 
apoptotic mechanism.  Caspase-3, caspase-7 and caspase-9 were selected to shed further 
light on the possible mechanisms by which the high-anthocyanin lines induce their 
proapoptotic effects. 
 
MCF-7 cells are known to have an exon mutation in the Casp-3 gene resulting in the 
loss of function and expression of caspase-3 in these cells. Staurosporine, a powerful 
and reliable inducer of apoptosis, was used a positive control for induction of apoptosis. 
Cells were exposed to 10 µM of staurosporine for 9 h, before collecting protein for 
western blot analysis. Untreated cells were used as a negative control. 
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3.3.8.1 Caspase-3 is not activated by exposure to high-anthocyanin tomato extract 
treatment  
Alterations to the expression of caspase-3 in MCF-7 and MDA-MB-231 cells after 
exposure to tomato extracts for different durations were investigated at the protein level 
by western blot. MCF-7 cells did not show any expression of caspase-3 in response to 
any treatment, which is in agreement with previous reports of the total absence of 
caspase-3 expression in MCF-7 due to an exon mutation in Casp-3. 
 
In MDA-MB-231 cells, caspase-3 expression in response to anthocyanin-enriched 
tomato extracts was measured after 0 h, 3 h, 6 h, 9 h, 12 h and 24 h. Neither treatment 
with the positive control staurosporine, nor exposure to any of the anthocyanin tomato 
extracts resulted in activation (cleavage) of caspase-3. Figure 3.11 shows the inactive 
(uncleaved) caspase-3 expression in MDA-MB-231 cells in response to different 
exposure times to high-del treatment. 
 
 
 
 
Figure 3.11: Caspase-3 protein levels in MDA-MD-231 cells after a 9 h exposure to 10 µM of 
staurosporine (positive control; C) or treatment periods of 0 h, 3 h, 6 h, 9 h, 12 h and 24 h with 
1% high-del tomato extract. 
 
 
3.3.8.2 High-del tomato extract activates caspases-7 and -9 
Activation of caspase-7 and -9 was induced in both MCF-7 and MDA-MB-231 cells 
after treatment with high-del tomato extract (Figure 3.12). The 3 h exposure to high-del 
extract was sufficient to induce cleavage of caspase-7 in MCF-7 cells. No change in the 
MCF-7 caspase-7 expression signal was observed in response to different treatment 
exposure times (Figure 3.12 A). In the negative control (0 h) caspase-7 was only present 
in its inactive, uncleaved form, whilst 9 h exposure to 10 µM staurosporine (positive 
control; C) also resulted in activation of caspase-7. However, there may have been a 
problem with the loading of the untreated control as protein bands are severely 
distorted. Short term (3 h and 6 h) exposure to high-del extract did not activate caspase-
   C     0h     3h   6h   9h   12h  24h 
Caspase-3 
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7 in MDA-MB-231 cells. However, there was activation of caspase-7 after prolonged 
exposure of 9 h and 12 h to high-del extract in MDA-MB-231 cells (Figure 3.12 B). 
These results indicate that the activation of caspase-7 by high-del treatment is exposure 
time-dependent in MDA-MB-231 but not in MCF-7.  
 
Activation of the initiator caspase-9 after exposure to high-del extract was observed in 
both MCF-7 (Figure 3.12 A) and MDA-MB-231 (Figure 3.13 B). In MCF-7, cleavage 
of caspase-9 was only detectable after the treatment exposure of 24 h, whilst in MDA-
MB-231 cells cleavage of caspase-9 was observed at all exposure times (3 h to 24 h) 
and no significant changes in the levels of active, cleaved caspase-9 were observed in 
response to increased exposure times. 
 
3.3.8.3 High-pel extract activates caspase-7 and caspase-9 
A time-independent activation of caspase-7 was observed in high-pel treated MCF-7 
cells (Figure 3.14 A). A weak band corresponding to cleaved caspase-7 was present in 
the 3 h to 24 h treated cells but absent in the untreated (0 h) samples, indicating the 
ability of high-pel tomato extract to induce activation of caspase-7. 
 
High-pel tomato extract also induced activation of caspase-9 in both MCF-7 and MDA-
MB-231 cells through cleavage of procaspase-9 (Figure 3. 15). High-pel-induced 
activation of caspase-9 was independent of the duration of extract exposure and 
appeared after only 3 h and persisted up to the final 24 h time point.  
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Figure 3.12: Caspase-7 protein levels in (A) MCF-7 and (B) MDA-MD-231 cells after a 9 h 
exposure to 10 µM of staurosporine (positive control; C) or treatment periods of 0 h, 3 h, 6 h, 9 
h, 12 h and 24 h with 1% high-del tomato extract. 
 
 
 
 
Figure 3.13: Caspase-9 protein levels in (A) MCF-7 and (B) MDA-MB-231 cells after a 9 h 
exposure to 10 µM of staurosporine (positive control; C) or treatment periods of 0 h, 3 h, 6 h, 9 
h, 12 h and 24 h with 1% high-del tomato extract. 
 
 
 
 
Figure 3.14: Caspase-7 protein levels in (A) MCF-7 and (B) MDA-MB-231 cells after a 9 h 
exposure to 10 µM of staurosporine (positive control; C) or treatment periods of 0 h, 3 h, 6 h, 9 
h, 12 h and 24 h with 1% high-pel tomato extract.  
 
 
 
A             B 
    C      0h    3h    6h   9h  12h 
24h 
    C     0h    3h   6h   9h  12h 
24h 
Caspase-7 
Cleaved Caspase-7 
A        B 
Caspase-9 
Cleaved Caspase-9 
    C      0h   3h   6h  9h  12h 24h     C     0h   3h    6h  9h  12h 24h 
A             B 
Cleaved Caspase-7 
Caspase-7 
    C    0h    3h   6h   9h   12h 24h     C      0h   3h   6h  9h  12h 24h 
145 
 
 
 
Figure 3.15: Caspase-9 protein levels in (A) MCF-7 and (B) MDA-MB-231 cells after 
a 9 h exposure to 10 µM of staurosporine (positive control; C) or treatment periods of 0 
h, 3 h, 6 h, 9 h, 12 h and 24 h with 1% high-pel tomato extract. 
 
 
3.3.8.4 Low-cyan tomato extracts also induce apoptosis in breast cancer cell lines 
The low cyanidin (low-cyan) tomato extracts induced similar inhibition of the metabolic 
status and proapoptotic effects in the MCF-7 and MDA-MB-231 as observed in 
response to high-del and high-pel extract exposure. The effects were, however, much 
less pronounced, which may be a consequence of the relative low total anthocyanin 
content found in the low-cyan line. The results will be summarized here and data are 
available in Appendix section 3. 
 
Low-cyan tomato extracts induced a modest, growth-inhibitory response in the breast 
cancer cell lines. Analysis of the cell cycle and revealed that low-cyan extracts induced 
an increase of cells in the G2/M phase indicative of cells being arrested at the final cell 
cycle checkpoints. 
 
Low-cyan tomato extracts induced apoptosis in MCF-7 and MDA-MB-231 cells in a 
time-dependent fashion. A reduction in healthy cells in the population was most 
pronounced and statistically significant after 24 h exposure (p<0.05) to low-cyan 
extract, when ~50% of MCF-7 cells and ~40% of MDA-MB-231 cells were either late 
apoptotic or necrotic (Appendix Table 3ii).  
 
Western blot analyses revealed that low-cyan tomato extract treatment induced the 
activation of caspase-7 in both MCF-7 and MDA-MB-231 cells. Cleaved caspase-7 was 
detected only at the 9 h and 12 h time points but not at earlier time points.Caspase-9 
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was not activated in MDA-MB-231 cells in response to treatment with low-cyan tomato 
extract.  
 
These findings reveal that the low-cyan extract is capable of inducing an apoptotic 
response in both breast cancer cell lines through activation of proapoptotic proteins and 
alterations of the cell cycle but the effects are more dramatic for the other two high-
anthocyanin tomato extracts. 
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3.4 Discussion 
Regular consumption of fruit and vegetables has been associated with health benefits 
and protection from many chronic diseases, including certain cancers. Results from both 
in vitro cell and in vivo human and animal studies have provided strong evidence that 
the intake of fruit and vegetables can reduce the incidence of tumour development and 
progression and inhibit cancer cell proliferation. Different structural and functional 
classes of phytochemicals have been associated with anticancer activities, which include 
both chemopreventive and chemotherapeutic properties. The health benefits of purified 
resveratrol and anthocyanins have been extensively researched with conflicting results 
and little attention has been given to the possible synergistic or additive effects taking 
place in the food matrix of whole foods.  
 
In this chapter I investigated the cell metabolic status-inhibiting effects of select purified 
polyphenolic compounds and compared them to the biological activity of whole tomato 
extracts. This comparative analysis was intended to shed further light on the question of 
whether the biological effects of certain phytochemicals are modulated by the food 
matrix environment and subsequently, whether the inhibitory effects on cell metabolic 
activity that were observed with the anthocyanin extracts were attributable to the 
induction of cell death through an apoptotic pathway or necrosis. 
 
Very few comparative analyses of anthocyanins involve whole food products rather 
than dietary supplements. There is increasing evidence that the health benefits 
associated with the consumption of phytonutrients could be heavily influenced by their 
food context that may involve synergistic interactions with other components in the 
food matrix. The growth-inhibitory effects of a number of commercially available 
polyphenols (resveratrol, polydatin, rutin and delphinidin-3-glucoside) and the two most 
abundant anthocyanins purified from the high-del tomatoes were investigated and 
compared to the biological effects induced by different whole tomato extracts using the 
WST-1 cell proliferation/metabolic activity assay (Roche) that measures the metabolic 
activity of viable cells. Our study revealed that whole tomato extracts containing either 
high amounts of resveratrol (Figure 3.6 B) or anthocyanins (3.7 A and B) had 
significantly stronger effects on the metabolic activity and exerted their cyto-inhibitory 
effects at lower equimolar concentrations than the purified compounds (3.4 A-C and 3.5 
A-C). No growth-inhibitory effects were associated with WT tomato extracts indicating 
148 
 
that the growth-inhibitory effects observed in the high-anthocyanin and high-resveratrol 
tomato extract-treated cells were caused by the novel polyphenols present only in those 
transgenic tomatoes. We observed little reduction in metabolic activity after exposure to 
the pure polyphenolic compounds. These findings suggest that polyphenolic compounds 
such as anthocyanins and resveratrol may not be as active when in their purified form 
but are likely to interact with other components in the food matrix that potentiate their 
biological effects or increase their bioavailability.  
 
The mechanisms by which these synergistic or additive effects are exerted and whether 
they involve other plant polyphenols or structurally unrelated compounds remain to be 
discovered. However, these findings are in agreement with other studies suggesting that 
whole food products are more efficient in exerting health benefits than dietary 
supplements alone (Liu et al., 2009, Prior et al., 2008, Titta et al., 2010).  
 
In this Chapter, I investigated the growth-inhibitory and proapoptotic effects of extracts 
from various transgenic tomato lines, using MCF-7 and MDA-MB-231 breast cancer 
cells. The main objective of this study was to investigate whether the presence of 
compounds such as anthocyanins or resveratrol, unique to the transgenic tomato lines, 
confer enhanced health benefits, such as improved anticancer properties. The metabolic 
activity studies (Figures 3.7) provide clear evidence that all high-anthocyanin tomato 
lines as well as the high-resveratrol (high-res) tomato line exhibited antiproliferative 
activity in the human breast cancer cells MCF-7 and MDA-MB-231. The three high-
anthocyanin tomatoes investigated, displayed varying degrees of growth-inhibitory 
effects that correlated well with the amount of anthocyanins present in the different 
extracts. High-del tomato extract contained approximately 100 µM total trihydroxylated 
anthocyanins and exhibited the strongest anti-proliferative effects (Figure 3.7 A), 
followed by the high-pel tomato extracts containing 40 µM of anthocyanins (Figure 3.7 
B). Strong antiproliferative activities were also observed after exposure to high-res 
extract (Figure 3.6 B).  
 
We also aimed to compare anthocyanin tomato extracts containing different 
anthocyanin classes to investigate whether anthocyanin structure impacts their 
biological activity. Cells were treated with whole high-anthocyanin tomato extracts 
rather than purified compounds in order to assess the biological effects in a food 
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context. The anthocyanin-containing tomatoes allow for the comparison of 
trihydroxylated delphinidins with monohydroxylated pelargonidins in similar chemical 
environments. Anthocyanin levels varied between the different tomato lines, with high-
del exhibiting the highest total anthocyanin content, approximately 2.5 and 40 fold 
higher than that of the high-pel and low-cyan tomatoes, respectively. Direct 
comparisons between the different tomato extracts were therefore impossible and high-
del tomato extracts were diluted 2.5 times with WT tomato extract to match the 
concentration of total anthocyanins (40 µM) present in the high-pel tomatoes. Due to 
their comparatively low anthocyanin content, the low-cyan tomatoes were excluded 
from the comparative experiment. My results showed that MCF-7 and MDA-MB-231 
cells responded with different sensitivities to the different high-anthocyanin extracts 
(Figure 3.9). Cell viability of MCF-7 cells was significantly reduced in response to the 
highest concentration of both high-pel and high-del extracts that each contained 40 µM 
of total anthocyanins. This observation suggests that there is no difference in the 
biological efficacy of tomato extracts containing trihydroxyalated delphinidins or 
monohydroxylated pelargonidins on MCF-7 cells. In contrast, MDA-MB-231 cells did 
show an effect of the different anthocyanin classes. 1% of high-pel extract containing 40 
µM of monohydroxylated anthocyanins inhibited MDA-MB-231 cell metabolic status 
by 70% (Figure 3.9 A) compared to only 35% after treatment with equimolar 
concentration of trihydroxylated anthocyanins (Figure 3.9 B). These findings suggest 
that pelargonidins are somewhat more effective than delphinidins at mediating 
anthocyanin-induced MDA-MB-231 cell death.  
 
Both trihydroxylated delphinidins and dihydroxylated cyanidins have been extensively 
researched with respect to their anti-cancer activities whereas pelargonidins have 
remained largely unresearched which could be explained by their relatively low natural 
abundance compared to delphinidin and cyanidin (Chen et al., 2006a, Feng et al., 2007, 
Lamy et al., 2006, Lazze et al., 2004, Syed et al., 2008, Yun et al., 2009). Several 
studies have compared the efficacy of individual anthocyanins but have yielded 
inconclusive results. Cell type dependent differences in the response to individual 
anthocyanins might be responsible for the reported discrepancies in the results. That 
highlights the difficulty of comparing these studies in order to draw any conclusion 
regarding the links between anthocyanin structure and biological efficacy. Some studies 
have reported that pelargonidins have weaker biological effects than delphinidins or 
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cyanidin, whereas other findings suggest that the specific type of cells used may impact 
the biological efficacy observed more than the anthocyanin compound under 
investigation (Lamy et al., 2006, Zhang et al., 2005b). Wang et al. (2011) reported that 
trihydroxylated, O-methylated malvidin chloride was more effective than 
monohydroxylated pelargonidin chloride in inhibiting the growth of Caco-2 colon 
adenocarcinoma cells but that pelargonidin chloride was more effective than malvidin 
chloride in reducing the growth of HepG2 liver cells. Pelargonidin-containing tomato 
extracts were significantly more effective in inhibiting growth of MDA-MB-231 cells 
than of MCF-7 cells, whilst no differences in the biological efficacy of pelargonidin- or 
delphinidin-containing extracts was detected in MCF-7 cells. The trihydroxylated 
delphinidin purified from the high-del tomato seemed to be slightly more effective than 
its O-methylated form petunidin. At the highest concentration tested the delphinidin 
induced a significant reduction in metabolic activity of ~20% in both MCF-7 and MDA-
MB-231 cells (Figure 3.5 B), whereas the petunidin-induced changes  to the cell 
metabolic status were not statistically significant (Figure 3.5 C). Delphinidin and 
petunidin are different anthocyanins that share a common trihydroxylated backbone. 
The decoration of anthocyanins through glycosylation, acylation and methylation 
increases their stability in the plant but are likely to have an impact on the 
bioavailability of these anthocyanins by impacting their absorption and metabolism in 
the human body (Kroon et al., 2004).  
 
My findings support the idea that the biological efficacy of a given compound or 
structural class may depend strongly on the specific type of cells and that individual cell 
lines may respond differently to the same agent. Furthermore, these compounds might 
exert their biological activity by targeting specific molecules in a given cell type rather 
than being non-selectively cytotoxic. In order to determine whether anthocyanin 
structure affects biological activity, many cell lines from different tissues as well as a 
set of structurally diverse anthocyanin compounds should be included in the study. 
 
The use of cell proliferation or cell viability assays allows for a preliminary assessment 
of a cell population’s overall health. Other assays and experiments are required to 
investigate the mechanisms by which particular treatments induce growth-inhibition or 
cell death. All anthocyanin extracts induced an apoptotic response independent of the 
cell line used. The Annexin-V/PI assay allowed cells to be tracked whilst undergoing 
151 
 
different stages of apoptosis and the expression analysis of proapoptotic caspases 
provided further evidence that these cells undergo apoptotic cell death in response to 
anthocyanin extract treatment. However, the large amount of cell debris that was 
detected by FACS analysis upon exposure to the anthocyanin extracts may suggest that 
a significant proportion of the cell population died trough a different form of cell death. 
 
The induction of apoptosis by anthocyanin-rich extracts measured by Annexin-V/PI 
assays was confirmed by characteristic morphological changes and activation of 
proapoptotic proteins such as caspases (caspase-7 and -9). Anthocyanin extract-induced 
alterations to the cell cycle further confirmed the hypothesis that anthocyanin tomato 
extracts are potent inducers of cell death in vitro. Anthocyanin tomato extracts inhibited 
growth of MCF-7 and MDA-MB-231 cells and blocked G2/M phase progression. 
Studies by several different research groups have reported that anthocyanins can inhibit 
the growth of different tumour cell lines, and have linked this to caspase-dependent 
apoptosis, activating both the intrinsic and extrinsic apoptotic pathway (Chen et al., 
2006b, Lazze et al., 2004, Lee et al., 2009, Reddivari et al., 2007, Sun and Hai Liu, 
2006). Results of the Annexin-V apoptosis assay (Table 3iii) demonstrate that high-
anthocyanin tomato extracts are powerful inducers of apoptosis in both MCF-7 and 
MDA-MB-231. This observation is in agreement with the previously reported 
proapoptotic effects of different anthocyanins and their glycosides in other cancer cell 
lines (Feng et al., 2007, Shih et al., 2005, Yun et al., 2009). However, anthocyanin 
concentrations equal or higher than 200 µM were used in these studies, whereas we 
observed a more dramatic and rapid apoptotic response at much lower anthocyanin 
concentrations (1% of high-pel and high-del tomato extract contained 40 µM of 
monohydroxylated anthocyanins and 100 µM of trihydroxylated anthocyanins, 
respectively). These findings suggest that the use of food supplements may not deliver 
the same beneficial health effects that are associated with a diet rich in fruit and 
vegetables. 
 
The FACS analyses of Annexin-V/PI stained cells also revealed that high-del and high-
pel extracts induced the very rapid onset of apoptotic cell death of MCF-7 and MDA-
MB-231 and also led to the accumulation of a large percentage of dead cells and debris 
in the samples after prolonged exposure times (Table 3iii B and C). The Annexin-V/PI 
assay does not discriminate between cells that die as a result of apoptosis or necrosis. 
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However, the distinct time-dependent migration of cells from early apoptotic (Annexin-
V positive and PI positive) to late apoptotic (Annexin-V positive and PI negative), 
suggests that the intact cell populations analysed by Annexin-V/PI were indeed 
undergoing apoptosis rather than necrosis.  
 
The accumulation of cell debris increased dramatically with prolonged exposure times 
to high-anthocyanin tomato extracts. It is important to note, that only the intact cell 
population was included in the Annexin-V/PI analysis. Cell debris or severely damaged 
cells show up as false healthy cells (Annexin-V negative and PI negative) and were 
therefore excluded from the analysis of the apoptotic state in order to maintain data 
fidelity. The increased amount of cell debris in the high-anthocyanin extract treated 
cells could be indicative of acute treatment toxicity that may have induced very rapid 
necrotic cell death. Apoptosis and necrosis are two very distinct routes to cell death that 
are triggered through different pathways and involve a complex and unique set of pro-
death signals (see general introduction). Necrotic cell death is associated with high 
cytotoxicity and is a consequence of acute disruption of cellular metabolism, leading to 
mitochondrial and cellular swelling, activation of degradative enzymes, plasma 
membrane failure and cell lysis. It is possible that within the same population, 
individual cells responded to the extracts with different cell death mechanisms. Varying 
degrees of chemosensitivity could explain that those cells that accounted for the cell 
debris suffered rapid membrane rupture and necrotic cell death in response to the 
anthocyanin tomato extract treatment, whilst those identified by the Annexin-V/PI assay 
as undergoing apoptosis were more resilient and responded more slowly through a 
coordinated induction of proapoptotic signals. 
 
Furthermore, high-anthocyanin tomato extracts induced activation of caspase-7 and 
caspase-9 in both MCF-7 and MDA-MB-231 but not caspase-3 in MDA-MB-231 
(MCF-7 does not produce detectable levels of caspase-3 due a deletion in the exon of 
Casp-3). However, anthocyanin-induced activation of caspase-3 has been reported for 
U937 human leukaemia cells (Lee 2009), HL-60 human leukaemia cells (Chang 2005), 
MDA-MB-453 but not MCF-7 or MDA-MB-231 human breast cancer cells (Hui et al., 
2010) and in LNCaP prostate cancer cells but not in PC-3 prostate cancer cell 
(Reddivari et al., 2007). This suggests that anthocyanins differentially induce apoptosis 
in various cell lines through caspase-3 dependent and independent pathways. Caspase-9 
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occupies an essential role in the caspase cascade as the upstream activator of caspase-3 
and caspase-7 which, in turn, then go on to propagate the caspase cascade by activating 
caspase-2, -6, and -10 (Slee et al., 1999). Both caspase-7 and -9 were activated in both 
cell lines after exposure to tomato anthocyanin extracts, demonstrating that even 
without the activation of caspase-3, anthocyanin extract-induced apoptosis involves the 
caspase-dependent pathway. The non-discriminatory induction of apoptosis in both 
MDA-MB-231 and the caspase-3-deficient MCF-7 cells indicated that caspase-3 is not 
imperative for the anthocyanin extracts to induce fast and sustained alterations to the 
cell cycle and time-dependent apoptosis. However, it should be noted that sample 
loading, especially of the untreated control, was an issue in some Western blots, which 
made it difficult to draw any conclusion regarding de novo synthesis of caspases in 
response to treatment with anthocyanin-enriched tomato extracts. Caspase-
corresponding protein bands were often substantially weaker in the untreated control 
compared to the treated samples which could suggest de novo synthesis of procaspases 
in the treated samples or simply indicated discrepancies in the amount of protein loaded. 
 
My findings do not allow for conclusions regarding the mechanisms by which apoptosis 
is induced in the breast cancer cells and further experiments would be required to 
distinguish between the different routes of mammalian cell death induced by the high-
polyphenol tomato extracts and their interactions with key effectors in the apoptotic 
pathway. 
 
Anthocyanins and other polyphenols have been shown, both in in vitro test systems and 
in vivo animal models, to induce substantial biological responses associated with the 
protective effects of diets rich in fruit and vegetables against degenerative and chronic 
diseases. With the aim of developing dietary recommendations for major 
phytochemicals, a number of studies have investigated the bioavailability and metabolic 
fate of those compounds within the human body. Up to now, our understanding of the 
biological fate of polyphenols, after entering the digestive tract, has remained somewhat 
fragmented. Only fractions (nanomolar ranges) of several hundred mg of polyphenols 
are detected after ingestion, whilst the metabolic fate of the remaining anthocyanins 
remains largely unknown (Scalbert and Williamson, 2000). Polyphenol conjugates are 
likely to be substantially modified and metabolized during absorption, making the post-
digestive detection increasingly difficult. 
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I exposed breast cancer cells to medium containing a maximum of 100 µM of total 
anthocyanins (high-del tomato extracts) or 200 µM of purified polyphenols. These 
concentrations are relatively high and may not be physiologically relevant. In vivo, cells 
in tissues distal to the digestive system are likely to be exposed to much lower 
concentration of those compounds in the blood. However, my in vitro observations 
complement the results of a previously conducted preclinical intervention study with 
Trp53
-/-
 knockout mice in which feed, supplemented with high-anthocyanin tomatoes 
significantly prolonged their average lifespan by delaying tumour development (Butelli 
et al., 2008). Animals fed on the WT tomato supplemented diet showed no increase in 
lifespan compared to animals fed standard diet, whereas Trp53
-/-
 knockout mice 
consuming the high-anthocyanin tomato-supplemented diet lived ~ 30% longer. The 
p53 tumour suppressor gene plays a key role in cell cycle regulation, tumour 
suppression and control of apoptosis. Increased cell proliferation and failure to undergo 
apoptosis are defining criteria of cancerous cells and re-establishing or inducing 
mechanisms that control these processes, may improve therapeutic treatment 
significantly. High-anthocyanin tomato extracts strongly inhibited cell metabolic 
activity which is linked directly to cell proliferation and growth, induced cell cycle 
alterations and activated pro-apoptotic proteins in breast cancer cells in vitro. My 
findings suggest strongly that the delay in tumour development and subsequent 
prolongation of lifespan of Trp53
-/-
 knockout mice fed on a diet supplemented with 
high-anthocyanin tomatoes, are the result of an anthocyanin-induced activation of the 
apoptotic programme, possibly through mechanisms bypassing or compensating for the 
loss of p53 function, as well as a modulation of the cell cycle, which reduces the 
proliferation of aberrant cells.  
 
The results from Butelli’s epidemiological study using the well-established Trp53-/- 
knockout mouse cancer model and my in vitro breast cancer tests confirmed that 
anthocyanins confer improved health benefits to the transgenic tomatoes by enhancing 
their anti-cancer bioactivities.  
 
In order to gain a more complete understanding of the molecular mechanisms 
underlying the anthocyanin tomato-mediated induction of apoptosis, further 
investigation of key apoptotic signalling and executing molecules is required, including 
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expression analysis p53 and p53-regulated genes and other signalling pathways like 
extracellular signal-regulated kinases (ERKs) or phosphatidylinositide 3-kinases 
(PI3Ks) which are associated with cell survival. 
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4 Chemosensitizing effects of high-
resveratrol and high-delphinidin 
tomato extracts 
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4.1 Introduction  
A number of plant polyphenols have been suggested to prevent or reduce the initiation 
of cancer or suppress its development. These compounds exert their effects through 
modulation of intracellular cell signalling pathways that are involved in tumourigenesis. 
Evidence has emerged that these phytochemicals may also play a role in enhancing the 
tumoricidal effects of pharmacological agents by increasing their systemic availability, 
abrogating drug resistance or protecting normal cells from therapy-induced damaging 
and toxic effects (Satoh et al., 2003, Casanova et al., 2012, Jazirehi and Bonavida, 2004, 
Molnár et al., 2008, Misra and Sahoo, 2011, Younes-Sakr et al., 2012). 
 
Several studies have reported that the combination with drugs or pre-treatment with 
phytochemicals result in greater inhibition of cancer cell proliferation and enhanced 
induction of apoptosis, than the drugs alone. Genistein, an isoflavone and phytoestrogen 
found in many soy products, significantly enhanced the sensitivity of human breast, 
prostate and pancreatic cancer cells to the chemotherapeutic agents such as adriamycin, 
cisplatin and docetaxel (Li et al., 2005, Satoh et al., 2003). Furthermore, pre-treatment 
with genistein enhanced radiation-mediated inhibition of prostate tumour cells (Raffoul 
et al., 2006, Hillman et al., 2004). 
 
Resveratrol, a stilbene and natural phytoalexin predominantly found in the skin of 
grapes, has received substantial scientific attention due to its alleged anti-aging, anti-
cancer and cardiovascular-protective effects (Park and Pezzuto, 2002). A number of 
studies demonstrated that resveratrol can also act as powerful chemosensitizer for a 
number of chemotherapeutic agents. Combinatorial treatment of melphalan, roscovitine 
or doxorubicin with resveratrol significantly enhanced the effect of drug-induced 
apoptosis and cell death in various cancer cell lines (Węsierska-Gądek et al., 2008, 
Fulda and Debatin, 2004, Casanova et al., 2012). 
 
Similarly, improved cytotoxic and pro-apoptotic effects were reported after co-treatment 
with the plant polyphenolic compound, (-) epigallocatechin-3-gallate (EGCG), a major 
constituent of green tea, and cyclooxygenase-2 (COX-2) inhibitors targeting prostate 
cancer cells in vitro (Adhami, 2007).  
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Figure 4.1: Chemical structures of (A) resveratrol, (B) genistein, and (C) (-) epigallocatechin-3-
gallate. 
 
 
The mechanisms by which chemosensitizing effects may be exerted are diverse and 
could involve the regulation of the NF-κB and Akt cell survival pathways which are 
involved in drug resistance (Gill et al., 2007, Hillman et al., 2004, Pommier et al., 2004) 
and the activation of proapoptotic pathways involving the induction of p53, p21 
together with caspases (Li et al., 2005, Raffoul et al., 2006, Surh, 2003). Furthermore, 
polyphenols may increase the endogenous antioxidant defence potential and thus 
modulate cellular redox state. Oxidants and free radicals are not only implicated in 
normal intracellular signalling but also in the pathogenesis of chronic inflammatory 
diseases and cancer. Polyphenols may act as both anti- or pro-oxidants depending on 
their concentrations and therefore modulate intracellular ROS signalling (Rahman et al., 
2006).  
 
Phytochemical-induced immunomodulation or –potentiating effects may also account 
for some of their chemosensitizing effects. Phytochemicals have been implicated in 
improving the immune response and reducing chemotherapy-induced side effects by 
enhancing lymphocyte proliferation, natural killer cell cytotoxicity and cytokine-
producing CD4+/CD8+ ratio, which have been associated with immunity against 
tumours. Plant bioactives also modulated the production of interleukins and interferons 
that involved in regulating the response of the entire immune system to foreign antigens 
(Falchetti et al., 2001, Zhang et al., 2005a). 
 
Despite a significant choice of chemotherapeutic agents, the heterogenic nature of 
tumours and their ability to develop resistance to drugs remains a significant challenge 
for delivering effective and successful cancer treatments with minimized effects on non-
A B C 
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target tissues. Novel treatment strategies will most certainly involve combinatorial 
treatments of established drugs and could include compounds that sensitize or decrease 
the development of resistance to cytotoxic drugs by tumours or confer protection to 
normal cells from chemotherapy drug damage. The concept of combinatorial drug 
treatments to treat cancer is not a new one. The idea of combining different agents that 
act as sensitizers and inducers is, however, novel and promising. So far, little research 
has been conducted into the potential of plant natural compounds as components of 
multi-drug chemotherapy treatments. Yet, the many positive health effects attributed to 
dietary polyphenols and the lack of reported adverse effects on whole organisms from 
dietary levels of these compounds make them attractive candidates for inclusion in 
chemotherapy drug regimes. Resveratrol, genistein and curcumin, a phenolic 
curcuminoid found in the spice turmeric, are among the polyphenolic compounds that 
have attracted significant scientific and medical attention because of their health 
benefits as cancer chemopreventive, anti-inflammatory and cardioprotective agents 
(Park and Pezzuto, 2002). More research into the chemosensitizing effects of these 
dietary supplements and the underlying mechanisms, by which they are induced, is 
required to make any recommendations for their use as adjuvants in chemotherapy. 
Furthermore, the impact of dietary intervention as a strategy to improve the body’s 
resistance against the adverse effects associated with most pharmacological agents has 
been largely ignored. Changes in dietary habits that involve the increased consumption 
of plant-based food products, rich in bioactive phytochemicals with confirmed 
chemosensitizing effects, together with a reduction in food components that have 
known adverse health effects, like those containing high amounts of sugars and trans 
fats may reduce the systemic impact of chemotherapy, improve treatment success and 
ultimately, improve the long-term clinical outcome for chemotherapy patients. 
 
 
4.2 Aims: 
Strong chemosensitizing effects have been associated with a number of dietary 
supplements, including resveratrol, curcumin and EGCG. In this chapter, we 
investigated whether co-treatment with high-resveratrol and high-delphinidin tomato 
extracts potentiated the cytotoxic effects of the chemotherapeutic agents, doxorubicin 
and roscovitine. Human breast cancer cell lines MCF- and MDA-MB-231 were exposed 
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to different combinatorial doses of phytochemical-enriched tomato extracts and 
chemotherapy drugs to test their potential to induce chemosensitizing effects.  
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4.3 Experimental procedures  
 
4.3.1 Chemicals  
Doxorubicin (Dox), also known under the brand name of Adriamycin is an 
anthracycline antibiotic and chemotherapy drug that acts as a topoisomerase-2 inhibitor 
blocking cell division and growth. Roscovitine (Rosc) is a small purine-like cyclin-
dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets 
including CDK1, CDK2, CDK5, CDK7 and CDK9. Doxorubicin and roscovitine were 
purchased from Sigma and dissolved in DMSO to a stock concentration of 10 mM and 
30 mM, respectively. Resveratrol was also purchased from Sigma and dissolved in 
EtOH to a stock concentration of 100 mM. Small aliquots were stored at -20°C until 
further use. 
 
4.3.2 Tomato extract preparation  
High-res and high-del tomato extracts were prepared as described in Chapter 3.2.3. 
 
4.3.3 Cell culture and treatment  
MCF-7 and MDA-MB-231 cells were cultured following the cell culture procedures 
outlined in Chapter 3. Cells were exposed to Dox diluted in complete DMEM medium 
at 0.1 µM, 1 µM, 3 µM, 5 µM and 10 µM, Rosc diluted in medium at 1 µM, 5 µM, 10 
µM, 20 µM and 30 µM or pure resveratrol diluted in medium at 10 µM, 20 µM, 30 µM, 
50 µM and 100 µM. Tomato extracts were diluted in medium to a final concentration of 
0.05%, 0.1%, 0.2%, 0.3% and 0.5%. Cells were exposed to treatment media for 24 
hours, followed by analysis or incubation with treatment-free, complete medium for 
another 24 hours. Cell metabolic activity was measured using the WST-1 assay as 
described in Chapter 3.2.4.2 (Roche). 
 
4.3.4 Statistical methods 
The statistical significance was determined using Student’s t-test. P-values ≤ 0.05 were 
considered statistically significant. 
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4.4 Results  
 
4.4.1 Effect of resveratrol, doxorubicin and roscovitine on cell metabolic 
status 
The effects of resveratrol, Dox and Rosc on the metabolic status of MCF-7 and MDA-
MB-231 breast cancer cell lines were investigated (Table 4.i). Cell metabolic status was 
measured after 24 h exposure to treatment (Table 4i A) or after a total of 48 h (24 h 
treatment + 24 h incubation in treatment-free medium; Table 41 B). In MCF-7 cells, 24 
h incubation with resveratrol induced a dose-dependent reduction in cell proliferation 
(Table 4i A). At 100 µM, the number of actively metabolising cells relative to the 
untreated control was significantly reduced by 35%. The 24 h treatment with resveratrol 
(10 µM to 100 µM) significantly stimulated the metabolic activity of MDA-MB-231 
cells by up to 30%.  
 
In a second experiment, cells were incubated with resveratrol-containing medium for 24 
h before replacing the medium with treatment-free medium and incubation for another 
24 h (Table 4i B). The metabolic activity of MCF-7 cells treated with 100 µM 
resveratrol was not compromised when 24 h exposure to resveratrol was followed by 24 
h recovery in treatment-free medium (Table 4i B). This indicates that the resveratrol-
mediated inhibition of metabolic activity of MCF-7 cells may have been the result of 
cytostatic rather than cytotoxic effects as cells recover in treatment-free medium. The 
metabolic status of MDA-MB-231 was reduced by 15% in cells that were exposed to 
resveratrol-containing medium followed by 24 h recovery in treatment-free medium. 
This observation may be due to experimental variability or indicate that non-toxic doses 
of resveratrol may compromise the long-term metabolic activity of MDA-MB-231 cells. 
 
Treatment with Dox significantly reduced the metabolic activity of both MCF-7 and 
MDA-MB-231 cells in a dose-dependent manner (p<0.001; Table 4i A). At low 
concentrations MDA-MB-231 cells were more sensitive to Dox than MCF-7 cells. At 
the highest concentration (10 µM), Dox-induced inhibition of metabolic activity was 
77% and 84% for MCF-7 and MDA-MB-231 cells, respectively (Table 4i A). 
Incubation with Dox-containing medium followed by 24 h incubation with treatment-
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free medium resulted in a weak recovery of MDA-MB-231 cells. Interestingly, the 
metabolic status of MCF-7 cells was significantly more reduced in cells that received 24 
h Dox treatment followed by 24 h Dox-free treatment than those that were exposed to 
24 h Dox without 24 h recovery in treatment-free medium (Table 4i B). This 
observation suggests that Dox induces long-term, cytotoxic effects that persist, even 
after removal of Dox and is indicative of strong cytotoxicity. In contrast, the metabolic 
status of Dox-treated MDA-MB-231 cells was slightly higher in those cells that 
incubated for another 24 h in treatment-free medium, suggesting that the cells started to 
recover after removal of the Dox.  
 
Treatment with Rosc resulted in the reduction of the metabolic status of both cell lines. 
(Table 4i) MCF-7 cells were more sensitive to Rosc than MDA-MB-231 and treatment 
with the highest concentration of Rosc (30 µM) resulted in 70% and 35% in MCF-7 and 
MDA-MB-231 cells, respectively (Table 4i A).Treatment with Rosc followed by a 24 h 
incubation in treatment-free medium did not change the metabolic activity of the cells 
compared to the 24 h Rosc treatment without further incubation in treatment-free 
medium (Table 4i B)These observations suggest that Rosc is cytotoxic and that cells do 
not recover following treatment. MCF7 cells appear more sensitive to Rosc than highly 
metastatic MDA-MB-231 cells Both Dox and Rosc are potent cytotoxic compounds that 
effectively inhibit metabolic activity of both breast cancer cell lines and continue to 
exert their inhibitory effects after their removel from the medium (Table 4i).  
 
Resveratrol, at the concentrations tested, induced a moderate reduction in metabolic 
activity of MCF-7 cells. Compared to Dox and Rosc, higher equimolar concentrations 
of resveratrol were required to induce biological effects. This is not surprising as 
resveratrol is a dietary component with little known adverse systemic effects, whereas 
both Dox and Rosc are highly cytotoxic causing severe disruption the DNA replicative 
machinery and cell cycle regulation.  
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Table 4i: Dose response curves for (A) 24 h treatment with resveratrol, doxorubicin or roscovitine or (B) 24 h treatment + 24 h treatment-free 
medium containing resveratrol, doxorubicin and roscovitine on the proliferation of MCF-7 and MDA-MB-231 cells. 
 
 
 
B                                                                                  24 h + 24 h treatment-free 
  Concentration 10 µM 20 µM 30 µM 50 µM 100 µM 
MCF-7 Resveratrol 96.7 ± 6.2 111.1 ± 4.0 * 101.8 ± 11.4 121.6 ± 3.8 * 104.5 ± 6.5 
MDA-MB-231 Resveratrol 105.7 ± 3.4 97.8 ± 4.3 96.7 ± 0.9 88.3 ± 3.7 ** 84.8 ± 1.8 ** 
  Concentration 0.1 µM 1 µM 3 µM 5 µM 10 µM 
MCF-7 Doxorubicin 113.1 ± 6.8 20.1 ± 3.9 *** 8.9 ± 1.3 *** 9.1 ± 2.3 *** 6.1 ± 1.9 *** 
MDA-MB-231 Doxorubicin 95.5 ± 6.3 71.4 ± 3.4 ** 40.4 ± 1.8 *** 31.2 ± 1.3 *** 25.9 ± 2.1*** 
  Concentration 1 µM 5 µM 10 µM 20 µM 30 µM 
MCF-7 Roscovitine 108.9 ± 1.4 ** 100.5 ± 4.6 91.2 ± 17.6 82.7 ± 8.4 32.9 ± 10.9 ** 
MDA-MB-231 Roscovitine 98.6 ± 2.9 41.2 ± 3.7 * 91.4 ± 1.9 * 73.0 ± 4.8 * 64.1 ± 5.1 ** 
 
Results are expressed as a percentage of metabolically active cells after treatment relative to the untreated control. Data shown as mean ± standard error (n=3 technical 
replicates. Experiments were performed at least twice). * p<0.05; ** p<0.01; *** p<0.001. 
A                                                                                                             24 h 
  Concentration 10 µM 20 µM 30 µM 50 µM 100 µM 
MCF-7 Resveratrol 94.6 ± 3.4 93.1 ± 6.2 94.6 ± 2.8 95.8 ± 2.8 64.0 ± 1.9 *** 
MDA-MB-231 Resveratrol 111.1 ± 3.6 * 114.8 ± 4.4 * 116.21 ± 0.2 *** 128.7 ± 6.2 * 118.7 ± 2.4 ** 
  Concentration 0.1 µM 1 µM 3 µM 5 µM 10 µM 
MCF-7 Doxorubicin 118.5 ± 2.0 ** 86.3 ± 0.2 *** 71.9 ± 1.4 *** 60.4 ± 0.4 *** 22.8 ± 0.5 *** 
MDA-MB-231 Doxorubicin 95.7 ± 6.3 67.5 ± 3.4 ** 40.5 ± 1.6 *** 31.2 ± 1.2 *** 15.9 ± 1.7 *** 
  Concentration 1 µM 5 µM 10 µM 20 µM 30 µM 
MCF-7 Roscovitine 105.7 ± 1.5 * 96.5 ± 4.8 95.7 ± 2.1 73 ± 2.5 ** 31.4 ± 0.5 *** 
MDA-MB-231 Roscovitine 100.6 ± 2.6 92.2 ± 1.8 * 87.4 ± 1.3 ** 75 ± 5.2 * 66.1 ± 5.4 ** 
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4.4.2 Combinatorial effects of resveratrol and roscovitine and doxorubicin 
Having determined the responses of the two cell lines to the chemotherapy agents and 
the plant polyphenols, the next stage of the experiments was to explore the use of 
combinations of treatments at submaximal levels, to evaluate potential antagonistic or 
additive effects. The effects on the metabolic status of cells were investigated following 
the treatment with combinatorial doses of resveratrol and Rosc and Dox (Figure 4.2). 
 
Neither resveratrol (50 µM) nor roscovitine (5 µM or 10 µM) alone had inhibitory 
effects on the metabolic activity of MCF-7 cells. However, the combination of 
resveratrol (10 µM, 25 µM and 50 µM) with either 5 µM or 10 µM roscovitine (Figure 
4.2 A) induced a gradual reduction in the metabolic activity of MCF-7 cells which was 
significant (p<0.05) at the combinatorial dosage of resveratrol at 25 µM and 50 µM and 
Rosc at 10 µM. The reduction in metabolic activity of MCF-7 was weaker but highly 
significant (p<0.01) in the combinatorial treatment of resveratrol and 5 µM Rosc 
(Figure 4.2 A). 
 
No resveratrol-Rosc-induced inhibitory effects on the metabolic activity were observed 
in MDA-MB-231 cells. In contrast, combinatorial treatment of resveratrol and 5 µM of 
Rosc significantly stimulated metabolic activity (Figure 4.2 A). 
 
A similar experiment was conducted to investigate the potential combinatorial effects of 
resveratrol and Dox on the metabolic status of both cell lines. Treatment with 5 µM or 
2.5 µM of Dox alone reduced the metabolic activity of MCF-7 cells by 40% and 30%, 
respectively (Figure 4.2 B). The combination of resveratrol at 10 µM, 25 µM and 50 
µM with doxorubicin (2.5 µM or 5 µM) did not inhibit the growth of MCF-7 cells 
significantly. The combination of 2.5 µM doxorubicin and different doses of resveratrol 
resulted in a slight, statistically insignificant decrease in cell proliferation relative to 
cells treated with 2.5 µM of doxorubicin alone. Co-treatment of 5 µM of doxorubicin 
and resveratrol (25 µM) resveratrol even increased the proliferation of MCF-7 cells by 
10% compared to the drug treatment alone.  
 
Metabolic status of MDA-MB-231 cells was inhibited by 70% and 60%, respectively, 
after treatment with Dox at 5 µM or 2.5 µM. No pro- or anti-stimulatory effects on the 
metabolic activity of MDA-MB-231 cells were observed after co-treatment with 
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resveratrol and Dox (Figure 4.2 B). Consequently, there was no evidence of additive or 
synergistic effects between Dox and resveratrol in either cell line. 
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A  MCF-7          MDA-MB-231 
 
 
B    MCF-7        MDA-MB-231 
 
 
Figure 4.2: Combinatorial effects of resveratrol (Res) and (A) roscovitine (Rosc) or (B) 
doxorubicin (Dox) on proliferation of MCF-7 and MDA-MB-231 cells were investigated. Cells 
were exposed to Res, Rosc or Dox alone, or to a combination of Res and Rosc or Res and Dox 
to the concentrations indicated. Results are expressed as a percentage of cell metabolic activity 
after treatment relative to the untreated control. Data shown as mean ± standard error (n=3 
technical replicates. Experiments were performed at least twice). The statistical significance of 
the effect of combined treatment compared to the treatment with 10 µM ROSC alone was 
determined. * p<0.05; ** p<0.01; *** p<0.001. 
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4.4.3 Combinatorial effects of tomato extracts and roscovitine and 
doxorubicin 
The effects of whole tomato extracts on the metabolic status of MCF-7 and MDA-MB-
231 cells were investigated (Table 4ii). The extracts used were prepared from tomatoes 
that contained either large amounts of delphinidins (high-del) or resveratrol (high-res) 
or from unmodified tomatoes (WT) that contained no anthocyanins and very low levels 
of resveratrol. 
 
 
Table 4ii: Final concentration of tomato extract and the molar equivalents of their main 
active compounds. 
Extract 
Active 
compound 
0.1% 0.3% 0.4% 0.5% 0.6% 0.7% 0.8% 0.9% 1% 
high-
del 
Anthocyanin 
10 
µM 
30 
µM 
40 
µM 
50 
µM 
60 
µM 
70 
µM 
80 
µM 
90 
µM 
100 
µM 
high-
res 
Resveratrol 2 µM 
6 
µM 
8 µM 
10 
µM 
12 
µM 
14 
µM 
16 
µM 
18 
µM 
20 
µM 
 
 
Extracts were prepared as described in Chapter 3 and cells were exposed to different 
concentrations of tomato extract in the medium. Final cell medium concentrations of the 
tomato extract (in %) and their corresponding active compounds (in µM) are 
summarized in Table 4ii. 
 
As discussed in Chapter 3, WT tomato extract had no effect on the metabolic status of 
MCF-7 and MDA-MB-231 cells, while both high-del and high-res tomato extracts 
significantly reduced the metabolic status of both cell lines (Table 4iii). 
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Table 4iii: Dose response curves for 24 h treatment with WT, high-del and high-res 
tomato extracts on the metabolic status of MCF-7 and MDA-MB-231 cells.  
  concentration 0.25% 0.50% 0.75% 1% 
MCF-7 WT 111.0 ± 3.1 * 110.8 ± 7.9 113.8 ± 6.4 106.9 ± 6.8 
MDA-MB-231 WT 118.2 ± 6.9 * 110.1 ± 7.7 108.0 ± 4.6 * 95.3 ± 3.9 
        
  MCF-7 High-del 108.6 ± 6.5 96.9 ± 4.9 40.7 ± 8.7 ** 0.0 ± 0.4 *** 
MDA-MB-231 High-del 109.0 ± 6.9 64.1 ± 4.9 ** 11.6 ± 4.4 *** 6.3 ± 2.2 *** 
          
 MCF-7 High-res 102.8 ± 11.0 106.4 ± 12.5 108.9 ± 15.7 29.1 ± 6.3 ** 
MDA-MB-231 High-res 102.6 ± 6.3 109.8 ± 2.3 * 68.1 ± 7.2 * 7.0 ± 1.8 *** 
 
Results are expressed as a percentage of metabolically active cells after treatment relative to the untreated 
control. Data shown as mean ± standard error (n=3 technical replicates. Experiments were 
performed at least twice). * p<0.05; ** p<0.01; *** p<0.001. 
 
 
4.4.4 Combinatorial effects of tomato extracts and roscovitine  
Co-treatment effects between Rosc and and high-del tomato extract were investigated 
by treating cells with 10 µM of Rosc and different concentrations of high-del extract 
(Figure 4.3 A). Treatment with either 0.5% high-del extract, corresponding to 50 µM of 
anthocyanins, or 10 µM of Rosc alone did not impact on the metabolic activity of MCF-
7 cells. The co-treatment of 10 µM of Rosc with different concentration of high-del 
tomato extract did not result in a significant dose-dependent inhibition of cell metabolic 
activity. A small, significant (p<0.05) 10% reduction in the metabolic activity of MCF-7 
cells was observed after 24 h combinatorial treatment with 0.2% of high-del extract but 
not with higher extract concentrations. This observation is probably the result of 
experimental variation as this reduction in metabolic activity was not observed with 
increasing combinatorial concentrations of high-del extract. 
 
Treatment with 10 µM of Rosc alone did not inhibit the metabolic status of MDA-MB-
231 cells while treatment with high-del extract resulted in a 40% reduction (Figure 4.3 
A). Co-treatment of Rosc (10 µM) and high-del tomato extract resulted in a dose-
dependent inhibition of MDA-MB-231 cell metabolic activity. Co-treatment with Rosc 
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(10 µM) and 0.5% high-del extract, which corresponds to 50 µM of total anthocyanins, 
resulted in a strong inhibitory effect of 60% compared with 40% after treatment with 
0.5% high-del alone. The reduction in the metabolic status of co-treated MDA-MB-231 
cells compared 0.5 % high-del treated cells was highly statistically significant (p<0.01). 
This suggests that synergistic effects between Rosc, which on its own did not exert 
inhibitory action, and the active compounds in the high-del extract may play a role in 
exerting the increased reduction in metabolic activity of MDA-MB-231 cells. 
 
I also tested the combinatorial effects of Rosc (10 µM) and high-res tomato extract on 
the metabolic status of MCF-7 and MDA-MB-231 cells. 0.5% of high-res tomato 
extract contained approximately 20 µM of total resveratrol (Table 4ii) and did not affect 
the metabolic status of either cell line. Co-treatment with Rosc (10 µM) and increasing 
concentrations of high-res tomato extract resulted in a 15% reduction in the metabolic 
status of MCF-7 cells that was statistically significant (p<0.05) at the highest 
combinatorial treatment dose of 0.5% of high-res extract and 10 µM of Rosc (Figure 4.3 
B).  
 
Combinatorial treatment with high-res tomato extract and 10 µM of Rosc resulted in a 
weak but statistically significant reduction in metabolic activity in response to treatment 
with low concentrations of high-res extract (0.1% and 0.2%) and 10 µM of Rosc (Figure 
4.3 B). However, co-treatment with the highest dose of high-res tomato extract (0.5%) 
did not reduce the metabolic activity of MDA-MB-231 cells, which suggests that the 
putative the co-treatment effects observed with low concentrations of high-res extract 
might be due to experimental variation. 
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 A   MCF-7        MDA-MB-231 
 
B   MCF-7         MDA-MB-231 
 
 
Figure 4.3: Combinatorial effects of roscovitine (Rosc) and (A) high-delphinidin tomato extract 
(high-del) or (B) high-resveratrol tomato extract (high-res) on metabolic activity of MCF-7 and 
MDA-MB-231 cells were investigated. Cells were exposed to Rosc, high-del or high-res alone, 
or to a combination of Rosc and high-del or Rosc and high-res to the concentrations indicated. 
Results are expressed as a percentage of cell metabolic activity after treatment relative to the 
untreated control. Data shown as mean ± standard error (n=3 technical replicates. Experiments 
were performed at least twice). The statistical significance of the effect of combined treatment 
compared to the treatment with 10 µM Rosc alone was determined.  
* p<0.05; ** p<0.01; *** p<0.001. 
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4.4.5 Combinatorial effects of tomato extracts and doxorubicin 
The co-treatment effects between high-del or high-res tomato extracts and Dox on the 
metabolic status of MCF-7 and MDA-MB-231 cells were investigated. Treatment with 
5 µM of Dox alone resulted in a reduction in metabolic activity of MCF-7 and MDA-
MB-231 cells by 40% and 70%, respectively.  
 
Treatment with 0.5% high-del tomato extract inhibited metabolic activity of MDA-MB-
231 cells by 40% but had no effect on MCF-7 cells. In MCF-7, the co-treatment with 5 
µM of Dox and low doses of high-del tomato extract (0.05%, 0.1% and 0.2%) 
stimulated metabolic activity significantly (p<0.01; Figure 4.4 A). However, at higher 
combinatorial concentrations of high-res extract the stimulatory effect was lost and 
metabolic activity was similar to that of Dox alone. 
 
Similarly, stimulatory effects were observed in MDA-MB-231 cells in response to co-
treatment with low doses of high-del tomato extract and 5 µM of Dox compared to Dox 
treatment alone (Figure 4.4 A). However, at increasing co-treatment concentrations of 
high-del tomato extract (0.3% and 0.5%) cell metabolic activity was significantly 
reduced compared to treatment with Dox alone indicating potentially synergistic effects, 
although those were small. 
 
As observed previously, treatment with 0.5% of high-res extract which corresponded to 
20 µM of total resveratrol did not inhibit the metabolic activity of either cell line. The 
metabolic status of MCF-7 cells appeared to be slightly decreased, but not statistically 
significantly, in response to co-treatment with higher doses of high-res extract 
compared to treatment with Dox alone (Figure 4.4 B). 
 
In MDA-MB-231 cells, combinatorial treatment of 5 µM of Dox and 0.5% of high-res 
tomato extract significantly reduced the metabolic activity of MDA-MB-231 cells 
compared to treatment with Dox alone (Figure 4.4 B) indicating synergistic effects 
between the two treatments. 
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A   MCF-7      MDA-MB-231 
 
 
B   MCF-7      MDA-MB-231 
 
  
Figure 4.4: Combinatorial effects of doxorubicin (Dox) and (A) high-delphinidin tomato 
extract (high-del) or (B) high-resveratrol tomato extract (high-res) on proliferation of MCF-7 
and MDA-MB-231 cells were investigated. Cells were exposed to Dox, high-del or high-res 
alone, or to a combination of Dox and high-del or Dox and high-res to the concentrations 
indicated. Results are expressed as a percentage of cell metabolic activity after treatment 
relative to the untreated control. Data shown as mean ± standard error (n=3 technical replicates. 
Experiments were performed at least twice). The statistical significance of the effect of 
combined treatment compared to the treatment with 5 µM Dox alone was determined. 
* p<0.05; ** p<0.01. 
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4.5 Discussion 
I investigated the potential co-treatment effects of resveratrol, high-del or high-res 
tomato extracts and the chemotherapeutic agents, Dox or Rosc. Dox, also known under 
the brand name Adriamycin, is commonly used to treat certain leukaemias and 
Hodgkin's lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, 
thyroid, soft tissue sarcoma and multiple myeloma. Rosc is an experimental drug 
candidate that is currently undergoing Phase II clinical trials for the treatment of cancers 
like non-small cell lung cancer and B-cell lymphomas, including multiple myeloma. 
 
Chemotherapeutic drugs are indispensable for the treatment of most cancers and often 
used in conjunction with radiation and surgery to inhibit or prevent the formation of 
metastases. Their mode of actions depends on the chemotherapeutic agent but they 
commonly interfere with DNA and RNA synthesis, including the prevention of DNA 
replication and translation (e.g. inhibition of topoisomerases such as Doc), DNA 
intercalation or alteration of the cell cycle (e.g. cyclin-dependent kinase (CDK) 
inhibitors like Rosc) or mitotic inhibitors such as paclitaxel, which can block the 
formation of microtubules that is essential angiogenesis and metastasis. As proliferation 
and growth is de-regulated and up-regulated in cancer cells, they are often more 
susceptible to cytotoxic agents that interfere with these parameters than normal, non-
cancerous cells. However, many of chemotherapy treatment effects are systemic 
affecting not just aberrant cells as most cytotoxic agents lack the specificity to 
discriminate between normal and cancerous cells. Fast-dividing cells of the body, such 
as blood cells and the cells lining the mouth, stomach, and intestines are particularly 
susceptible to drug-induced damage that may result in the severe side effects commonly 
associated with chemotherapy such as fatigue, anaemia, suppression of the immune 
system, gastrointestinal distress, nausea and hair-loss, infertility and organ-damage, 
particularly cardiotoxicity. 
 
Development and clinical trials of agents that specifically target abnormal cells are 
currently underway to minimize the effects on non-target tissues. For example, the 
development of drugs that target molecules only expressed on the surface of tumour 
cells are amongst the most promising strategies that are currently explored (Maeda et 
al., 2009, van Rijt and Sadler, 2009, Petros and DeSimone, 2010). Furthermore, there is 
scope for significant improvements to existing cytotoxic agents like enhanced delivery 
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of cytotoxic compounds to the tumour cells (e.g. through the use of nanoparticles or 
tissue-specific antibodies) or the use of adjuvants that increase sensitization of tumours 
or prevent the development of resistance to cytotoxic agents. 
 
Polyphenolic compounds are among those natural compounds that have received 
substantial scientific and medical interest due to their anti-cancer and anti-inflammatory 
properties and their low or minor systemic toxicity. To date, several studies reported the 
use of polyphenolic compounds as adjuvants in the treatment of cancer cells with 
chemotherapeutic agents (Węsierska-Gądek et al., 2008, Raffoul et al., 2006, Fukui et 
al., 2010, Gill et al., 2007, Jazirehi and Bonavida, 2004). 
 
Węsierska-Gądek and colleagues (2008) reported that the addition of non-toxic doses of 
resveratrol potentiated the antiproliferative effects of Rosc on MCF-7 breast cancer 
cells. I was able to confirm the results reported by Węsierska-Gądek for MCF-7 cells 
and performed the same experiment with the MDA-MB-231 breast cancer cell line. 
Resveratrol alone reduced the metabolic activity of MCF-7 cell by at least 35% but did 
not inhibit the metabolic activity of MDA-MB-231 cells up to a treatment concentration 
of 100 µM (Table 4i A). In contrast, treatment with resveratrol alone stimulated the 
metabolic activity of MDA-MB-231 significantly. A resveratrol-induced stimulation of 
metabolic activity of MDA-MB-231 was also observed in combination with non-
cytotoxic levels of Rosc (5 µM; Figure 4.2 A).  
 
The concomitant use of Dox and resveratrol did not significantly impede the metabolic 
status of either cell lines but treatment with 5 µM of Dox and non-toxic doses of 
resveratrol (25 µM) increased the metabolic status of MCF-7 cells (Figure 4.2 B). 
Several studies have demonstrated that co-treatment with resveratrol can potentiate 
drug-induced apoptosis in certain cancer cell types (Węsierska-Gądek et al., 2008, 
Kweon et al., 2010, Komina and Węsierska-Gądek, 2008, Casanova et al., 2012). 
However, there are some conflicting reports suggesting that resveratrol may promote 
tumour growth and attenuate drug-induced apoptosis in cancer cells. Delphinidin, for 
example, induced proliferation and apoptosis in human colon carcinoma cells in vitro 
and inhibited tumour-induced lymph node lymphangiogenesis in tumour-bearing rats in 
vivo but strongly promoted tumour growth and metastasis to the lymph nodes of rats 
developing tumours derived from rat mammary carcinoma cells (Thiele et al., 2013). 
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Castillo-Pichardo et al. (2013) also reported increased mammary tumour growth 
(derived from MDA-MB-231 and the highly metastatic MDA-MB-435 breast cancer 
cell lines) and metastasis in immunocompromised mice after feed supplementation with 
resveratrol. Fukui et al. (2010) showed that concomitant use of resveratrol reduced 
apoptosis of several breast cancer cell lines, including MDA-MB-231, that were treated 
with paclitaxel, a microtubule-targeting agent that induces G2/M cell cycle arrest as 
well as apoptosis. However, another study reported the resveratrol-mediated 
sensitization of non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-
induced apoptosis (Jazirehi and Bonavida, 2004).  
 
To date, publications reporting the chemopreventive and -sensitizing effects of 
resveratrol, outweigh those reporting any adverse effects associated with resveratrol. 
However, it is evident that the pharmacological effects associated with resveratrol differ 
strongly between independent studies and are also highly dependent on the cell type and 
model used. For example, at 100 µM, I observed resveratrol-mediated inhibition of 
metabolic activity of MCF-7 breast cancer cells but stimulatory effects on MDA-MB-
231 cells. Similarly, Pozo-Guisado et al. (2002) observed resveratrol-mediated 
apoptosis and alteration of the cell cycle in MCF-7 but not in MDA-MB-231. These cell 
lines differ in their biochemical characteristics such as the oestrogen dependence of ER
+
 
MCF-7 cells and the oestrogen independence of ER
-
 MDA-MB-231 cells which may 
affect their response and sensitivity to certain pharmacological agents. Some of the 
contradictory results regarding the chemopreventive and –sensitizing effects of 
phytochemicals such as resveratrol may be the result of their multiple modes of action 
that are strongly dependent on dosage and cell type and affect their ability to potentiate 
or interfere with some cytotoxic agents.  
 
I also investigated the co-treatment effects of the chemotherapeutic compounds, Dox 
and Rosc, with high-del or high-res tomato extracts on the metabolic status of breast 
cancer cells. Despite many reports on the protective and inhibitory effects of 
anthocyanins on different cancer cell lines and tumours, there are no reports on the 
effects of combinatorial treatments including anthocyanin supplements or anthocyanin-
rich extracts and chemotherapeutic agents. I used extracts from the delphinidin-
containing high-del tomatoes in combination with Dox and Rosc to identify any 
synergistic effects affecting the metabolic status of human breast cancer cells.  
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The addition of low, non-toxic concentrations of high-del extracts increased the 
metabolic status of cells treated with Dox and Rosc, an effect that was not observed 
with the addition of the high-res extract. This suggests that at non-toxic concentrations, 
high-del extracts may be protective leading to attenuation of doxorubicin-mediated 
toxicity in MDA-MB-231 cells (Figure 4.4 A). I observed the same increase in 
metabolic activity after treatment with low doses of purified resveratrol indicating that 
phytochemicals can act as stimulants or inhibitors depending on the concentrations to 
which the cells are exposed. However, the concomitant use of Dox and Rosc and 0.5% 
high-del extract potentiated the effects of drug-induced inhibition of the metabolic 
status of MDA-MB-231 cells but not MCF-7 cells (Figure 4.3 A and 4.4. A). Co-
treatment with high-res tomato extract weakly potentiated the inhibition of metabolic 
activity of Dox and Rosc-treated MCF-7 cells (Figure 4.3 B and 4.4. B). Combinatorial 
use of 0.5% of high-res tomato extract and Dox reduced the metabolic status of MDA-
MB-231 cells by almost 50% compared to the treatment with Dox alone but had little 
effect on Rosc-treated cells (Figure 4.4 B). 
 
The results from the combinatorial use of tomato extracts and cytotoxic agents 
highlighted the complex mechanisms that are responsible for chemosensitization and 
chemoprevention. In the MDA-MB-231 cells, for example, a clear correlation between 
increasing concentrations of high-del extracts and increased cytotoxic effects of Dox 
and Rosc was observed suggesting that anthocyanin-containing tomato extracts and 
chemotherapeutic agents may act synergistically to exert stronger cytotoxic effects than 
each treatment alone. These synergisms were not observed in the MCF-7 cells which 
suggest that at least some of the mechanisms responsible for inducing the cytotoxic 
effects may be associated with targets that are unique to particular cell types. 
Anthocyanins are thought to exert their anti-cancer activities through modulation of 
signalling pathways involved in the induction of apoptosis or cell cycle regulation 
(Chen et al., 2006b, Xia et al., 2009, Lee et al., 2009, Lee et al., 2010, Huang et al., 
2011, Afaq et al., 2005). The combination of compounds, which individually target 
different components of the cancer cell, may partly explain the synergistic or additive 
effects observed with combinatorial treatment. However, anthocyanins and other 
polyphenolic compounds may also improve or reverse drug resistance of cancer cells by 
chemosensitizing them to the cytotoxic drugs. Several plant compounds, including 
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flavonoids have been shown to inhibit the function of multidrug resistance (MDR) 
proteins which are present in the majority of human tumours and are strongly associated 
with tumour resistance and subsequently, therapeutic failure (Molnár et al., 2008, Wink 
et al., 2012). Co-formulation of Dox and curcumin, for example, suppressed the 
development of multidrug resistance in human leukaemia (K562) cells (Misra and 
Sahoo, 2011).  
 
The ability of many phytochemicals to regulate a wide network of different signalling 
pathways that directly affect the survival of cancer cells through induction of apoptosis, 
alteration of the cell cycle or indirectly through prevention of resistance development to 
other cytotoxic agents are likely to explain the chemosensitizing effects observed. The 
inconsistency in the reports and the variability between different cell lines makes it 
difficult to interpret the data and make some reliable predictions for further application. 
More in vivo animal studies are required to confirm whether synergistic effects between 
physiologically relevant concentrations of phytochemicals and chemotherapy drugs also 
take place in a whole organism. Cells in tissues distal to the gastrointestinal tract are 
unlikely to be exposed to polyphenol (or their metabolites) concentrations exceeding 
nanomolar ranges. However, cells lining the gastrointestinal tract may experience much 
higher concentrations of these bioactives and are actively involved in their uptake and 
biochemical modification. Novel formulations such as encapsulation of food bioactives, 
that increase bioavailability or stability of polyphenolic compounds and facilitate 
controlled release of bioactive food additives are currently being explored (Gandía-
Herrero et al., 2010, Kropat et al., 2013). However, it is essential to rule out any 
combinatorial effects that might interfere with the efficacy of chemotherapy drugs 
before recommending the use of phytochemicals as adjuvants in chemotherapy 
treatment. Despite the lack of clear evidence for the efficacy of polyphenols as 
therapeutic adjuvant, their dietary consumption may still confer substantial health 
benefits by stimulating the body’s immune response and enhance its protection from 
chemotherapy-induced side effects. Due to their severe systemic toxicity, 
chemotherapeutic agents are usually delivered in intervals in order to allow the body the 
recover in between treatments. Plant polyphenolics are natural constituents of the 
human diet with low or no systemic toxicity and no adverse health effects have been 
associated with a high intake of fruit and vegetables. These compounds may not be 
highly effective as single anti-cancer agents but their combinatorial use with 
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chemotherapeutic agents may open up new avenues for more specific and effective 
targeting of tumour cells or reduce the systemic effects of chemotherapeutic drug 
regimes (Younes-Sakr et al., 2012). Dietary chemosensitization is an emerging field in 
pharmacology but due to the lack of reliable clinical data, no recommendations have 
been established. However, there is strong evidence from chemoprevention studies that 
phytochemicals or their food sources can inhibit the proliferation and growth of tumour 
cells and induce immune responses that may target cancer cells directly or can protect 
against the systemic effects of cytotoxic agents. 
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5 Summary and future directions 
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To date, plant metabolic engineering has been used successfully to enrich different 
plants, including model species such as Arabidopsis as well as important crop species, 
with essential and health-beneficial nutrients or to reduce the content of toxic or 
undesirable compounds. The Golden Rice Project development of β-carotene-enriched 
rice heralded the use of metabolic engineering for the nutritional enhancement of crops 
with health-promoting or essential dietary components. Golden rice, developed to 
combat vitamin-A deficiency in developing countries, demonstrated the potential of 
plant metabolic engineering, where previous conventional breeding approaches had 
failed.  
 
 
5.1 Metabolic engineering to control different anthocyanin branches 
in tomato 
Plant polyphenols are the largest and most diverse group of secondary metabolites, and 
amongst them, anthocyanins are probably the most ubiquitous and conspicuous 
compounds. To date, more than 600 different anthocyanins have been identified and 
their structural identity and decoration varies significantly between individual species 
and clades. Few plants produce all three structural classes of anthocyanins that are 
defined by the number of hydroxyl groups on the phenyl B-ring (pelargonidin, cyanidin, 
delphinidin), yet accumulation of anthocyanins of all three classes is found in the fruit 
of mulberry, pomegranate and black currents (Engmann et al., 2013, Noda et al., 2001, 
Slimestad and Solheim, 2002). However, the majority of plants accumulate no more 
than twenty different molecular structures that belong to one or two classes of 
anthocyanins.  
 
Substrate specificity of late anthocyanin biosynthetic pathway enzymes is often 
associated with failure to synthesise a particular structural group, while a lack of 
activation of early biosynthetic genes is linked to the total absence of anthocyanins. 
 
Commercial tomato varieties do not accumulate anthocyanins in the fruit due to the 
absence of transcriptional activation of the structural genes involved in anthocyanin 
biosynthesis (Figure 2.1). Introgression with wild relatives that synthesise anthocyanins 
in fruit resulted in the cold- and light-inducible accumulation of anthocyanins in the 
182 
 
peel of tomatoes (Povero et al., 2011). Conventional breeding strategies have, however, 
failed to induce production of anthocyanins in the pericarp of the tomato fruit. 
Metabolic engineering of the tomato flavonoid metabolism using anthocyanin-specific 
transcription factors from A. majus, resulted in the accumulation of high amounts of 
anthocyanins in the fruit (Butelli et al., 2008). The anthocyanin-enriched tomatoes 
developed by Butelli accumulated up 3 mg/g FW of anthocyanins, amounts that are 
comparable to those found in many berries.  
 
The pharmacological properties of anthocyanins are well studied both in vitro and in 
vivo and dietary consumption has been associated with a reduced risk of developing 
CVDs, type 2 diabetes, cancer, inflammatory bowel disease and many other non-
communicable diseases (discussed in Chapter 1.6). Butelli’s transgenic, anthocyanin-
enriched tomatoes significantly prolonged the lifespan of cancer-prone Trp53
-/-
 mice by 
delaying or slowing down the onset of the disease. These observations provided strong 
evidence that nutritional enhancement of food crops through plant metabolic 
engineering is a promising and effective strategy to deliver health-promoting 
compounds and combat dietary-related chronic diseases.  
 
How anthocyanins exert their health-promoting effects remains unclear. Most 
compounds appear to modulate signalling and regulatory pathways implicated in 
disease development and progression but there is mounting evidence that they may 
interact directly with the DNA through modulation of epigenetic modifications. Little is 
known however, about the impact of structural variation of individual compounds on 
the biological activity of these compounds and how the food matrix affects their 
bioavailability and efficacy in vivo. 
 
I used metabolic engineering to develop new tomato lines that accumulate mono- and 
dihydroxylated anthocyanins in their fruit which would allow us to compare the 
biological activity of different structural classes of anthocyanins to the trihydroxylated 
anthocyanins of the purple tomatoes in the physicochemical environment of the same 
food matrix. The transcriptional regulators Delila and Rosea1, which control 
anthocyanin biosynthesis in the flowers of A. majus, successfully activated the 
production of trihydroxylated anthocyanins in  Del/Ros1 tomatoes (Butelli et al., 2008). 
Substrate specificity of tomato DFR for DHM impeded the formation of mono- and 
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dihydroxylated anthocyanins in Del/Ros1 tomato fruit. I demonstrated that inhibition of 
F3’5’H and introduction of a substrate-independent DFR from A. majus could induce 
accumulation of pelargonidin- and cyanidin-type anthocyanins in tomato fruit of 
AmDfr/Del/Ros1/f3’5’h-/-. The total amount of anthocyanins accumulated by the 
AmDfr/Del/Ros1/f3’5’h-/- line was, however 2.5 fold below that of the delphinidin-
accumulating Del/Ros1 line. I hypothesised that failure of Del and Ros1to upregulate 
f3’h activity in the flesh of AmDfr/Del/Ros1/f3’5’h-/-significantly was responsible for 
the low level accumulation of cyanidins and the presence of pelargonidins in the fruit 
flesh. 
 
In order to generate tomato plants accumulating only monohydroxylated anthocyanins, I 
concomitantly inhibited F3’H and F3’5H activity using f3’h RNAi and the f3’5’h 
mutation, which resulted in plants that failed to self-pollinate and develop fruit. The a 
mutant, which lacked F3’5’H activity, was characterised by a reduced amount of fruit 
development compared to WT plants. The observation that inactivation of F3’5H 
reduced fertility and loss of both F3’H and F3’5’H resulted in infertile plants suggested 
that these structural enzymes are involved gametogenesis or pollen tube formation. The 
engineering of a tomato line that produces only monohydroxylated anthocyanins may 
not be possible, if the activity of F3’H is an essential requirement for fruit development. 
 
 
5.2 Accumulation of anthocyanins enhanced the health benefits of 
tomatoes 
The novel anthocyanin tomato line, AmDfr/Del/Ros1/f3’5’h-/-, accumulated, however, 
substantial amounts of predominantly monohydroxylated anthocyanins. The comparison 
with the Del/Ros1 tomato line revealed that fruit extracts of both anthocyanin tomato 
lines induced alterations in the cell cycle and strong proapoptotic effects by activating 
proapoptotic caspases in the human breast cancer cell lines, MCF-7 and MDA-MB-231. 
Extracts of WT tomato fruit had no biological effects on the breast cancer cell lines 
suggesting that the anthocyanins, possibly in synergy with other compounds in the 
extracts of Del/Ros1 and AmDfr/Del/Ros1/f3’5’h-/-, exerted the tumoricidal effects. 
Treatment with purified dietary supplements such as rutin, delphinidin-3-glucose, and 
anthocyanins purified from Del/Ros1 tomato fruit had little or no effect on the metabolic 
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activity of MCF-7 and MDA-MB-231 cells. These findings indicate that 
phytochemicals such as anthocyanins are more effective in the physicochemical 
environment of the food matrix, where their biological effects are potentiated through 
interaction with other compounds. A number of studies have reported reduced 
biological effects of dietary supplements compared to their whole food sources (Prior et 
al., 2008, Titta et al., 2010). The complex interactions between the constituents of food 
that might explain the potentiating effects of the food matrix on the biological activity 
of anthocyanins and other phytonutrients remain to be elucidated. It is possible that 
other components in the food matrix enhance the uptake or tissue delivery of poorly 
bioavailable compounds such as anthocyanins. On their own, these different dietary 
compounds may have only weak biological activity, but by acting on multiple targets in 
the disease pathway their combinatorial effects could be much more powerful. Since 
phytonutrients such as anthocyanins are always consumed in foods, it is important to 
define their bioactivities within the context of the food matrix. Anthocyanins in berry 
extracts, for example, may not have the same bioactivity as anthocyanins in tomato 
extracts, which could explain much of the incoherent and inconclusive results from 
epidemiological studies that investigated general dietary patterns rather than individual 
food groups. 
 
Supplementation of WT tomato extract, which did not display anti-cancer activity, with 
purified anthocyanins should be performed to test the hypothesis that the food matrix 
and its different components impact the biological effects observed with the high-
anthocyanin tomato lines. If anthocyanin-supplemented WT tomato extracts exerted 
stronger biological activity than purified anthocyanins, this would provide evidence that 
food matrix components are implicated in the strong biological effects observed with 
the high-anthocyanin transgenic tomato extracts. 
 
 
5.3 How can plant metabolic engineering contribute to human 
nutrition and health? 
Many chronic, non-communicable diseases have been associated with the dietary and 
habitual changes of a modern Westernized lifestyle. Global incidences of cancer, CVDs 
and type 2 diabetes are highest in Westernized cultures and on the rise in emerging 
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economies as they adopt a Westernized lifestyle. Lack of exercise and an unhealthy diet 
have been identified has the leading factors behind the global obesity epidemic and are 
associated with most cases of CVDs and certain types of cancer. The 5-a-day campaign, 
that was introduced to raise awareness for the benefits of a healthier diet and increase 
intake of fruit and vegetables (Foerster et al., 1995), has, so far, failed to significantly 
promote healthier eating behaviour across all population groups.  
 
Access to large amounts of different fruit and vegetables that would naturally deliver 
these bioactives may be difficult for certain population groups and in many countries 
due to the inaccessibility or high costs associated with them. Malnutrition and 
deficiency in micronutrients and phytochemicals can be significantly reduced through 
biofortification of popular crop species such as maize, rice, wheat, potato and tomato 
using plant metabolic engineering (Zhao and Shewry, 2011). Plant metabolic 
engineering is a powerful tool that can be used to increase the amount of specific 
bioactive compounds through upregulation or activation of metabolic pathways (e.g. 
golden rice, high-flavonol or high-carotenoid tomatoes).  
Advances in the fields of pharmacology and epidemiology investigating the 
mechanisms that govern the biological effects of phytonutrients and understanding of 
the relationship between dietary habits and the prevalence of certain non-communicable 
diseases should be considered in future crop improvement strategies. A concerted 
approach using evidence from clinical studies, nutrition and pharmacology is required 
to develop novel crop species that meet the nutritional demands of future generations 
and deliver appropriate amounts of the compounds that are important for maintaining 
and promoting health. 
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Chapter 2 related: 
 
Tomato transformation growth media and supplements 
Regeneration medium contained 1x MS salts, myo-inositol 100 mg/L, 1x Nitsch's 
vitamins, Sucrose 20 g/L, Agargel 4 g/L and was adjusted to pH 6.0 with KOH. After 
autoclaving the shoot-inducing cytokinin trans-zeatin riboside was added to the medium 
at 2mg/L. The antibiotics, augmentin and kanamycin, were added at 500 µg/mL and 100 
µg/mL, respectively, to select for the T-DNA transformation markers. 
 
Table 2.1: Nitsch's Vitamins composition and concentration   
Compound Final concentration mg/L 1000x stock (mg/100ml) 
Thiamine 0.5 50 
Glycine 2.0 200 
Nicotinic acid 5.0 500 
Pyridoxine HCl 0.5 50 
Folic acid 0.5 50 
Biotin 0.05 5 
 
 
Shooting medium contained 0.5x MS medium, Sucrose at 5g/L, Gelrite at 2.25g/L and 
was adjusted to pH 6.0 with KOH. The antibiotics, timentin at 320 mg/L and kanamycin 
at 50 mg/L, were added to the medium to kill the Agrobacterium and select for 
transformed shoots, respectively. 
 
 
